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Abstract
Microvascular endothelial cells were isolated from the brain and lung tissue of C57 
mice establishing a model for studies concerning the functional and behavioural 
diversity of these cells. Brain microvascular endothelial cells were isolated and 
cultured using a modification of published methods. A novel procedure was developed 
for the isolation and purification of lung microvascular endothelial cells. The isolation 
and culture techniques for lung derived cells were extensively developed in order to 
overcome the difficulties encountered in obtaining pure microvessel fragments. In the 
modified technique, the whole lung tissue was perfused in situ and the pleural 
membrane devitalised; the peripheral lung tissue was homogenised, digested with 
collagenase/dispase, and the isolated microvessel fragments were purified by Percoll 
gradient centrifugation and differential plating. The cells were successfully cultured on 
collagen coated culture wells in Ham's F-10 culture medium supplemented with 
endothelial cell growth factors, maintaining their differentiated characteristics.
Lung and brain microvessel cultures were characterised by morphological and 
immunocytochemical studies using light and electron microscopy. Lung microvascular 
endothelial cells grew as colonies of polygonal shaped cells while brain endothelial 
cells grew as colonies of spindle shaped cells which formed typical contact-inhibited 
monolayers. In order to enhance culture purity, the lung derived cell colonies were 
selectively cloned forming contact-inhibited monolayers. Brain and lung microvascular 
endothelial cells had the ability to express von Willebrand factor, accumulate 
fluorescently labelled acetylated low density lipoprotein (Bo-Ac-LDL) and provide a 
non-thrombogenic surface to platelets. In addition, lung derived cells formed capillary­
like structures on Matrigel confirming their endothelial origin.
Binding studies conducted at 4°C and 37°C using an analogue of a-Melanocyte 
stimulating hormone, [125I-Tyr2, Nle4 D-Phe7] a-MSH, indicated that a small 
population of melanocortin receptors was expressed on the surface of brain but not lung 
microvascular endothelial cells. The existence of a specific binding site for a-MSH on 
brain endothelial cells was confirmed by photoaffinity labelling with [1251-Tyr2, Nle4, 
D-Phe7, ATB-Lys11] a-MSH and SDS-PAGE analysis. This study provides a valuable 
insight into the isolation, culture and characterisation of organ-derived microvascular 
endothelial cells.
To
Mum and Dad 
Julie, Clayton and "Junior" Hardisty 
and




I would like to thank my supervisors Dr Steve Moss, Dr Sarah Branch and Dr Lidia 
Notarianni for their constant support and encouragement throughout this thesis and Dr 
Colin Pouton for his assistance and advice. I would also like to thank Dr George Olivier 
for synthesising the peptides used in this work and Dr Abdu Ahmed for his help with the 
photoaffinity labelling studies. I would like to thank Liz Roberts for her help with the 
statistical analysis of the data and Ulrike Sahm for all her help particularly with binding 
studies. I would like to thank my friends in Scotland for their support and 
encouragement and all my friends from Bath especially Lisa Sidoli, Nick Noble, Andy 
Richards, Philippa Coates, Caron Challinor, Joanne Peart and in particular Catrin and 
John Lord for making my years in Bath so much fun. In addition, I would like to thank 
the technicians in the Department of Pharmacy and Pharmacology for their advice and 
assistance. Finally, I would like to thank the S.E.R.C for the financial support and the 
University of Bath for providing the research facilities.
Abbreviations
APS Ammonium persulphate
ACE Angiotensin converting enzyme
Ac-LDL Acetylated low density lipoprotein
ACTH Adrenocorticotrophic hormone
BSA Bovine serum albumin
BAEC Bovine aortic endothelial cells
CPM Counts per minute




DMEM Dulbecco's modified eagles medium
DAB 3-3' Diaminobenzedine tetra hydrochloride
EDTA Ethylenediaminetetraacetic acid
ECM Extracellular matrix
ECGS Endothelial cell growth supplement
ELAM-1 Endothelial leukocyte adhesion molecule-1
aFGF acidic Fibroblast growth factor
bFGF basic Fibroblast growth factor
FCS Foetal calf serum
FAB-MS Fast atom bombardment-mass spectrometry
GS-1 Griffonia simplicifolia-1
HUVEC Human umbilical vein endothelial cells
HBSS Hanks balanced salts solution
HMEC-1 Human microvascular endothelial cell line-1
HEPES 4-(2-hydroxyethyl)-1 -piperazineethanesulphonic acid
HBT Hepes buffered tyrode
HPLC High performance liquid chromatography
ICAM-1 Intercellular adhesion molecule-1
ICAM-2 Intercellular adhesion molecule-2
IL-1 Interleukin-1
Lu-ECAM-1 Lung-endothelial cell adhesion molecule-1
LDL Low density lipoprotein
MSH Melanocyte stimulating hormone





NEAA Non essential amino acids
PAEC Porcine aortic endothelial cells
PEC AM-1 Platelet-endothelial cell adhesion molecule-1
PDS Plasma derived serum
PPHS Platelet poor human serum
PDGF Platelet derived growth factor
PD-ECGF Platelet derived-endothelial cell growth factor
POMC Pro-opiomelanocortin
PCR Polymerase chain reaction
PBS Phosphate buffered saline
p g i2 Prostaglandin2
RDGF Retinal derived growth factor
SDS Sodium dodecylsulphate
SDS-PAGE Sodium dodecylsulphate polyacrylamide gel electrophoresis
SEM Scanning electron microscopy
TNF Tumour necrosis factor
TGF-P Transforming growth factor-P
TLCK tosyl-lysine-chloromethyl-ketone
TFA Trifluoroacetic acid
TEM Transmission electron microscopy
UEA-1 Ulex europeaus-1
VEGF Vascular endothelial growth factor
v/v volume for volume





















1.1.1 Distribution of Endothelial Cells........................................................... 2
1.1.2 Microvascular Endothelial Cell Structure..............................................3
1.1.3 Endothelial Cell Functions.....................................................................7
1.1.4 Large Vessel Endothelial Cell Culture....................................................14
1.1.5 Microvessel Endothelial Cell Culture......................................................17
1.1.6 Isolation Techniques...............................................................................18
1.1.7 Separation Techniques........................................................................... 23
1.1.8 Cell Culture Conditions.......................................................................... 26
1.1.9 Growth Factors.......................................................................................28
1.1.10 Extracellular Matrix............................................................................ 31
1.1.11 Methods of Characterisation................................................................32
1.1.12 Microvascular Endothelial Cell Lines.................................................. 35
1.1.13 Blood-Brain Barrier............................................................................ 37
1.1.14 The Melanotropins............................................................................... 38
1.1.15 a-Melanocyte Stimulating hormone: Structure and Functions 38
1.1.16 Melanocortin Receptors.......................................................................39
1.1.17 Aims and Scope................................................................................... 41
2. GENERAL MATERIALS AND METHODS.............................................................42
2.1 Cell Culture......................................................................................................... 43
2.1.1 Culture of Cell Lines.............................................................................. 43
2.1.2 Cell Culture Medium and Solutions....................................................... 43
2.1.3 Equipment..............................................................................................45
2.1.4 Cell Culture Methods............................................................................. 47
2.2 Primary Culture................................................................................................... 51
2.2.1 Primary Culture of Murine Brain and Lung Microvascular 
Endothelial Cells..................................................................................................................51
2.2.2 C57 Mice................................................................................................ 51
2.2.3 Buffer and Stock Solutions.....................................................................51
2.2.4 Preparation of a Percoll Gradient............................................................53
2.2.5 Preparation of Collagen Coated Plates................................................... 53
2.2.6 Equipment..............................................................................................54
2.2.7 Primary Culture Medium and Supplements............................................ 55
2.2.8 Growth of Cells on Filter Membranes.................................................... 57
3. PRIMARY CULTURE OF MURINE LUNG MICROVASCULAR 
ENDOTHELIAL CELLS................................................................................................. 58
3.1 Introduction........................................................................................................ 59
3.2 Materials and Methods........................................................................................60
3.2.1 Preliminary Isolation Technique.............................................................60
3.2.2 Variations in the Isolation Technique..................................................... 61
xi
3.2.3 Culture Conditions: Substrata and Extracellular Matrices...................62
3.2.4 Culture Conditions: Medium, Serums and Growth Factors..................63
3.2.5 The Final Method for the Isolation and Culture of Murine Lung 
Microvascular Endothelial Cells........................................................................................ 64
3.2.6 Cell Purity...............................................................................................66
3.3 Results................................................................................................................ 68
3.3.1 Preliminary Isolation and Culture...........................................................68
3.3.2 Lung Microvascular Endothelial Cell Growth and Morphology............78
3.4 Discussion.......................................................................................................... 91
4. PRIMARY CULTURE OF MURINE BRAIN MICROVASCULAR 
ENDOTHELIAL CELLS................................................................................................96
4.1 Introduction........................................................................................................ 97
4.2 Materials and Methods........................................................................................98
4.2.1 Isolation and culture of murine brain microvascular endothelial cells.... 98
4.2.2 Cell Purity............................................................................................... 100
4.2.3 Growth rates........................................................................................... 101
4.3 Results............................................................................................................... 103
4.3.1 Brain Microvascular Endothelial Cell Isolation and Culture.................. 103




5.2 Materials and Methods........................................................................................ 121
5.2.1 Light and Electron Microscopy.............................................................. 121
5.2.2 Uptake of Acetylated Low Density Lipoprotein..................................... 123
5.2.3 Expression of von Willebrand factor.......................................................124
5.2.4 Platelet Adhesion....................................................................................126




5.3.3 Acetylated LDL Uptake......................................................................... 140
5.3.4 Expression of von Willebrand factor.....................................................144
5.3.5 Platelet Adhesion Studies....................................................................... 147
5.3.6 In vitro Angiogenesis by Lung Microvascular Endothelial Cells
Grown on Matrigel..............................................................................................................150
5.4 Discussion............................................................................................................153
6. BINDING OF [125I-TYR2, NLE4, D-PHE7] a-MSH TO MURINE BRAIN 
MICROVASCULAR ENDOTHELIAL CELLS............................................................ 158
6.1 Introduction.........................................................................................................159
6.2 Materials and Methods........................................................................................160
6.2.1 Synthesis of [Nle4, D-Phe7] a-MSH.......................................................160
6.2.2 Iodination of [Nle4, D-Phe7 ] a-M SH.....................................................160
6.2.3 Binding of [125I-Tyr2, Nle4, D-Phe7] a-MSH at 4°C .............................163
6.2.4 Binding and Uptake of [125I-Tyr2, Nle4, D-Phe7] a-MSH at 37°C.........163
6.3 Results.................................................................................................................165
6.3.1 Iodination of [Nle4, D-Phe7] a-MSH......................................................165
6.3.2 Binding of [125I-Tyr2, Nle4, D-Phe7] a-MSH at 4°C .............................165
6.3.3 Binding and Uptake of [125I-Tyr2, Nle4, D-Phe7] a-MSH at 37°C.........176
6.4 Discussion............................................................................................................179
7. PHOTOAFFINITY LABELLING OF MURINE BRAIN
MICROVASCULAR ENDOTHELIAL CELLS............................................................184
7.1 Introduction....................................................................................................... 185
7.2 Materials and Methods.......................................................................................186
7.2.1 Synthesis of [Nle4, D-Phe7, ATB-Lys11] a-M SH ................................... 186
7.2.2 Iodination of [Nle4, D-Phe7, ATB-Lys11] a -M S H ................................. 186
7.2.3 Photoaffinity Labelling of Brain microvascular Endothelial Cells 186
7.3 Results................................................................................................................191
7.4 Discussion...........................................................................................................193
8. GENERAL DISCUSSION.......................................................................................... 195
REFERENCES.................................................................................................................. 201
xiv
1. In t r o d u c t io n
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1.1. Introduction
Endothelial cells are the most widely distributed cell type in the body forming a single, 
continuous cell layer which lines the blood vessels of the entire vascular system. It is 
now widely accepted that the function of endothelial cells is not simply as an inert barrier 
lining. Due to its strategic position at the interface between the blood and the tissue, the 
endothelium plays a vital role in the maintenance of homeostasis and the control of many 
other events in vascular biology. Studies conducted over the past 30 years have 
identified a diverse range of structures and functions of the endothelial cell layer in 
normal activities and diseases. Differences in the functional activities of the microvessels 
have been shown to exist between various organs and tissues and these diverse activities 
are paralleled by the structural variations of the microvascular endothelium (Simionescu 
and Simionescu 1984; Wagner 1988; Ryan 1989).
The work in this thesis has involved the isolation, culture and characterisation of pure 
cultures of organ derived microvascular endothelial cells from murine tissues, and the 
investigation of a receptor mediated pathway for the uptake of a-melanocyte stimulating 
hormone on these cells. The introduction will describe the structure and functions of 
endothelial cells and the problems associated with isolating, maintaining and 
characterising pure microvascular endothelial cells in culture. The functions of the 
melanotropins and melanotropin receptors, and finally the aims of this project will be 
briefly described.
1.1.1. Distribution of Endothelial Cells
Three categories of endothelium have been determined based on variations in the 
continuity of the endothelium and its basement membrane: continuous; fenestrated and
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discontinuous (sinusoidal) endothelium. The continuous endothelium is the most widely 
distributed in mammalian tissues, it occurs in large vessels, arterioles, most venules of 
skeletal, heart and smooth muscles, lung, brain, skin, subcutaneous tissue, sinus and 
mucous membranes.
Fenestrated endothelial cells are found in organs whose functions require a high rate of 
fluid exchange (Taylor and Granger 1984), this includes the intestinal mucosa, exocrine 
and endocrine glands and the glomerular and peritubular capillaries of the kidney. These 
cells display circular openings known as fenestrae which usually occur in clusters at 
irregular intervals and are commonly closed by a thin diaphragm possibly derived from 
the basal lamina.
The distribution of discontinuous endothelial cells is more restricted than other 
endothelial cell types: they are found predominantly in the liver, spleen and bone marrow 
and are characterised by their lack of basement membrane (Simionescu and Simionescu 
1984; Malik and Siflinger-Bimboim 1993).
1.1.2. Microvascular Endothelial Cell Structure
The components of the microvascular wall are dynamic features able to facilitate many 
physiological activities such as permeability, transport, uptake, synthesis and metabolism 
of many substances. The microvessel wall is a composite of various parallel layers of 
different composition and function: the plasma-endothelial interface, endothelium, basal 
lamina and adventitia (Petrak and Goddard 1989). The unique position of the endothelial 
cell is such that the luminal face is directly exposed to the blood, and the abluminal face 
is exposed to the interstitial fluid. The abluminal face is attached to the basal lamina 
which is produced by the endothelial cell itself; this in turn mediates contact with the 
surrounding tissues (Simionescu and Simionescu 1984).
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Endothelial cell surface
At the luminal face of the endothelial cell is the plasma membrane which, depending on 
the location within the tissue, coats open plasmalemmal vesicles, coated pits, 
transendothelial channels and fenestral diaphragms but is omitted from intercellular 
junctions. This endothelial cell coat is formed from a variety of membrane components 
including: plasma proteins, such as heparin; albumin and fibrin, which are adsorbed on to 
the luminal surface; glycoproteins; sialoglycoconjugates and proteoglycans, such as 
heparan sulphate. Together these membrane components constitute the plasma- 
endothelial interface.
The distribution of these membrane components varies in different organs as well as 
along the surface of the endothelium of the same organ; the plasma membrane is more or 
less prominent in areas such as the vesicles, transendothelial channels and fenestral 
diaphragms (Simionescu et al. 1981b; Simionescu et al 1982a). These membrane 
components may function as: 1) a sieving network; 2) a locally differentiated charge 
barrier generated by preferential distribution of the different components; and 3) specific 
binding sites and receptors for molecules undergoing endocytosis and transcytosis, with 
some of these components being continuously active while others require stimulus.
The endothelial cell surface, vesicles, channels and fenestrae exhibit microdomains of 
different charge. The preferential distribution of the sialoglycoconjugates, proteoglycans 
and glycoproteins is related to the distribution of these differentiated microdomains 
throughout the endothelium. Electrophysiology studies (Sawyer and Srinivasan 1972) 
and studies involving charged tracers in situ (Skutelsky et al., 1975) and in vitro (Pelikan 
et a l, 1979) have shown that the endothelial cell surface has an overall negative charge 
although the anionic sites have a very refined distribution (Simionescu et al., 1981a).
The differentiated microdomains are involved in endocytosis and transcytosis across the 
capillary endothelium. In addition the combination of the molecular composition of the
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cell and the charge causes the endothelial cell to exhibit a non-thrombogenic surface. 
Concurrently, this effects the involvement of the endothelial cell surface in coagulation, 
anticoagulation and homeostasis (Simionescu and Simionescu 1986).
The endothelial cell surface also displays a number of receptors and binding sites 
including, those for histamine, lipoproteins, insulin (Hachiya et al., 1988), thrombin, 
transferrin (Jefferies et al., 1984) and albumin (Shasby and Shasby 1985). A variety of 
enzymes are also associated with the luminal surface of the microvascular endothelium 
such as angiotensin-converting enzyme (Ryan et al., 1976), Factor VIII (Jones et al., 
1981) and prostacyclin which also contribute to the diverse functions of the endothelium 
(Simionescu and Simionescu 1986; Ryan 1989).
Coated pits, plasmalemmal vesicles and transendothelial channels
Coated pits (diameter: ~80-120nm) and vesicles have been located on both endothelial 
surfaces , however they are more numerous on the luminal surface. They are found in 
most endothelial cell types, but particularly in the bone marrow sinusoids and endocrine 
tissues. In continuous and fenestrated capillaries coated pits and vesicles have high- 
affinity anionic sites however, in sinusoidal capillaries, both anionic and cationic sites are 
expressed (Simionescu and Simionescu 1984). High affinity receptors have also been 
located in coated pits, demonstrating their ability to take up specific macromolecules 
such as low-density lipoproteins (LDL) by receptor-mediated endocytosis (Vasile et al.,
1983).
Microvascular endothelial cells are particularly rich in spherical, membranous 
plasmalemmal vesicles (diameter: ~60-80nm). Of these vesicles, 70% appear on the 
luminal face enabling the actual surface area to increase two-fold, while the remaining 
30% of the vesicles are located within the cytoplasm. The density of these plasmalemmal 
vesicles depends on the organ in which they are located and the type of microvessel, the
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brain microvessels display the lowest vesicle density. Plasmalemmal vesicles are involved 
in endocytosis and transcytosis. In addition they fuse together to form transendothelial 
channels, which are also involved in membrane transport. Although transendothelial 
channels have been located in several types endothelia the morphology of these channels 
is different in continuous and fenestrated capillaries (Simionescu and Simionescu 1984).
Basement membrane, smooth muscle cells and connective tissue
The endothelium is supported by a basement membrane 5-8 nm thick, known as the basal 
lamina. It is composed of collagens (primarily types IV and V), laminin, glycoproteins 
and fibronectin all of which are produced by the endothelial cells themselves. The 
basement membrane is uninterrupted in continuous and fenestrated capillaries but 
discontinuous in sinusoids, in all cases forming a negatively charged barrier (Simionescu 
etal., 1982b).
The cells which are adjacent to the microvascular endothelium are the pericytes, they are 
surrounded by an endothelial cell basal lamina and are widespread in the 
microvasculature of most tissues (Shepro and Morel 1993). Smooth muscle cells along 
with the pericytes provide the contractile elements of the microvessel wall. Unlike 
pericytes which are found in the basal lamina, smooth muscle cells have their own 
basement membrane. However both of these cell types have discrete points of contact 
with the endothelium. The microvessel wall also contains elastic fibres, connective tissue 
consisting of components such as fibrils, mast cells and macrophages and nerves. These 
components fulfil a complex role providing varying degrees of support, production of 
vasoactive mediators and defence, according to the location of the microvessels.
Intercellular junctions
The endothelial cells in the microvascular endothelium are squamous endothelia, linked 
together by two types of intercellular junctions: occluding "tight" junctions and
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communicating "gap" junctions. These junctions are considered to be important in the 
regulation of the permeability of ions and small metabolites, and the maintenance of cell 
surface polarity. The tight junctions (zonula occludens) have been shown to exhibit 
high-resistance and are considered to seal the intercellular spaces between cells in both in 
vivo and in vitro studies (Larson and Sheridan 1982). These junctions are present in 
several types of endothelial cells and are especially prominent in brain vascular 
endothelium (Rutten et al., 1987). The variation of tight and gap junctional distribution 
and of gap junctional size (up to 6nm) throughout the microvasculature reflects the 
various degrees of tightness and permeability in different organs (Simionescu and 
Simionescu 1984; Franke etal., 1988).
1.1.3. Endothelial Cell Functions
The role of the endothelium extends to many more diverse functions in normal conditions 
and diseases such as: regulation of membrane transport and uptake; regulation of 
coagulation and fibrinolysis; synthesis and release of vasoactive hormones; participation 
in immune reactions and tumour cell adhesion and vascularisation. It is clear that the 
structural variations of the endothelium can account for the distinct functions of the 
endothelium of various organs and of specific regions within a single organ.
Selective membrane transport and uptake
One of the primary fimctions of the endothelium is to act as a semipermeable membrane 
through which fluids and solutes are transported, thereby controlling the plasma and 
extracellular fluid volume (Ryan 1989). Transport of substances such as water, ions, 
small lipid-soluble and lipid-insoluble molecules and large lipophilic and hydrophilic 
proteins occurs by diffusion, passive or active transport, endocytosis and transcytosis, 
(Vetvicka and Fomusek 1988; Renkin and Curry 1982). Several factors control the 
transport of plasma molecules across the vascular endothelium including: plasma and
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haemodynamic forces (hydrostatic and oncotic pressure forces); physicochemical 
properties of the molecules (molecular size, shape, charge and chemistry) and the 
properties of the endothelial cells themselves (surface charge, structure and site- 
specificity) (Renkin and Curry 1982; Simionescu and Simionescu 1984).
Molecules can be internalised into the cell by adsorptive or fluid-phase endocytosis. 
Alternatively molecules are transported across the cell to the interstitial fluid by non­
specific adsorptive, fluid-phase or receptor-mediated transcytosis (Simionescu 1988). 
Microvascular permeability was originally studied in vivo or in situ (Crone and Levitt
1984), however more recent studies performed in vitro have involved endothelial cells 
cultured on permeable filter membranes. This provides a rapid method of assessment of 
endothelial permeability and drug metabolism (Del Vecchio et al, 1987; Siflinger- 
Bimboim et a l, 1987; Shasby and Roberts 1987; Albelda et al., 1988). Further studies 
investigated the specific binding sites involved in receptor mediated transcytosis for 
several plasma components including albumin (Shasby and Shasby 1985; Ghitescu et a l, 
1986; Cooper et a l, 1987), insulin (Hachiya et a l, 1988), transferrin (Jefferies et a l, 
1984; Tavassoli 1988) and lipoprotein lipase (Saxena et a l, 1991).
The variations in the transport and permeability throughout the endothelium can be 
accounted for by the differences in the morphology of the vascular endothelium 
(Simionescu 1988). For each type of capillary endothelium, specific pathways have been 
designated which play a role in capillary transport; a schematic diagram of capillary 
endothelial transport is shown in Figure 1. The routes of transport that are thought to 
exist in the continuous capillary endothelium are 1) the transcellular pathway which 
transports water, small lipid soluble substances and respiratory gases; 2) the vesicular 
pathway whereby plasmalemmal vesicles carry plasma or interstitial fluids across the cell 
depending on the concentration gradient and the density of vesicles; 3) small and large 
"pore" pathways which may provide a continuous route across the cell and 4) 
transendothelial channels which are formed by the opening of two or more vesicles
8
simultaneously (Taylor and Granger 1984; Renkin 1988; Malik and Siflinger-Bimboim 
1993). Transport processes for fenestrated capillaries are the same as that of 
unfenestrated capillaries, in addition however, the unique features of the fenestrated 
capillary are also involved in transport processes. These features are open fenestrae 
where the basement membrane provides a restrictive barrier and diaphragmed fenestrae 
(Renkin 1988). Transport processes in discontinuous endothelial cells occurs via the 
vesicular pathway and endothelial gaps.
Figure 1. The endothelial cell layer: PM = plasma membrane; V = vesicle; CH =
transendothelial channel; F = fenestrae, J = endothelial cell junction, BM = 
basemant membrane. The transport processes: (1) = the vesicular pathway;
(2) = transendothelial channels; (3) = through fenestrated capillary endothelial 
cells; (4) = through gaps in discontinuous endothelial cell capillaries; (5) = 
transcellular pathway (modification of Simionescu and Simionescu 1984).
Coagulation and fibrinolysis
The endothelium plays an important role in homeostasis regulating the fluidity of the 
blood due to its involvement in anti-coagulation, fibrinolysis and pro-coagulation 
processes. Thrombomodulin (TM) is a transmembrane glycoprotein located on the 
endothelial cell surface, its main function is to bind the procoagulant protease thrombin 
changing its properties to result in the generation of anti-coagulant activity. The 
formation of this thrombin-TM complex activates the Protein C anti-coagulation 
pathway, decreasing clotting activity, Factor V activation and platelet activation.
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Activation of Protein C is in turn involved in the inactivation of Factors Va and Villa 
which are responsible for the anticoagulant effect (Esmon 1988; Ryan 1989; Ford 1992). 
Endothelial cells also produce heparin-sulphate and other heparin-like proteoglycans 
which act as anti-coagulants by binding to antithrombin III resulting in the inactivation of 
thrombin and Factor Xa (Marcum et. aL, 1988).
The fibrinolytic system is primarily involved in the dissolution of blood clots. This 
involves components such as plasminogen activators and plasminogen activator inhibitors 
which effect the conversion of the inactive proenzyme plasminogen into the active form, 
plasmin. It is the endothelium that synthesises and secretes these components of the 
fibrinolytic system, in addition it is likely that the endothelial cell surface and its 
extracellular matrix components contribute to the regulation of vascular fibrinolysis 
(Curriden e ta l, 1988).
Under normal conditions the endothelial cell provides a non-thrombogenic surface, 
responsible for the anti-coagulant mechanisms which prevent activation of coagulation 
and fibrin deposition on the vessel wall. In diseased states, however, endothelial cells 
become procoagulant when exposed to substances such as endotoxin, thrombin, 
interleukin-1 (IL-1) or tumour necrosis factor (TNF). As a result of these stimuli there is 
an increased synthesis and expression of thromboplastin by the endothelial cells which 
can initiate blood coagulation by activating Factor IXa and Xa. Factor Xa activates 
thrombin initiating the production of insoluble fibrin, activation of platelets and inhibition 
of fibrinolytic activity.
Synthesis and release o f vasoactive substances.
As described previously, endothelial cells express receptors and specific binding sites for 
a number of vasoactive substances such as angiotensin-converting enzyme (ACE) and 
prostacyclin. ACE activates the vasopressor hormone angiotensin II and inactivates
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bradykinin, thereby playing an important role in blood pressure regulation. The 
endothelial cell surface has been targeted as a site of drug therapy due to the accessibility 
of the blood stream to the endothelial surface receptors and binding sites.
Inflammation and immune reactions
Under normal conditions the endothelium is immunologically unreactive, however 
inflammatory conditions activate the vascular endothelium inducing a variety of 
reactions. These responses include synthesis and secretion of prostacyclin, endothelin, 
TNF and IL-1, expression of surface antigens and increased vascular permeability (Pober 
and Cotran 1990).
Endothelial cells have been shown to express a number of cell surface adhesion 
molecules. These molecules have a role in both inflammation and metastasis. In the 
event of inflammation for instance, lymphocytes specifically attach to the vascular 
endothelium at sites of inflammation. The lymphocytes subsequently migrate through the 
post-capillary venule wall into the inflamed tissue. It is the expression of cell adhesion 
molecules known as "homing receptors", which are activated by inflammatory cytokines 
such as IL-1 and TNF, that may pinpoint the position for these events to occur (Springer 
1990). Several endothelial cell adhesion molecules are thought to be involved in 
inflammation these include: Endothelial leukocyte adhesion molecule-1 (ELAM-1), 
Vascular cell adhesion molecule-1 (VCAM-1) and Intercellular adhesion molecules-1 and 
2 (ICAM-1 and ICAM-2). The role of these and other adhesion receptors in the immune 
system is reviewed by Springer (1990) and Pober and Cotran (1991). This lymphocyte 
trafficking has also been shown to occur around the venules in the central nervous 
system when immune reactions develop (Hughes et al., 1988). The system involved in 
lymphocyte adhesion to the brain endothelium however, is thought to be peculiar to brain 
endothelial cells regulating the traffic of lymphocytes across the blood-brain barrier 
(Male et al., 1990).
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Tumour cell adhesion
Metastasis is the spread of tumours cells throughout the body via the blood stream. This 
is thought to occur through a complex cascade system: tissue invasion, detachment of 
malignant cells, transport through blood vessels, extravasation and proliferation at a 
secondary site (Hart et a l, 1989). Cell adhesion plays an important role in the metastatic 
process. Malignant tumour cells adhere to specific sites on the endothelium, and their 
subendothelial matrix (basement membrane). The adhesion receptors function in three 
ways: 1) as cell-substratum adhesion receptors present on the basement membrane; 2) 
cell-cell adhesion receptors that promote contact between the junctions of adjacent cells 
of the same type and 3) cell-cell adhesion molecules on the luminal surface of the cell 
which are important in tumour cell adhesion (Albelda 1991).
Tumour cell adhesion to the extracellular matrices and basement membranes has been 
shown to occur mainly at the site of the glycoproteins of the integrin receptors. The 
integrin receptors are a family of cellular receptors including fibronectin and vitronectin 
receptors and very late antigen (VLA) which link the cell cytoskeleton with the 
extracellular matrix (Haynes 1987; Albelda et a l, 1989). Many tumour cells express 
integrin-like molecules at the cell surface and it is an alteration in these integrins and the 
integrin receptors on the extracellular matrix that is associated with cancer progression 
(Hart et a l, 1989; Lauri e ta l, 1991; Steeg 1992).
The tight junctions which exist between adjacent cells are mediated by specific adhesion 
molecules providing the characteristic permeability barrier. There are a number of cell­
cell adhesion molecules which function in this way, including cadherins which provide 
calcium dependant adhesion, integrins (Fawcett and Harris 1992) and immunoglobulins, 
including platelet-endothelial cell adhesion molecule-1 (PECAM-1) (Albelda et a l, 
1990). Initial in vitro and in vivo studies showed that some tumour cells attach to the 
endothelial cells at the junctional points resulting in endothelial cell retraction and 
adhesion of the tumour cell to the subendothelial cell matrix (Kramer 1982).
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Metastasis appears to be regulated by organ-specific adhesion molecules expressed on 
the luminal surface of endothelial cells. Experimental evidence to support this theory has 
shown that lung and liver-metastatic cells adhere preferentially to endothelial cells 
isolated from lung and liver respectively (Nicolson et al., 1989). Since then a lung 
specific endothelial cell adhesion molecule (Lu-ECAM-1) has been identified (Zhu et. at., 
1991 and 1992). It has been the use of membrane vesicles (Johnson et al., 1991) and the 
recent advances in microvascular endothelial cell isolation and culture which have 
enabled further more extensive studies to be conducted. The organ preference of 
metastasis has been reviewed by several investigators including Pauli et al. (1990) and 
McCarthy ef. al. (1991).
Angiogenesis
Angiogenesis, or the formation of new blood vessels, occurs in normal conditions, such 
as wound healing, as well as in disease states such as atherosclerosis (Ross and Harker 
1976), inflammation (Pober and Cotran 1990) and tumour growth (Folkman and 
Klagsbum 1987; Folkman 1990). In tumour angiogenesis, vessels sprout from the pre­
existing circulatory system towards the tumour site. The first step in this process is the 
dissolution of the basement membrane of the post-capillary venule. Following this, the 
endothelial cells migrate towards the tumour and undergo cell division. Thereafter the 
developement of three-dimensional tube-like structures, vascular loops and a basement 
membrane occurs which eventually results in the development of a vascular bed (Blood 
and Zetter 1990).
Angiogenesis can be induced by a variety of factors including basic and acidic fibroblast 
growth factors (FGF's), TNF and angiogenin. FGF's and TNF modulate endothelial cell 
growth directly, unlike angiogenin which is produced by the tumour (Fett et. a l, 1985). 
Angiogenesis in vitro was initially studied by Folkman and Haudenschild (1980). They 
showed that capillary endothelial cells alone formed tube-like structures without the
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involvement of mast cells and pericytes which are associated with the capillary 
endothelial cell in vivo. Since this original study a variety of approaches of studying 
angiogenesis have been investigated in vitro, especially those concerning the effect of the 
extracellular matrix and growth factors on angiogenesis (Jackson and Jenkins 
1991;Vlodavsky etal., 1991; Kowalczyk and McKeown-Longo 1992).
1.1.4. Large Vessel Endothelial Cell Culture
Isolation and culture
The first studies into the structural and functional properties of endothelial cells which 
were limited to ultrastructural analysis in vivo and were conducted by several 
investigators including Weibel and Palade (1964). This was due to the difficulties 
encountered in isolating, identifying and maintaining pure cultures of endothelial cells in 
vitro. The techniques involved in the isolation and culture of large vessel endothelial 
cells were developed by a number of investigators. Human umbilical vein endothelial 
cells (HUVEC) (Jaffe et al., 1973a; Gimbome et al., 1974) and bovine aortic endothelial 
cells (BAEC) (Booyse et al., 1975) were isolated in these original studies.
Endothelial cells were isolated by collagenase digestion and cultured in media containing 
very high concentrations of foetal calf serum (-20-35%). The growth properties of the 
cultures were studied extensively using techniques such as DNA synthesis, [3H] 
thymidine incorporation and cell proliferation studies in which cells were counted with a 
haemocytometer chamber. Culture conditions were modified in order to obtain optimum 
growth whilst maintaining the characteristic cell morphology in primary culture and 
subculture. Each group of researchers however, modified the isolation technique and 




Endothelial cells were identified initially by phase contrast light microscopic studies of 
the cell morphology. Studies showed that endothelial cells adhered to the substratum as 
small clusters of polygonal cells which grew into a single cell-thick confluent monolayer 
where they showed a characteristic "cobblestone" morphology. Differentiation between 
endothelial cells and non-endothelial cell contaminants, particularly smooth muscle cells 
and fibroblasts, was also possible by light microscopy. Fibroblasts grew as long slender 
cells forming whirling patterns and overlapping layers (Jaffe et al., 1973a) and smooth 
muscle cells grew with a multi-layered characteristic "hill and valley" effect (Ross 1971; 
Chamley et al., 1977).
Cell morphology was examined further using scanning and transmission electron 
microscopy. The ultrastructure of cultured endothelial cells showed that the cytoplasm 
contained a large number of vesicles, prominent Golgi bodies, mitochondria, large 
quantities of smooth and rough endoplasmic reticulum, fine filaments and clusters of 
ribosomes. In addition the cytoplasm contained oval-shaped bodies first described by 
Weibel and Palade (1964). These Weibel-Palade bodies are peculiar to endothelial cells 
and were found in abundance in human umbilical vein endothelial cells (Jaffe et a l , 
1973a; Gimbome et a l, 1974). Although their presence was detected in bovine aortic 
endothelial cells, they were not as abundant as described in human umbilical vein 
endothelial cells (Schwartz 1978).
Original immunofluorescent studies demonstrated the presence of blood group antigens 
(Jaffe et a l, 1973a) and Von Willebrand factor (Jaffe et a l, 1973b; Booyse et a l, 1975) 
exclusively on endothelial cells. Following these early studies, the isolation, culture and 
characterisation techniques of large vessel endothelial cells have become well established. 
A wide variety of studies have been conducted using cultured endothelial cells in order to 
elucidate the structural and functional properties of the endothelium in health and 
diseased states. These include the effects of altering the culture conditions (Schlor et a l,
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1983), extracellular matrix (Young and Herman 1985) and the influence of growth 
factors (Vlodavsky et a l, 1979; Gospodarowicz 1990; Sutton al, 1991). Endothelial 
cells have also been used in permeability and transport studies (Albelda et a l, 1988; 
Ming-Liu et al., 1993; Alexander et a l, 1993) and investigations concerning the role of 
endothelial cells in inflammation (Cozzolino et al., 1990; Klein et al., 1992).
Alternative large vessel endothelia
As well as BAEC's and HUVEC, large vessel endothelial cells have been isolated from 
several different species and tissues. Porcine aortic endothelial cells (PAEC) were first 
isolated and characterised by Slater and Sloan (1975). The porcine cardiovascular 
system has been shown to possess many similarities to that of human, therefore cells 
isolated from porcine tissue provide a suitable alternative to HUVEC. Porcine 
endothelial cells are also useful in studies connected with atherosclerosis, as older pigs 
develop spontaneous aortic atherosclerotic plaques, thus providing a suitable 
experimental model for atherosclerosis (Rosenthal and Gotlieb 1990).
Large vessel endothelial cells have also been isolated from bovine and porcine pulmonary 
arteries. This has provided a useful model for studying endothelial cell functions in the 
lung. Studies have, for example, investigated the interactions of neutrophils and 
pulmonary endothelial cells with respect to vascular injury (Dodek et a l, 1990) and 
pulmonary artery permeability and transport mechanisms (Shepard et a l, 1989; Siflinger- 
Bimbiom et al 1991).
Variations exhibited by endothelial cells
Differences have been shown to exist between aortic endothelial cells isolated from 
different species. For example a feature typical of porcine aortic endothelial cells is their 
lack of ability to exhibit Von Willebrand factor or Weibel-Palade bodies which are 
characteristic of BAEC and HUVEC (Rosenthal and Gotlieb 1990). As well as species
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variations, differences have been reported to exist between large vessel endothelial cells 
isolated from various sites in the vasculature. These include the density of insulin 
receptors (Bar and Sandra 1988), types of intercellular junctions (Simionescu et a l, 
1976) and production of angiotensin-converting enzyme (Johnson 1980).
Since the early 1970's the structural and functional properties of large vessel endothelial 
cells have been extensively investigated, as these cells are easy to obtain and can be 
readily isolated and maintained in long-term culture. Species and site specific variations 
have been shown to exist in large vessel endothelial cells, however the comparison 
between large and microvessel endothelial cells was impeded due to the difficulty of 
isolating and maintaining pure cultures of microvessel endothelial cells.
1.1.5. Microvessel Endothelial Cell Culture
Organ-derived microvascular endothelia
As shown previously, the structural and functional properties of microvascular 
endothelial cells are heterogeneous. The phenotypic diversity of these cells from 
different tissues within an organism, as well as within different vascular beds, has opened 
up the study of endothelial cell biology. Since the importance of the microvasculature 
was established a number of investigators have attempted to isolate and maintain pure 
microvessel cultures from a variety of sources. Not only were microvascular endothelial 
cells isolated from different tissues but also different species:
1). Adrenal cortex: bovine (Folkman et a l , 1979; Voyta et al., 1984; Orlidge 
and D'Amore, 1987; Alessandri et. a l , 1992) and human (Folkman et al., 1979).
2). Skin: human (Davidson and Karasek 1981; Braverman 1989; Jackson et al., 
1990; Beitz et al., 1991).
3). Epididimal fat pads: rat (Madri et al., 1983; Williams et al., 1984).
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4). Heart: murine (Haisch et a l, 1990), rat and human (Nishida et a l, 1993).
5). Retinal: bovine (Gitlin and D’Amore 1983; Schor and Schor 1986).
6). Hepatic sinusoidal: murine (Belloni et a l, 1992), rat (Soda and Tavassolli
1984), guinea pig (Shaw et a l, 1984).
7). Ovary: murine (Auerbach et a l, 1985).
8). Lung: Bovine (Chung-Welch et a l, 1988; Ryan and White 1986; Del 
Vecchio et a l, 1992), human (Hewett and Murray 1993) rat (Ryan and White 
1986) and murine (Chopra et al., 1990; Belloni et al., 1992)
9). Brain: bovine (Bowman etal., 1983; Audus and Borchardt, 1986; Carson 
and Haudenschild 1986; Beer Stolz and Jacobson, 1991), rat (Hughes and 
Lantos, 1986; Rupnick etal., 1988; Abbott e ta l,  1992), human (Dorovini-Zis et 
al., 1991), porcine (Tontsch and Bauer 1989) and murine (Tontsch and Bauer 
1989; Belloni et al., 1992).
1.1.6. Isolation Techniques
For the isolation of organ-derived microvascular endothelial cells from different species, 
there is a wide range of materials and techniques involved in the isolation procedure. 
The isolation of microvascular endothelial cells basically requires two steps: 1) 
dissociation of the blood vessels from the surrounding tissue components and 2) 
separation of the blood microvessel fragments from large vessels and non-endothelial cell 
contaminants.
The techniques have been modified by the researchers in order to obtain the optimum 
conditions for the isolation of organ and species specific microvascular endothelial cells, 
that is, isolating the maximum number of microvascular endothelial cells whilst keeping 
non-endothelial cell contaminants to a minimum. Isolation procedures need to vary
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taking into account the amount of connective tissue and the ratio of microvessels to large 
vessels in the particular type of tissue, however differences also exist in the isolation 
procedures of the same type of tissue by different groups of researchers. Although 
several groups of workers have reported the isolation and culture of microvascular 
endothelial cells from various sources, some of the techniques used suggest that 
contamination with a variety of non-endothelial cells is inevitable.
Pre-treatment and dissection o f the tissue
Pre-treatment of the tissues in situ and in vitro has been utilised in order to remove 
blood cells from the tissue. When isolating murine lung microvessels Belloni et al.y
(1992) perfused the right ventricle of the heart with heparin to remove blood cells from 
the pulmonary circulation, this was followed by perfusion with 0.1% collagenase/dispase 
to initiate separation of the blood vessels from the connective tissue. Nishida et a l
(1993) used retrograde perfusion of rat heart tissue with oxygenated Krebs Henseleit 
bicarbonate buffer to remove the blood cells.
Isolation of microvascular endothelial cells from the lung and heart have the additional 
problem of mesothelial cell contamination. Mesothelial cells are a simple squamous cell 
type that covers the surfaces exposed to the inner body cavities, including the pleural 
membrane of the lung and the pericardium (Rheinwald 1989). These cells are not 
distinguishable from microvascular endothelial cells in culture using conventional 
characterisation methods (discussed in section 1.1.11). With lung and heart tissue from 
human or large animals the pleural membrane and pericardium can be removed manually 
(Chung-Welch et al., 1988; Hewett and Murray 1993; Nishida et al., 1993). However 
this is not physically possible in tissue obtained from small animals. Mesothelial cells can 
be devitalised by very brief treatment with 70% ethanol (Chopra et al., 1990; Nishida et 
al., 1993), followed by washing extensively with a buffer solution.
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Careful dissection of the tissue can dramatically reduce the contamination of the culture 
by non-endothelial cells and large vessel endothelial cells. Removal of large vessels from 
the tissue is an important step in reducing contamination by large vessel endothelia 
(Madri et al., 1983; Nishida et al., 1993). With lung tissue it is important to select the 
peripheral section of the lung as this avoids large vessels and therefore possible 
contamination (Chopra et a l, 1990; Hewett and Murray 1993).
For the isolation of brain microvessels the meninges and superficial blood vessels should 
be removed and also the mid- and hind-brain, the striatum, optic nerve and white matter 
(Bowman et al., 1983; Hughes and Lantos 1986; Audus and Borchardt 1986; Carson 
and Haudenschild 1986; Beer Stolz and Jacobson 1991; Abbott et al., 1992). Careful 
dissection at this stage reduces the possibility of contamination of cells such as 
astrocytes, pericytes, neurons and smooth muscle cells, although other separation 
techniques employed later in the isolation procedure and selective culture techniques also 
reduces contamination by non-endothelial cells.
Mechanical disruption o f the tissue
Mincing of the tissue using a scalpel, Dounce homogeniser, shearing using a glass pipette 
or other mechanical means are used to break up the tissue and release the microvessel 
fragments. This method of dissociation of the microvessels from the surrounding non- 
vascular tissue is usually accompanied by enzyme digestion.
Enzyme digestion
Enzyme dissociation of the capillary fragment separates the blood vessel from the 
basement membrane because of the high content of collagens on the microvascular basal 
lamina which can be digested by collagenase and other enzymes. Isolation of the 
capillary fragment can therefore occur by incubation with collagenase (Folkman et al., 
1979; Madri et al., 1983; Chung-Welch et al., 1988; Del Vecchio et al., 1992), a
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combination of collagenase with the neutral protease dispase, which has been reported to 
disperse fibroblasts to a single cell suspension without affecting the blood vessels 
themselves (Bowman et al., 1983; Zetter 1984; Abbott et al., 1992; Belloni et al., 1992) 
or with trypsin and EDTA (Davidson and Karasek 1981).
Several investigators have also used a combination of more than one of the above 
treatments: 1) The isolation of bovine brain microvascular endothelial cells by Audus 
and Borchardt (1986) used two enzyme digestion steps, the first involved incubation 
with 0.5% dispase at 37°C for 3 hours, and the second used lmg/ml collagenase/dispase 
for a further 5 hours at 37°C; 2). Nishida et a l, (1993) initially treated rat heart tissue 
with 0.2% collagenase for 30 minutes at 37°C, followed by incubation with 0.02% 
trypsin for a further 30 minutes at 37°C. However, they omitted the trypsinisation step 
when dealing with human heart. This perhaps gives some indication of the specialisation 
of the techniques required for isolation cells from different tissues as well as from 
different species.
The length of incubation with the enzyme solution, its concentration, and the 
temperature of incubation varies greatly between different groups of workers in the 
isolation of the cells from the same and different types of tissue and species. An isolation 
procedure which does not use enzyme digestion, or one which uses only a short 
digestion step, requires the endothelial cells to migrate out of the ends of a small segment 
of capillary fragment (Chopra et al., 1990). As a result of this, it would take longer to 
establish the cultures and heavier contamination with pericytes is also possible due to the 
incomplete removal of the basement membrane.
Longer dissociation times may be beneficial in producing purer cultures by actually 
minimising pericyte contamination. It has been suggested that endothelial cells do not 
appear to be affected by long incubations with proteases due to their low rate of 
endocytosis; pericytes however can internalise the enzymes and become damaged
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(Bowman 1990). Excessive disruption of the blood vessels with too high a 
concentration of collagenase or for an excessive duration, however, can result in the 
production of a suspension comprising primarily single microvascular endothelial cells, 
which generally show poor attachment and become non-viable in culture (Abbott et al.,
1992). The reason for the large range of incubation times, concentrations and types of 
enzyme used is unknown.
Isolation using "Dynabeads"
Human endothelial cells have the ability to bind selectively to the lectin Ulex europeaus 1 
(UEA-1) via the a-L-fructose residues on the endothelial cell surface (Hormia et al., 
1983). This selectivity can be adapted for use in the isolation of microvascular 
endothelial cells by covalently linking UEA-1 to magnetic polydisperse polymer particles 
"Dynabeads”. UEA-1 lectin is covalently bound to Tosyl-activated M-450 Dynabeads 
and incubated with enzyme treated microvessel tissue segments. The microvessels and 
single cells that attached to the beads are plated on to gelatin coated culture dishes in 
selective culture medium and the cells are detached from the beads by competitive 
binding with free fructose (Jackson et a l, 1990). Binding of UEA-1 lectin to Dynabeads 
can also be used as a method of purification of cultures contaminated with non- 
endothelial cells (Jackson etal., 1991). There may however be a variable degree of non­
specific binding in this preparation, and in some tissues there may also be a degree of 
cross-reactivity with mesothelial cells and some epithelial cells.
UEA-1 lectin is selective for endothelial cells from human tissue, other lectins may be 
useful in tissues from other species. It has been suggested that Griffonia simplicifolia 1 
lectin (GS-1) binds specifically to alveolar capillary endothelial cells from rat lung when 
examined in semi-thin and thin frozen sections (Bankston et a l, 1991). GS-1 is thought 
to be selective for the vascular endothelium of the rat lung, however applying this to
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tissue culture may again result in cross reactivity with mesothelial cells and other non- 
endothelial cell contaminants.
Microcarrier beads
Ryan and White (1986) described the isolation of endothelial cells from the pulmonary 
microvasculature using a non-enzymatic isolation technique involving microcarrier beads. 
The beads are approximately 40-80pm in size and are composed of a polystyrene core 
coated with a "special" coating, having an overall positive charge. The lungs of small 
animals are perfused in situ via the pulmonary artery with cold 0.02% EDTA solution 
containing the microcarrier beads, in order to loosen the cells. The lungs are perfused by 
anterograde perfusion (artery to vein) but the cells are not collected as they get trapped 
by the sieving action of the pulmonary capillary bed on account of their size. However 
the cells are collected when the direction of flow is reversed. This anterograde and 
retrograde perfusion technique is repeated several times until sufficient perfusate is 
collected.
This technique is reported to isolate pre- and post-capillary vessels without 
contamination with large vessel endothelial cells or capillary endothelial cells. However, 
when the perfusate is collected, large vessel contamination at the point of canulation is 
inevitable. Attempts to isolate capillary endothelial cells with 5-10pm sized beads were 
not successful as beads of that size are phagocytosed by the endothelial cells themselves 
(Ryan 1990).
1.1.7. Separation Techniques
The second step in the isolation procedure is the separation of microvascular endothelial 
cells from non-endothelial cell contaminants such as pericytes, smooth muscle cells and 
fibroblasts as well as from connective tissue debris. This involves the use of one or more
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of the following separation techniques: density dependant sedimentation with BSA;, 
Percoll gradient centrifugation; the use of dextran gradients; cell sieving, and differential 
plating methods.
Velocity sedimentation
The separation of capillaries from other cell types and tissue fragments is a crucial step in 
preparing pure endothelial cell cultures. There are several methods of separation by 
centrifugation which are used on their own or in conjunction with other techniques. 
Centrifugation with 25% BSA provides a density dependant gradient used in the isolation 
of brain microvessel fragments in the early stages of the isolation procedure (Hughes and 
Lantos 1986; Abbott et a l , 1992). This method separates the heavier capillary 
fragments from myelin, astrocytes, neurons and other single cells which are less dense. 
Separation with 10% BSA has also been utilised in the isolation of microvascular 
endothelial cells from rat epididimal fat pads (Madri et al., 1983) and murine lung tissue 
(Belloni etal., 1992).
Density dependant centrifugation with dextran is a widely used method, also providing 
initial separation during the early stages of the isolation procedure. The concentration of 
dextran used is variable, ranging between 13% and 20%. Separation using dextran has 
been used for isolation of microvascular endothelial cells primarily from brain tissue 
(Belloni and Nicolson 1988; Audus and Borchardt 1988; Rupnick 1988; Bowman 1990; 
Dorovini-Zis et al., 1991). This method removed myelin, and other cell debris from the 
crude capillary fragments.
The crude capillary fragments separated by BSA or dextran density dependant 
centrifugation are often treated with a second enzyme digestion step in order to further 
digest the basement membrane assisting the removal of the pericytes; this is followed by 
fractionation by Percoll gradient centrifugation (Audus and Borchardt 1986; Bowman
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1990; Dorovini-Zis et al., 1991; Abbott et a l, 1992). Separation of the capillary 
fragments occurs using a 45% or 50% Percoll gradient which is pre-spun at high speed in 
order to form the gradient and re-centrifuged at a lower speed in order to separate the 
endothelial cells from the debris. Alternatively, the cell suspension is layered on top of 
the Percoll solution and centrifuged at high speed; during this centrifugation the Percoll 
forms a gradient and the cell suspension separates forming the appropriate bands. This 
method of separation often occurs in the latter stages of the isolation procedure, and is 
used in the separation of the capillary fragments from pericytes, red blood cells, damaged 
cells and other cell debris.
Cell sieving
Selection of microvessel fragments using nylon screens of different screen size is a 
separation technique used in the isolation procedures of a variety of tissues. This 
includes capillary fragments isolated from: retina (Gitlin and D'Amore 1983), brain 
(Carson and Haudsenchild 1986; Belloni and Nicolson 1988; Bowman 1990), lung 
(Chung-Welch et al., 1988; Belloni et a l, 1992; Hewett and Murray 1993), adrenal 
glands (Folkman et a l, 1979) and heart (Nishida et al., 1993). Separation by this 
method is based on size and occurs individually or in conjunction with density dependant 
centrifugation. The cell suspensions are filtered through sterile nylon screens with a pore 
size of 100-160pm and the filtrate containing vessel fragments separated from the cell 
debris is collected and retained. Following this, a second filtration step is often employed 
using a mesh with a smaller pore size (approximately 50pm) where the material 
remaining on the screen is retained separating the capillary fragments from any single 
cells collected from the initial separation (Belloni and Nicolson 1988; Bowman 1990).
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Differential plating
Separation by differential plating occurs in conjunction with other techniques. The 
isolated capillary fragments are cultured on plastic tissue culture dishes, often coated 
with a physiologically relevant substratum such as collagen, gelatin or fibronectin. The 
vessel fragments adhere more rapidly to the culture dish than single cells (Zetter 1984). 
By rinsing the culture dishes with fresh culture medium 1-3 hours after plating it is 
possible to remove contaminating single cells such as smooth muscle cells, fibroblasts 
and pericytes whilst retaining the adhered vessel fragments (Gitlin and D'Amore 1983; 
Chung-Welch et al., 1988; Rupnick 1988). Smooth muscle cells and fibroblasts also 
adhere more rapidly and tightly to glass than endothelial cells. Therefore, following an 
incubation period of approximately 1 hour on glass coverslips, the non-adherent 
endothelial cells can be transferred on to coated plastic culture dishes (Haisch 1990).
1.1.8. Cell Culture Conditions
The growth conditions used for the culture of capillary endothelial cells varies with the 
species and tissue from which the cells are isolated. This includes the choice of medium, 
sera, extracellular matrices and growth factors. The culture conditions are modified in 
order to obtain the optimum conditions, that is, maximum endothelial cell growth 
without altering the cell morphology and keeping contaminating non-endothelial cells to 
an absolute minimum.
Culture medium
The culture medium used for the growth of microvascular endothelial cells is very 
variable. The alternative types of culture medium include: Dulbecco's modified Eagle's 
Medium (DMEM) (Chung-Welch et a l, 1988; Nishida et a l, 1993), Medium 199 
(M l99) (Madri et a l, 1983; Hewett and Murray 1993), Minimum Eagle's Medium 
(MEM) (Audus and Borchardt 1986), Dulbecco's modified Eagle's with F12 nutrient mix
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(DME-F12) (Belloni etal., 1992; Haisch 1990), Ham's F10 (Abbott etal., 1992), RPMI- 
1640 (Shaw et a l, 1984) and a 1:1 combination of fresh culture medium with medium 
conditioned with tumour cells (Folkman et al., 1979) or endothelial cells (Beer Stoltz 
and Jacobson 1991).
Tumour conditioned culture medium is prepared by incubation of the required medium 
for 24-48 hours with tumour cells, such as mouse sarcoma 180 or B16 melanoma cells 
(Folkman et al., 1979). Similarly endothelial cell conditioned medium is prepared from 
BAE cells (Gajdusek and Schwartz 1982). The use of conditioned medium has been 
reported to stimulate capillary endothelial cell growth (Folkman et al., 1979). This is 
thought to be due to the release of stimulatory factors from large vessel endothelial cells 
and tumours which effect the production and release of basic fibroblast growth factor 
(bFGF) in turn stimulating endothelial cell growth (Schweigerer et al., 1987). BAE cell 
conditioned medium may also inhibit the proliferation of smooth muscle cells (Carson 
and Haudenschild 1986). This is thought to be due to the secretion of a heparin-like 
substance from the endothelial cells which inhibits smooth muscle cell growth (Castellot 
et al., 1981). The selection of culture medium varies depending on the species and tissue 
from which the cells are isolated and the ability to provide optimum culture conditions 
when supplemented with various growth factors and serums.
Growth serum
Sera are supplemented into the culture medium to support cell growth. The type of 
serum and the concentration used is selected to provide the most satisfactory conditions 
for cell growth. The alternative types of serum include foetal calf serum (FCS), plasma 
derived serum (PDS) and calf serum (CS).
Plamsa derived serum has been produced from a number of sources including bovine, 
human, equine and porcine. It is prepared from platelet poor plasma and has been
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reported to selectively support the growth of endothelial cells in preference to non- 
endothelial cells. This is due to the fact that platelet poor serum does not contain 
platelet-derived growth factor (PDGF) which is required for growth of pericytes and 
smooth muscle cells (Gitlin and D'Amore 1983). Smooth muscle cells have been shown 
to express a receptor for PDGF. When isolated from primary culture and grown in the 
presence of PDGF or serum containing PDGF smooth muscle cells have also been shown 
to secrete PDGF (Speir et al., 1991). Chung-Welch et al. (1988) reported that medium 
containing PDS with additional growth factors promoted the most effective and selective 
growth of microvascular endothelial cells in the early stages of primary culture and 
passaged cultures. The cells did however, grow equally well in medium supplemented 
with FCS in the latter stages of growth.
1.1.9. Growth Factors
The long-term growth of capillary endothelial cells in vitro requires the addition of 
growth factors known to stimulate the proliferation and differentiation of endothelial 
cells. The growth factors utilised for this purpose are extracted from a number of highly 
vascularised tissues and can effect the growth of cells in culture either alone or in 
conjunction with heparin, often producing a synergistic stimulatory effect. There is an 
increasing number of growth factors which have been shown to provide a positive or 
negative effect on the growth of endothelial cells. These growth factors include acidic 
and basic fibroblast growth factor (aFGF, bFGF), transforming growth factor type P 
(TGF-P), endothelial cell growth supplement (ECGS), retinal-derived growth factor 




Acidic and basic FGF are closely related potent mitogens which stimulate the 
proliferation of large and capillary vessel endothelial cells in culture, and promote 
angiogenesis in vivo. Both of these proteins are isolated from a number of tissues such 
as retina, brain, adrenal gland, corpus luteum, as well as various tumours (Schweigerer et 
al., 1987), and are purified on the basis of their strong affinity for the glycosaminoglycan, 
heparin (D'Amore 1992). FGF is required to stimulate capillary endothelial cell growth 
when the cells are seeded at low densities (Speir et al., 1991), however, aFGF and bFGF 
are not equally potent as bFGF possesses 30-100 fold greater stimulatory effects on 
endothelial cells in culture (Gospodarowicz 1989).
The growth factor bFGF is located on the luminal surface of vascular endothelial cells 
and on the subendothelial extracellular matrix. Its release is thought to be effected by the 
presence of heparin and heparin-like molecules (Ishai-Michaeli et al., 1992), and is 
thought to act via high affinity receptors and cell surface heparin sulphate proteoglycans, 
determined to be low affinity receptors (Klagsbum and Baird 1991).
In culture, heparin is known to possess an inhibitory effect on smooth muscle cells and 
stimulatory effect on human umbilical vein endothelial cells. In addition, heparin 
potentiates the mitogenic effect of aFGF making it equally as potent as bFGF to large 
vessel endothelial cells. For the growth of capillary endothelial cells however, the 
addition of heparin to culture medium in the presence of aFGF or bFGF is thought to 
have a potent inhibitory effect on cell growth (Gospodarowicz 1989). However, bFGF 
is used as a growth factor in the culture of a number of microvascular endothelial cell 
preparations (Karasek 1989; Braunhut and Palomares 1991).
VEGF, PD-ECGF and TGF-JS.
Vascular endothelial growth factor (VEGF) is a heparin binding protein which 
stimulates the proliferation of endothelial cells in vitro but to a lesser extent than bFGF
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(Bikfalvi et a l, 1991). VEGF is angiogenic in vivo and may have a role in the 
development of blood vessels (Jakeman et a l, 1992). High density binding sites for 
VEGF are distributed throughout various vascularised tissues, including brain, pituitary 
gland, kidney and ovary, suggesting further physiological roles (Ferrera et al., 1992). 
Mouse sarcoma 180 and some smooth muscle cells have been shown to secrete a VEGF 
like mitogen (Ferrera et al., 1992). Culture of microvascular endothelial cells with 
sarcoma 180 conditioned medium has been used in a number of studies to stimulate cell 
growth (Folkman et al., 1979; Alessandri et al., 1992).
Platelet-derived endothelial cell growth factor (PD-ECGF) is also an endothelial cell 
mitogen but unlike FGF it does not bind heparin, nor does it stimulate fibroblast or 
smooth muscle cell growth. The specificity of PD-ECGF and the fact that it is derived 
from platelets suggests that PD-ECGF may have a role in maintaining the integrity of the 
blood vessels (Gospodarowicz 1990; D'Amore 1992).
Transforming growth factor p (TGF-P) has an inhibitory effect on endothelial cell 
proliferation. Studies involving the co-culture of endothelial cells with smooth muscle 
cells or pericytes were found to result in the inhibition of endothelial cell growth 
(D'Amore 1992). Studies also indicate that the effects of TGF-P on endothelial cell 
proliferation depend on the cell phenotype and extracellular matrix (Sutton et a l, 1991).
ECGS and RDGF
Endothelial cell growth supplement is a commercially prepared supplement derived from 
bovine neural or pituitary tissue, probably consisting of a number of endothelial cell 
stimulatory growth factors. ECGS is one of the most widely used endothelial cell 
growth supplements, used in the culture of microvascular endothelial cells from a variety 
of species and tissues. In the majority of studies ECGS is used in conjunction with 
heparin (Rupnick et al., 1988; Tontsch and Bauer 1989; Jackson et al., 1990; Haisch et
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al., 1990; Beer Stoltz and Jacobson 1991; Dorovini-Zis 1991; Belloni et al., 1992; 
Abbott et al., 1992; Hewett and Murray 1993). This combination has been shown to 
have a synergistic effect increasing microvascular and large vessel endothelial cell growth 
(Thornton et al., 1983; Abbott et al., 1992).
Retinal derived growth factor (RDGF) is generally prepared from bovine retinas and 
contains an endothelial cell mitogen. It is used in conjunction with heparin, PDS and 
FCS as a stimulant for endothelial cell growth, but not for the growth of pericytes (Gitlin 
and D'Amore 1982). Not only is RDGF used as a growth stimulant in cultures of retinal 
capillary cells (Gitlin and D'Amore 1982), but it is also used in cultures of adrenal cortex 
(Orlidge and D'Amore 1987), lung (Chung-Welch et al., 1988), heart (Nishida et al.,
1993) and brain (Carson and Haudenschild 1986).
1.1.10. Extracellular Matrix
The basement membrane and basal lamina, described in section 1.1.2, are specialised 
extracellular matrices on which endothelial cells sit (Mosher et al., 1992). This 
substratum influences cell functions such as growth, migration and differentiation. The 
influence of the extracellular matrix (ECM) on vascular endothelial cell growth has been 
widely studied in vitro. Original studies showed that capillary endothelial cells grown on 
interstitial collagens (type I and III) proliferated until they formed a typical monolayer, 
however cells grown on basement membrane collagens (type IV) were induced to form 
capillary tube-like structures (Madri and Williams 1983). Since then, the influence of the 
ECM and growth factors such as FGF and TGF|3 on capillary morphogenesis in vitro 
have been more widely studied (Grant et al., 1989; Aumailley et al., 1991; Jackson and 
Jenkins 1991; Schnaper et al., 1993), and is the subject of a short review by (Ingber and 
Folkman 1989).
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The selection of an appropriate substratum on which to culture capillary endothelial cells 
is therefore important for cell proliferation. ECM such as native collagen gels or 
Matrigel (Lawley and Kubota 1989; Kinsella et a l, 1992) promote the differentiation of 
cells resulting in the formation of capillary tube-like structures whereas purified ECM 
molecules such as laminin, fibronectin, collagens and gelatin promote cell proliferation 
forming endothelial cell monolayers (Ingber and Folkman 1989; D'Amore 1992). 
Microvascular endothelial cell monolayers in vitro are generally cultured on plastic 
culture wells coated with gelatin, fibronectin or collagen. The choice of substratum 
depends on the species and tissue from which the cells are isolated, as well as the culture 
conditions. The substratum is also selected on the basis of providing the optimum 
conditions for cell proliferation in culture.
1.1.11. Methods of characterisation
The ability to identify and distinguish between microvascular endothelial cells and non- 
endothelial cell contaminants in culture is based on the structural and functional 
properties of endothelial cells in vivo and in vitro. Microvascular endothelial cells 
display a distinctive pattern of growth in culture and possess a number of typical 
ultrastructural features. The typical markers for identification include: angiotensin 
converting enzyme (ACE), prostacyclin production, expression of Von Willebrand factor 
and uptake of acetylated low density lipoprotein (Ac-LDL). Other properties typical of 
endothelial cells include their ability to undergo angiogenesis in vitro, provide a non- 
thrombogenic surface to platelets and the expression a number of specific adhesion 
molecules. The morphology of microvascular endothelial cells, the effect of the culture 
conditions on cell growth and the expression of the endothelial cell markers has been 
shown to be species and organ specific (Rupnick et a l, 1988; Belloni et a l, 1992; 
Nishida et a l, 1993).
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Light and electron microscopy
Phase-contrast microscopy is utilised in demonstrating the characteristic growth patterns 
of microvascular endothelial cells in culture. Cells are seeded on to the culture wells as 
small clusters of cells or capillary fragments. These cell clusters and fragments grow 
forming small cell colonies which expand and merge to form typical contact-inhibited 
monolayers. The morphological characteristics of microvascular endothelial cells is 
distinct from non-endothelial contaminants such as fibroblasts and smooth muscle cells. 
The morphology of these contaminating cells is fairly distinctive and possible to identify 
in culture (see section 1.1.4).
Several of the ultrastructural features described previously (see section 1.1.4) are 
characteristic of microvascular endothelial cells. Another ultrastructural feature of 
endothelial cells is the existence of Weibel Palade bodies originally identified in large 
vessel endothelial cells (see section 1.1.4). These have been identified in some 
microvascular endothelial cells, but appear to be more abundant in human tissues than in 
bovine, murine or rat tissues (Folkman et al., 1979; Zetter 1984). Electron microscopy 
alone cannot offer conclusive proof of endothelial identity, as organ and species 
differences in ultrastructure are thought to exist, and epithelial and mesothelial cells may 
contain similar features.
Von Willebrandfactor
Factor VIII complex is composed of two components, von Willebrand factor (99%) 
bound to the protein Factor VIII (1%). Von Willebrand factor has two main functions in 
vivo: it facilitates platelet adhesion to the subendothelial matrix and the interaction with 
Factor Vm  to form blood clots. Factor VTH-related antigen is the antigen for von 
Willebrand factor, which is measured in the assay for Factor VIII. Synthesis of von 
Willebrand factor / Factor VHI-related antigen is localised to endothelial cells and 
megakaryocytes in the tissue and in culture making it a reliable marker for endothelial
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cells in vitro (Zimmerman et al., 1983). The endothelial cell origin can be detected by 
indirect staining of permeabilized cultured cells (Zetter 1984), however, the staining 
intensity is variable (Mukai et a l, 1980).
Uptake o f acetylated LDL
Receptor mediated uptake of low density lipoprotein occurs in cells such as endothelial 
cells, fibroblasts, monocytes and macrophages. The lipoproteins bind predominantly to 
the coated pits where the are internalised into the cell and degraded by the lysosome. 
The receptor mediated "scavenger cell pathway" is an alternative pathway for the 
metabolism of LDL which has been chemically modified by acetylation or 
acetoacetylation (Pitas et al., 1981). The receptor in the scavenger pathway is different 
to the receptor for unmodified LDL in terms of specificity, regulation of cholesterol 
levels and biochemical properties. More importantly with respect to endothelial cells, is 
that acetylated LDL metabolised by the scavenger pathway in endothelial cells occurs at 
a much accelerated rate compared to the other cell types. Voyta et al (1984) applied 
these properties to identify endothelial cells in culture using fluorescently labelled 
acetylated LDL.
Angiotensin converting enzyme and prostacyclin
Angiotensin converting enzyme (ACE) is found in large and microvessel endothelial cells 
(Caldwell et a l, 1976), alveolar macrophages (Friedland et a l, 1977) and some epithelial 
cells (Ward et a l, 1979). Due to the variety of tissues in which this enzyme is located, 
ACE cannot be used as a definitive marker of endothelial cell origin, however the 
absence of ACE would rule out endothelial cell origin. ACE can be detected 
immunologically (Auerbach et a l, 1982) and by radioimmunoassay (Ryan and Mayfield 
1986). Prostacyclin (PGI2) is involved in platelet aggregation, and have been shown to 
be produced by endothelial cells in vivo and in vitro. The production of prostacyclin in
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culture is stimulated by a variety of substances such as thrombin and can be used as 
another marker for endothelial cell origin (Zetter 1984).
Non-thrombogenic surface and angiogenesis
As described previously, the endothelium provides a non-thrombogenic surface, 
responsible for the prevention of platelet adhesion to the vessel wall. This phenomenon 
is maintained in culture and can be utilised as a method for distinguishing between 
endothelial cells and smooth muscle cells or fibroblasts, since platelets rapidly adhere to 
the surface of both smooth muscle cells and fibroblasts (Belloni e ta l,  1992).
Angiogenesis of microvessel endothelial cells can also be demonstrated in vitro (see 
section 1.1.3) and provides a very reliable method of distinguishing between endothelial 
and mesothelial cells (Chung-Welch et al., 1989; van Hinsbergh et at., 1990).
Alternative endothelial cell markers
Cell adhesion molecules have been used recently as endothelial cell specific markers in 
vitro (Hewett and Murray 1993). A number of cell adhesion molecules have been 
identified such as EndoCAM, an endothelial cell adhesion molecule which is involved in 
cell-cell adhesion (Albelda et al., 1990), PECAM-1, (Rubin, 1992) and organ specific 
adhesion molecules such as Lu-ECAM-1 (Zhu et al., 1991 and 1992). These adhesion 
molecules may be used in the identification of endothelial origin.
1.1.12. Microvascular Endothelial Cell Lines
The role of large vessel endothelial cells has been widely studied in vitro with cells 
isolated from primary culture and with the use of established cell lines. However, as 
significant differences exist between large vessel and microvessel endothelial cells. Many 
of the physiological events which occur in the vasculature happen at the microvascular
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level, the growth of pure cultures of microvascular endothelial cells has become very 
important. Due to the great difficulties of isolating and maintaining pure long term 
microvascular endothelial cell cultures from various species and tissues, studies involving 
the establishment of immortalised microvascular cell lines have been investigated ( 
Montesano etal., 1990; Dubois et al., 1991;Ades etal., 1992).
Ades et al., (1992) transfected and immortalised human dermal microvascular endothelial 
cells. Microvascular endothelial cells at passage 6 were transfected with the simian virus 
40 large T antigen and underwent characterisation studies in parallel with primary 
cultured cells for comparison. The immortalised cell line HMEC-1 assumed cobblestone 
morphology, and unlike primary cultures they could be passaged up to 95 times without 
affecting growth characteristics or morphology. HEMC-1 cells also tested positive for 
the expression of Von Willebrand factor, UEA-1, the uptake of Ac-LDL, and formed 
capillary tube-like structures when seeded on to Matrigel coated culture wells, although 
some differences with primary cultured cells did exist.
Murine microvascular endothelial cells are notoriously difficult to culture (Dubois et al.,
1991), therefore the establishment of murine microvascular endothelial cell lines has been 
investigated. Cell lines have been prepared from normal endothelial cells isolated from 
brain (bEnd.l cells) (Montesano et al., 1990), skin (sEnd.l) and thymus (tEnd.l) by 
infecting primary cultures of mouse brain with a hemangioma derived polyoma middle T 
oncogene-expressing retrovirus (Williams et al., 1988 and 1989). These cell lines have 
been utilised in studies investigating proliferation and angiogenesis of microvascular 
endothelial cells in vitro (Montesano et al., 1990; Bocchietto et al., 1993). A cell line 
has also been derived from vascular tumours (hemangiomas) in transgenic mice (Py-4-1) 
(Dubois et al., 1991). The angiogenic properties of these tumourigenic endothelial cells 




The blood-brain barrier consists of a single continuous layer of endothelial cells which 
lines the microvessels of the brain. These endothelial cells are bound together by tight 
intercellular junctions, exhibit only a few pinocytotic vesicles and lack fenestrations. 
Together, these unique properties provide a very selective, restrictive barrier that 
effectively excludes the passage of most polar molecules peptides and proteins from the 
blood to the brain. Some small water soluble molecules (e.g. amino acids) and 
neuropeptides are transported across the blood-brain barrier by specific carrier 
mechanisms, in addition, some water soluble drugs such as L-DOPA are transported by 
the neutral amino acid pathway (Partridge 1986; Audus 1990). Some reports also 
suggest that certain blood-borne proteins are transported across the blood-brain barrier 
by a vesicular mechanism (Guillot et al., 1990).
Initial studies of the blood-brain barrier in vivo provided useful information about the 
regional variations of the brain and provided indirect evidence of endothelial cell function 
as a selective barrier. However studies involving cultures of brain microvascular 
endothelial cells have allowed advances in the structural and functional analysis of the 
barrier, in particular, the study of transport mechanisms (Shah et al., 1989; Smith and 
Borchardt 1989; Audus and Borchardt 1986, Abbott etal., 1992).
In our laboratory, the structure and function of melanotropins and melanotropin 
receptors have been studied extensively with a view to exploiting receptor mediated 
processes involved in drug targeting to melanoma cells (Ahmed et al., 1992; Sahm et a l,
1994). This prompted an investigation into the expression of melanocortin receptors in 
the microvasculature as a mechanism of transport by receptor mediated transcytosis 
particularly across the blood-brain barrier.
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1.1.14. The Melanotropins
Pro-opiomelanocortin (POMC) is a peptide hormone precursor which is processed by 
post transcriptional cleavage into an array of biologically active neurohumoral peptides. 
It is expressed primarily in the pituitary, but is also present in distinct regions of the brain 
and other peripheral tissues. The substances produced by the processing of POMC 
include: a, P and y melanocyte stimulating hormone (a, P and y-MSH), P-lipotropic 
hormone, P-endorphin and adrenocorticotropic hormone (ACTH) which is the precursor 
of a-MSH. These peptides possess a variety of well known physiological actions 
including: the regulation of adrenal glucocorticoid and aldosterone production (ACTH); 
control of melanocyte growth and pigment production (a-MSH, P-MSH, p-lipotropic 
hormone and ACTH); and analgesia (p-endorphin), as well as having actions related to 
central neural functions such as behaviour, memory and learning (Eberle 1988).
1.1.15. a-Melanocyte Stimulating Hormone : Structure and Functions
a-Melanocyte stimulating hormone (a-MSH) is a linear 13 amino acid peptide: Ac-Ser1- 
Tyr2-Ser3-Met4-Glu5-His6-Phe7-Arg8-Trp9-Gly10-Lys11-Pro12-Val13-NH2. It is synthesised 
in the pars intermedia of the pituitary gland, in the brain and in peripheral tissues of 
mammalian species. It is located throughout the central nervous system (CNS) and in 
peripheral tissues including: skin; testes; ovaries; placenta; adrenal medulla and 
gastrointestinal tract (Eberle, 1988).
a-MSH is known to stimulate pigment dispersal in lower vertebrates and can induce 
melanogenesis in various mammalian cells. The activity of a-MSH on cultured murine 
B16 melanoma cells and human melanocytes has been widely studied (Siegrist et al., 
1988 and 1992; Eberle, 1991; Ahmed et al., 1992; Lunec et al., 1992; Hunt et al., 1994; 
Sahm et al., 1994). a-MSH has been shown to influence melanogenesis and metastatic 
behaviour in murine melanoma cells by binding to specific receptors on the cell
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membrane. Activation of the a-MSH receptor results in increased cyclic AMP 
production, stimulation of tyrosinase activity and increased melanin content (Lunec et 
a l, 1992; Siegrist et a l, 1988; Sahm et a l, in press). In human melanoma cells this 
mechanism is not so evident, although human melanocytes do express high affinity on 
binding of a-MSH (Eberle, 1991; Siegrist e ta l, 1992; Hunt e ta l, 1994).
In addition to the effects of a-MSH on pigment cells, a-MSH also has well recognised 
effects in the pituitary and peripheral tissues such as effecting the release of pituitary 
hormones such as prolactin, influencing the immune system by modulating some of the 
effects of interleukin-1 and having cardiovascular and renal effects (Eberle 1988).
a-MSH in the central nervous system has a wide variety of effects suggesting a role as a 
neuropeptide in the CNS. There are reported effects of a-MSH in the CNS on attention, 
hearing and memory as well as showing behavioural; neurophysiological and 
thermoregulatory effects (Eberle, 1988). It is the distinct pharmacological properties of 
melanocortins in the nervous and immune system compared with those expressed on 
melanocytes and adrenal cortical cells suggested that the existence of multiple 
melanocortin receptors.
1.1.16. Melanocortin Receptors
a-MSH and ACTH receptors (MC1-R and MC2-R, respectively) control pigmentation 
and adrenal steroidogenesis in response to stimulation from POMC peptides. These 
receptors are a G-protein coupled receptor subfamily based upon their sequence 
homology which stimulates adenylyl cyclase. Isolation of the receptors has enabled the 
identification of some unusual structural features which make them quite distinct (Cone 
and Mountjoy 1993).
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Studies investigating the presence of a-MSH receptors in lacrimal tissue suggested that 
a-MSH may function as a neurotransmitter (Leiba et al., 1990). These studies were 
conducted using [125I-Tyr2, Nle4, D-Phe7]a-MSH as a radioligand. This is a superpotent 
analogue of a-MSH exhibiting 10 times greater biological potency than the native a- 
MSH (Sawyer et al., 1980, Eberle 1988). The primary localisation of ACTH and a- 
MSH is the melanocyte and adrenal cortex, however binding sites for ACTH and a-MSH 
have been found throughout the brain using in situ hybridisation, having numerous 
regulatory properties. The cloning of receptors for a-MSH and ACTH (Mountjoy et al.,
1992) have provided probes for further examination of a-MSH and ACTH expression.
A receptor for a-MSH and ACTH peptides has been identified specifically in the 
hypothalamus and limbic system of the brain and is known as MC3 (Roselli-Rehfuss et 
al., 1993) which is activated by y-MSH peptides. The distribution of MC3-R mRNA in 
the neurons throughout the brain suggests the role of melanocortin peptides as 
neuromodulators and neurotransmitters as well as having a role in endocrine, 
cardiovascular and thermoregulatory functions. This MC3 receptor was also identified 
by Gantz et al., (1993a) using the technique of polymerase chain reaction (PCR). Like 
MC1-R and MC2-R it is thought to be a G-protein linked cell surface receptor, however 
unlike MC1-R, MC3-R is thought to recognise ACTH, a, P and y-MSH equally well 
which is demonstrated by cyclic AMP production. In addition to being expressed in the 
brain, MC3-R has also been identified in the placenta and gut but not in melanoma cells 
or in adrenal tissue.
A fourth member of the melanocortin receptor family is MC4-R. It has been shown to 
be expressed primarily in the brain with a notable absence in the adrenal cortex, placenta 
and melanocytes (Gantz et al., 1993b). MC4-R has been shown to demonstrate an 
increase in cyclic AMP levels in response to a-MSH and ACTH, and is thought to 
possess unique pharmacological characteristics, tissue distribution and chromosomal 
localisation.
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1.1.17. Aims and Scope
A great deal of research has been conducted in the area of endothelial cell biology, 
investigating the structural and functional diversity of endothelial cells from different 
organs and species. Many of the important functions attributable to the pulmonary 
vasculature occur at the microvascular level, however, most in vitro studies have 
concentrated on endothelial cells derived from large vessels, partly due to the great 
difficulties encountered in the isolation and culture of pure microvascular endothelial 
cells. Although much interest has been shown in microvascular endothelial cell biology, 
there are wide variations in the isolation techniques and culture conditions, and 
considerable variability between the properties reported for microvascular endothelial 
cell cultures. We now know that endothelial cells from different sites exhibit 
heterogeneity and clearly, there is a major need to have well characterised lung and brain 
derived microvascular endothelial cells in order to study their role in drug delivery.
The aim of this study is to determine the optimum conditions for the isolation, culture 
and characterisation of murine lung and brain derived microvascular endothelial cells, in 
order to assess the structural and functional diversity of these cells and their role in drug 
delivery.
Following the development of brain and lung derived microvascular endothelial cell 
cultures, it is the intention of this study to investigate the expression of receptors on the 
surface of the microvascular endothelia which could be involved in specific receptor 
mediated transcytosis. Of particular interest is the delivery of peptides to the brain, as 
the vascular endothelia of the blood-brain barrier provides a highly selective barrier to 
the passage of drugs and macromolecules. This may provide an important insight in to 
the mechanism of selective drug delivery involving extravasation of macromolecules 
from the vascular system.
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2. G e n er a l  M a t e r ia l s  a n d
M e t h o d s
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2.1. Cell Culture
2.1.1. Culture of Cell Lines
The three cell lines used throughout the study were bovine aortic endothelial cells (BAE- 
1), human umbilical vein endothelial cells (HUVEC) and fibroblasts (3T3-L1). BAE-1 
were obtained from the European collection of animal cell cultures (Porton Down) at 
passage number 18. HUVECS were obtained from the Wellcome Foundation, Kent, 
U.K. at passage number 21 and the fibroblasts were obtained from the department of 
biochemistry, University of Bath at passage number 13.
2.1.2. Cell Culture Medium and Solutions
Water
All water used for the preparation of cell culture medium and solutions was freshly 
double distilled by a bi-distillation Fistreem still (Fisons Ltd) fitted with a Fistreem 
predioniser (Fisons Ltd) and sterilised in an autoclave (British Steriliser Co. Ltd, 
Swingclave type SFT-LAB) at 121 °C for 15 minutes.
Balanced salt solutions
Phosphate buffered saline (PBS) was obtained in tablet form (Oxoid Ltd Basingstoke, 
Hants). Five tablets were dissolved in 500ml of freshly double distilled water, producing 
0.02M PBS pH7.4. This was sterilised at 121°C for 15 minutes and stored at 4°C.
Hanks' balanced salts solution without calcium and magnesium (Ca/Mg-free HBSS, 
Gibco BRL, Paisley, Scotland), was obtained as a 1 OX concentrate containing phenol red
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indicator. The concentrate was diluted to IX with sterile double distilled water, adjusted 
to pH7.4 with 1M NaOH and stored at room temperature.
Acid and base solutions
10%v/v hydrochloric acid (HC1), 7.5%w/v sodium bicarbonate (NaHCC>3) and 1M 
sodium hydroxide (NaOH) were prepared from stock solutions and solids obtained from 
BDH chemicals. The solutions were prepared with double distilled water, sterilised and 
stored at room temperature.
Tissue culture medium and supplements
Dulbecco's Modified Eagle's Medium (DMEM, Gibco), RPMI 1640 (Flow laboratories, 
Irving, Scotland) and Medium 199 (Ml 99, Gibco) were obtained as sterile 10X 
concentrates containing phenol red indicator but without L-glutamine and sodium 
bicarbonate. The concentrated solutions were diluted using sterile double distilled water. 
The medium supplements L-glutamine (200mM), penicillin (5000IU/ml) and 
streptomycin (5000pg/ml) (pen/strep) and non-essential amino acids (NEAA) were 
obtained from Flow laboratories and Gibco, respectively. Growth medium and NEAA 
were stored at 4°C whereas L-glutamine and penicillin/streptomycin were divided into 
aliquots and stored at -20°C.
Foetal calf serum was batch tested to obtain the serum which provided the most suitable 
cell growth. Batch testing involved supplementing different serums at various
concentrations to normal growth medium, in order to determine the serum which 
provided maximum cell growth without effecting cell morphology. The most suitable 
growth occurred with serum obtained from Flow laboratories (batch numbers 9130012 
and 10855) and with serum obtained from Gibco (batch number 30A0212S). The serum 
was divided into aliquots and stored at -20°C. New-born calf serum was obtained from 
Flow laboratories (batch number 056005) and stored at -20°C.
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Endothelial cell growth supplement (ECGS) from bovine neural tissue was obtained from 
Sigma Chemical Company, Poole, Dorset. One vial contained 15mg of ECGS which 
was diluted as required with Hanks’ balanced salts solution (HBSS) and filtered using a 
0.2pm sterile filter unit (ministart NML, Sartorius) The ECGS was dispensed into 
aliquots and stored at -20°C.
Heparin was obtained from Sigma containing 176 units/mg, weighed out as required, 
dissolved in HBSS and sterile filtered. The heparin solution was divided into aliquots 
and stored at -20°C.
Culture medium was prepared aseptically from sterile components according to the 
following recipes, stored at 4°C and used within two weeks:
DMEM M199 R PM I1640
10X Medium 50ml 50ml 50ml
Water 410ml 421.5ml 421.5ml
L-glutamine 5ml 5ml 5ml
Penicillin/ streptomycin 5ml 5ml 5 ml
NEAA 5ml 5ml 5 ml
FCS 55.6ml as required by as required by
different cell lines different cell lines
2.1.3. Equipment
All sterile tissue culture procedures were carried out using standard tissue culture 
techniques, in a vertical recirculating laminar flow cabinet (MDH Ltd.). Non-sterile 
procedures were performed at the bench.
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The cells were maintained in an LEEC PF2 incubator (Laboratory and Engineering 
Company) and kept humidified under a constant atmosphere of 5% C02 gas. The 
thermostatic controls were adjusted to give a temperature of 37°C, which was regularly 
checked using a digital thermometer with a thermocouple probe (Jenway Ltd.)
Cell growth and morphology were monitored daily using an inverted biological 
microscope (WILD M40, Wild Heerbrugg Ltd, Switzerland). The cells were counted on 
a standard double grid haemocytometer (Fisons Ltd) having been stained with 0.4% 
trypan blue (Sigma) in PBS (see section 2.1.4).
Tissue culture flasks were obtained from Falcon (Becton Dickinson UK Ltd) in sizes: 
25cm2, 75cm2 and 175cm2. Six-well, 24-well and 96-well plates were obtained from 
Coming, U.K. Sterile tissue culture tubes of various sizes and 30ml screw topped sterile 
universal vials were obtained from Sterilin Ltd. Polypropylene 2ml ampoules for 
freezing cells in liquid nitrogen were obtained from J. Bibby Sciences.
Items of glassware that were re-used were rinsed immediately after use. The glassware 
was subsequently soaked in a 2% solution of RBS 25 (Fisons Ltd) at approximately 
40°C for 30 minutes. The glassware was then washed thoroughly, rinsed in three 
changes of tap water and soaked in the final change for 30 minutes. This rinsing process 
was repeated with single distilled water and finally all items were soaked in freshly 
double distilled water for 1 hour. The glassware was dried in a hot air oven, capped with 
aluminium foil and sterilised by dry heat at 160°C (Gallencamp Sterilising Oven) for a 
minimum of 1 hour.
Non-glass items including plastic syringes, Gilson pipette tips, bottle tops and other re­
usable plastics were also rinsed immediately after use. They were washed thoroughly by 
boiling in three changes of fresh distilled water, soaked in double distilled water, dried, 
sealed in autoclave bags (DRG Hospital Supplies, Bristol, U.K.) and sterilised at 121°C 
for 15 minutes.
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Long glass pipettes and Pasteur pipettes were plugged with cotton wool, sealed in 
autoclave bags and sterilised at 121 °C for 15 minutes.
2.1.4. Cell Culture Methods
Routine culture o f BAE-1 and 3T3-L1 cell lines
The cell lines were routinely grown in DMEM supplemented with 7.5% NaHC0 3 , 1%L- 
glutamine, 50IU/ml penicillin, 50pg/ml streptomycin, 1% NEAA and 10% foetal calf 
serum and adjusted to pH7.4. The cells were generally grown in 75cm2 flasks in a C02 
incubator at 37°C, allowing the cells to be buffered under an atmosphere of 5% C02. 
The medium was changed on alternate days and the cells were subcultured weekly when 
they had reached confluence.
To sub-culture the cells, the old medium was discarded and the cells were washed three 
times with PBS. The flask was then incubated with 0.25% trypsin, 0.02% 
ethylenediaminetetraacetic acid (0.25%w/v trypsin/0.02%w/v EDTA) for 5 minutes at 
37°C. After trypsinisation the cell suspension was gently agitated to dislodge all the cells 
and aspirated with a sterile Pasteur pipette. From one confluent flask between 4 and 6 
flasks of BAE-1 and 3T3-L1 cells were obtained depending on the experimental 
requirements. Each confluent 75 cm2 flask contained approximately 2xl07cells.
Routine culture o f HUVECS
Human umbilical vein endothelial cells (HUVECS) were routinely cultured in growth 
medium comprising a 1:1 mixture of M199 and RPMI 1640. Both Ml 99 and RPMI 
1640 were supplemented with 7.5% NaHCC>3, 1% L-glutamine, 50IU/ml penicillin, 
50pg/ml streptomycin and 1% NEAA and adjusted to pH7.4 with 1M NaOH. The 1:1 
mixture of Ml 99 and RPMI was prepared and then supplemented with 5% new-born calf
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serum, 5% foetal calf serum, 17 units/ml of heparin and 2.5pg/ml endothelial cell growth 
supplement (ECGS); the cells were cultured at 37°C in a C02 incubator. The cells were 
subcultured by incubation with 0.25% trypsin, 0.05% EDTA for approximately 1-2 
minutes at room temperature and split in a ratio of 1:3 or 1:4 as required.
Determination o f cell number
Determination of the cell density required the preparation of a suspension of subcultured 
cells. The cell suspension was thoroughly agitated and 0.4 ml of this suspension was 
removed and mixed with 0.1 ml of trypan blue dye, this suspension was loaded on to a 
haemocytometer chamber under a coverslip and the cell number was determined.
Each side of the haemocytometer chamber was divided into nine large squares by triple 
white lines, the four comer squares being further sub-divided into sixteen squares per 
comer. A total count of the four comer squares and the central square of the 
haemocytometer grid was made using the inverted microscope. Each large square had 
an area of 1mm2, when the coverslip was attached to the chamber such that interference 
patterns could be observed, the depth of the chamber was 0.1mm. The total volume of 
each square was therefore:
1 x 1 x 0.1 = 0.1mm3 = 0.0001cm3 = 10-4ml
The total cell number per ml was given by 104 x n where n is the mean of the five large 
squares. When the dilution of the cell suspension with the dye was accounted for, the 
final equation for assessing cell density became: 5 ( n x l 0 4/ 4) .
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Cell viability
The cell viability was also determined during the haemocytometer count of the cell 
density using trypan blue exclusion. Viable cells excluded this dye whereas non-viable 
cells become stained dark blue.
Cell storage in liquid nitrogen
Cells which required longer term storage were frozen down routinely in liquid nitrogen 
vapour. A cell suspension was prepared from a confluent flask by the standard 
trypsinisation procedures and resuspended in 5ml of fresh medium. The cell suspension 
was transferred into sterile centrifuge tubes and centrifuged at 400g for 10 minutes 
(Jouan B3-11 bench centrifuge). The supernatant was discarded, and the cell pellet was 
resuspended in 1ml of growth medium in the presence of the cryoprotectant dimethyl 
sulphoxide (DMSO). A 10% solution of DMSO prepared in growth medium was 
sterilised by filtration with a 0.2pm filter prior to use. Replicate 1ml aliquots of the cell 
suspension were placed in 2ml polypropylene screw top ampoules and placed in a 
biological freezer unit plug (Type BF6, Union Carbide) in the top of a liquid nitrogen 
freezer (Type LR 33-10, Union Carbide). This allowed the cells to be cooled to below - 
70°C in liquid nitrogen vapour at a rate of approximately 1°C per minute. The ampoules 
were then transferred to a liquid nitrogen freezer (Type LR-40, Union Carbide) for long 
term storage.
This method for freezing cells was used for BAE-1 and 3T3-L1 cell lines. For 
HUVECS, however, samples needed to be frozen in medium which comprised 20% 
foetal calf serum, 10% DMSO and 70% growth medium.
Recovery from liquid nitrogen
When the cells were recovered from long term storage, the ampoule from storage was 
thawed out immediately in a water bath pre-set at 37°C. The contents of the ampoule
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were aseptically removed, resuspended in 9ml of growth medium and centrifuged at 
400g for 10 minutes. The supernatant was removed and the pellet was resuspended in 
fresh culture medium and transferred into a culture flask to undergo routine culture. The 
procedure for the recovery of cells from liquid nitrogen was the same for all cell lines.
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2.2. Primary Culture
2.2.1. Primary Culture of Muriue Brain and Lung Microvascular Endothelial 
Cells
The development of the individual techniques for the isolation and culture of murine 
brain and lung microvascular endothelial cells will be discussed in future chapters (see 
sections 3 and 4). Several of the materials and methods utilised in the finalised 
techniques established for isolation and culture of microvascular endothelial cells were 
common for both brain and lung tissue.
2.2.2. C57 Mice
Both male and female C57 mice were used for preparation of microvascular endothelial 
cells. The mice were obtained from Harlan Olac Ltd. Oxon, England.
2.2.3. Buffer and Stock Solutions
Preparation o f HEPES buffer.
A HEPES buffer solution comprising of Ca/Mg-free HBSS (with phenol red indicator) 
with between 10mM-25mM HEPES (4-(2-hydroxyethyl)-1 -piperazineethanesulphonic 
acid, Calbiochem), 100 I.U./ml penicillin and 100 jig/ml streptomycin was aseptically 
prepared one day prior to use. The buffer was adjusted, to pH7.4 with 1M NaOH and 
stored overnight at 4°C.
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Immediately prior to use the buffer was oxygenated (95%C>2 / 5%CC>2) for 10 minutes 
under sterile conditions. In addition the buffer was supplemented with bovine serum 
albumin (BSA, Sigma fraction V) in order to produce a final concentration of 0.5% 
BSA. The final solution was readjusted to pH7.4 with 1M NaOH.
Preparation o f BSA solution
A 25% BSA solution was prepared in HEPES buffer solution one day prior to use. The 
BSA powder was scattered on the surface of the buffer and allowed to dissolve slowly 
for approximately P/2 hours to avoid the BSA congealing. The BSA solution was 
subsequently filtered using a 0.8pm filter, thereafter sterilised using a 0.2pm filter and 
stored in a sterile universal vial at 4°C overnight.
Preparation o f enzyme solutions
The basic enzyme digestion mixture consisted of 0.1% collagenase/dispase obtained from 
Boehringer Mannheim, dissolved in a solution of Ca/Mg- free HBSS containing 10 mM 
HEPES, 100 IU/ml penicillin and 100 pg/ml streptomycin. The enzyme solution was 
sterile filtered using a 0.2pm filter, aliquoted and stored at -20°C.
DNase-1 and TLCK (tosyl-lysine-chloromethyl-ketone) were both obtained from Sigma. 
DNase-1 (2000U/vial) was dissolved in 1ml Ca/Mg-free HBSS, dispensed into 200pl 
aliquots and stored at -20°C. TLCK was dissolved in freshly double distilled water 
(2.49mg/20ml), sterile filtered, divided into aliquots and stored at -20°C.
Before use, the enzyme digestion solution was warmed to 37°C and oxygenated under 
sterile conditions for 2-3 minutes. The solution was readjusted to pH 7.4 and 
supplemented with 20 units/ml DNase 1 and 0.147 pg/ml TLCK.
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2.2.4. Preparation of a Percoll Gradient
50% isotonic Percoll gradient medium was aseptically prepared and stored at 4°C until 
required. The Percoll gradient medium consisted of 50ml Percoll, obtained from Sigma, 
with the addition of 5.5ml of 10X strength HBSS containing calcium and magnesium and 
45ml of IX strength HBSS. The pH was adjusted to pH7.4 with 10% HC1.
The ultracentrifuge tubes required for the preparation of the Percoll gradient were 
cleaned and sterilised prior to use. The screw capped ultracentrifuge tubes (10ml size, 
Dupont (UK) Ltd) were cleaned by sonication in Milton sterilising fluid, filled with 
double distilled water and resonicated before use. The tubes were sterilised by shaking 
with ethanol for approximately 2-3 minutes and rinsed with buffer. Fresh buffer was 
added to the tubes and agitated on a shaker at 37°C for approximately 20 minutes.
The Percoll gradient medium was allowed to warm up to room temperature and the pH 
carefully readjusted. Under sterile conditions 7ml of the Percoll gradient medium was 
transferred to the ultracentrifuge tubes and the gradient was formed by 
ultracentrifugation at 25000g for 1 hour at 4°C (16500rpm on a Beckman L8-70M 
ultracentrifuge with a 70,000rpm Type70.ITI rotor head, serial number 6E 1064).
2.2.5. Preparation of Collagen Coated Plates
Collagen type 1 from calf skin (Sigma) was required as an extracellular matrix. Under 
sterile conditions, 50mg collagen was dissolved in a few drops of glacial acetic acid and 
diluted with 150ml of sterile double distilled water. The collagen solution was divided 
into aliquots and stored at -20°C.
Collagen coated plates were freshly prepared on the day of use. 96-well plates were 
incubated with lOOpl of collagen solution per culture well, for 24 and 6-well plates
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0.25ml and 1ml of collagen solution, respectively, was required for each well. The plates 
were incubated at room temperature for 1-2 hours.
Following incubation, the collagen was fixed on to the plates by exposure to ammonia 
vapour according to the following protocol. In a fume hood, approximately 3-5 ml of 
ammonia solution (BDH chemicals) was added to tissue in a plastic box. Under sterile 
conditions the collagen solution was carefully removed from the plates, these were then 
transferred to the fume hood where they were exposed to the ammonia vapour for 10 
minutes. The plates were removed from the vapour and washed, under sterile 
conditions, with Ca/Mg-free HBSS. After three washes the plates were incubated with 
Ca/Mg-free HBSS at 37°C until required. This procedure could be carried out at any 
time during the day they were required provided the plates were not allowed to dry out 
at any point.
2.2.6. Equipment
Preparation o f dissection equipment
All dissection instruments were washed thoroughly with double distilled water, covered 
with aluminium foil and sealed with autoclave tape. The instruments were sterilised in an 
autoclave at 121°C for 15 minutes. To maintain sterility, all instruments were soaked in 
70% alcohol during the dissection procedure.
Preparation o f glassware andpipettes
All items of glassware and re-usable plastics were sterilised by autoclaving (see section 
2.1.3). The Pasteur pipettes, some of which were fire polished in a Bunsen flame to 
constrict the tips, were plugged with cotton wool sealed in autoclave bags and 
autoclaved at 121 °C for 15 minutes.
54
Dissection conditions
All dissection work carried out under aseptic conditions was performed in an open 
fronted laminar flow cabinet (Fellclean air Ltd), swabbed with 70% alcohol. Non-sterile 
preparations were carried out on the bench.
2.2.7. Primary Culture Medium and Supplements
Tissue culture medium
Lung and brain microvascular endothelial cells were grown in Ham's F-10 nutrient mix 
obtained from Gibco as a 10X concentrated liquid without sodium bicarbonate. The 
medium was diluted to IX with sterile, freshly double distilled water as required.
Tissue Culture Supplements
Stock solutions of penicillin (5000 I.U./ml) and streptomycin (5000pg/ml) (pen/strep) 
and L-glutamine (200mM) were divided into 5ml aliquots and stored at -20°C.
Endothelial cell growth supplement (ECGS), obtained from Sigma in a 15mg vial was 
dissolved in 2ml Ca/Mg-free HBSS, dispensed into 20 x I O O j l i I  aliquots and stored at - 
20°C.
A stock solution of heparin was prepared by dissolving 400mg (176 units/mg) in 50 ml 
Ca/Mg-free HBSS. This solution was sterile filtered, divided into 4-5ml aliquots and 
stored at -20°C.
Amphoteracin B (Fungizone) was obtained sterile from Gibco, as a 250pg/ml stock 
solution prepared in water. It was divided into 4-5ml aliquots and stored at -20°C.
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Foetal calf serum, obtained from Flow laboratories, (batch number 10855) was divided 
into 20ml aliquots and stored at -20°C.
Platelet poor human serum (PPHS) was obtained from Sigma (batch number 122H9300), 
sterile filtered using a 0.2pm filter, divided into 10ml aliquots and stored at -20°C.
A solution of various growth supplements was prepared containing:
Double distilled water 10ml
Vitamin C (Ascorbic acid, BDH chemicals) lOmg/ml 500pl
Glutathione (reduced form, Sigma) 325mg
Insulin (from bovine pancreas Sigma) 5mg
Transferrin (bovine, iron free, Sigma) 5mg
Selenium dioxide (Sigma) 500pg/ml lOpl
The supplement solution was sterile filtered, divided into 1ml aliquots and stored at 
-20°C.
Hams F-10 medium was prepared aseptically, each time it was required, from sterile 
components according to the following recipe:
IX Hams F-10 medium 10ml








2.2.8. Growth of Cells on Filter Membranes
Preparation o f filters
Filter culture was performed on transparent Falcon cyclopore cell culture inserts (25mm 
diameter) suitable for use in 6-well plates, where the pores on the membrane were
0.45pm in diameter. The filters were transferred to 6-well plates using sterile forceps, 
some of the filters were coated with collagen type 1 following the same method used for 
coating the culture well plates. The filters were prepared for seeding by applying 1.5- 
2.5ml of complete culture medium to each well of the 6-well plate (basolateral section) 
and 1.5-2.5 ml of medium to each filter chamber (apical section). The plates were placed 
in a humidified C02 incubator at 37°C to ensure that the filter was sufficiently moist 
whilst the cells were being prepared for seeding.
Culture on filter membranes
Cells were seeded directly from primary culture or subculture following growth on 
collagen coated 6-well plates, where the appropriate trypsinization procedures were used 
for each cell type (see sections 3.2.5 and 4.2.1). The cells were added to the apical 
chamber, at the required density, in complete culture medium. The medium from the 
apical chamber containing non-adherent cells was changed after 2-4 hours in culture, 
thereafter the medium from both chambers was changed on alternate days using a sterile 
long glass Pasteur pipette.
The growth and morphology of the cells on filter membranes was assessed at regular 
intervals using light and electron microscopy (see section 5.2.1).
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3.1. Introduction
The preliminary studies of lung microvascular endothelial cell culture were based on 
several published methods for large vessel and microvascular endothelial cell isolation 
and culture (Folkman et a l, 1979; Gitlin and D'Amore 1983; Zetter 1984; Haisch et a l, 
1990; Abbott et a l, 1992; Belloni et a l, 1992; Nishida et a l, 1993). A wide variety of 
isolation techniques, extracellular matrices and culture conditions were studied in order 
to obtain the optimum conditions for isolation and culture of murine lung microvascular 
endothelial cells. These optimum conditions included the isolation of the maximum yield 
of endothelial cells, without excessive contamination by large vessel endothelia or non- 
endothelial cells. In addition, modification of the culture conditions was also required to 
provide optimum growth, whilst maintaining the characteristic cell morphology in 
primary culture and subculture.
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3.2. Materials and Methods
3.2.1. Preliminary Isolation Technique
The original isolation technique involved the use of six C57 mice, either male or female, 
for each preparation (see section 2.2.2). The mice were killed by cervical dislocation, the 
lungs removed and transferred into a sterile universal vial containing Ca/Mg-free HBSS. 
Under sterile conditions the peripheral section of the lung was dissected and chopped 
into 1 -2mm pieces. The dissected lung tissue was subsequently incubated for 1 hour at 
37°C with 0.5% collagenase type II (Sigma), dissolved in high glucose DMEM (Sigma).
Following the incubation procedure the enzyme digestion mixture was centrifuged at 
200g for 10 minutes and the pellet was resuspended in Ca/Mg-free HBSS. This process 
was repeated and the pellets were combined, and recentrifuged at 400g for 5 minutes. 
The supernatant was removed and the pellet was suspended in M l99 supplemented with 
7.5% NaHC(>3, 2mM L-glutamine, 50IU/ml penicillin, 50pg/ml streptomycin, 1% 
NEAA and 2.5pg/ml Amphoteracin B, and the cells were plated on to a gelatin coated 6- 
well culture dish (see section 3.2.3).
After 2-3 hours in culture the cells were washed with Ca/Mg-free HBSS and incubated 
with fresh medium. After 24 hours in culture the medium was removed and replaced 
with fresh Ml 99 with supplements and in addition containing 100jug/ml Heparin and 
75pg/ml ECGS but without Amphoteracin B. This represented the standard culture 
medium used in preliminary experiments.
60
3.2.2. Variations in the Isolation Technique.
In order to improve the isolation protocol and increase the initial yield of cells isolated 
from the tissue, variations in the isolation technique were investigated. Improvements of 
the isolation protocol were assessed daily by examination of the cultures using phase 
contrast light microscopy.
Enzyme digestion
Variations in the enzyme digestion technique were examined. Sigma type II collagenase 
concentrations were varied between 0.05% and 0.5% for digestion times of 30 minutes 
to 3 hours. Other types of collagenase were investigated: collagenase/dispase obtained 
from Sigma and collagenase/dispase from Boerhinger. The use of TLCK and DNase 1 in 
the enzyme digestion mixture and the effect of a second enzyme digestion step was also 
examined (Hughes and Lantos 1986, Audus and Borchardt 1986). Pretreatment of the 
lungs to cause initial breakdown of the tissue by perfusion of the lungs in situ with 
solutions of collagenase (0.05-0.1%) in Ca/Mg-free HBSS was also investigated (Belloni 
etal ,  1992).
Homogenisation
A homogenisation step using between 2 and 10 strokes of a Dounce homogeniser was 
examined as a method of breaking up the tissue further. This was followed by further 
shearing of the tissue with a long glass Pasteur pipette to ensure that the maximum yield 
of cells was being obtained from the lung tissue. The effect of sieving the tissue through 
nylon mesh to separate out fragments on the basis of size was also investigated.
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Centrifugation
The effect of variation in the speed and the length of time of centrifugation was 
examined. Speeds of between 200g and 800g for up to 10 minutes were applied during 
washing steps to establish whether these variations caused any disruption of the tissue. 
Disintegration of the tissue to some extent during the initial washing procedure would be 
beneficial, however in the later stages of the isolation procedure harsh disruption of the 
fragments was not recommended.
Separation of the homogenised tissue by density dependent centrifugation was studied. 
The tissue was centrifuged on a BSA density gradient (between 10 and 25%) at 1200g 
for 15 minutes (Zetter, 1984). The use of a 40%/25%, discontinuous Percoll gradient 
(Haisch et a l , 1990) and a 50% preformed isotonic Percoll gradient (Abbott et al., 
1992) was also investigated in order to improve separation of the capillary fragment.
3.2.3. Culture Conditions: Substrata and Extracellular Matrices.
Substrata
The effect on cell growth and morphology of the density at which the cells were seeded 
from initial culture and subculture, and the different substrata was investigated. The cells 
were cultured on 96, 24, and 6-well plastic tissue culture plates (Corning), Primera 
culture plates (Falcon, Becton Dickinson) and 2-well chamber slides (Lab-Tek, Nunc 
Inc.). Cells were also grown on transparent anopore filter membranes (Nunc), Millipore 
CM transparent filters and Falcon transparent filter membranes (Becton Dickinson).
Extracellular matrices
A variety of extracellular matrices were tested to establish the most suitable conditions 
for cell growth. Tissue culture wells were coated with sterile solutions of 0.5% and 1%
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gelatin (tissue culture grade, Sigma). The gelatin solution was incubated on the plates 
for 1 hour at room temperature and the excess solution was aspirated prior to the 
addition of the cells.
The effect on cell growth and morphology of collagen type 1 from calf skin and rat tail 
was investigated. The collagen was fixed to the plastic wells by ammonia vapour, and 
washed with Ca/Mg-free HBSS prior to the addition of the cells (section 2.2).
Cell growth and morphology on fibronectin coated wells was also studied. A 25pg/ml 
solution of fibronectin was prepared in Ca/Mg-free HBSS and filter sterilised. The 
fibronectin was added to the wells, and the excess was aspirated after 1 hour.
Cell growth and morphology was examined on the basement membrane Matrigel (see 
section 5.2.5).
3.2.4. Culture Conditions: Medium, Serums and Growth Factors
Culture medium
Several types of culture medium were studied in order to establish the most suitable 
conditions for microvascular endothelial cell culture. The cells were cultured in Ml 99, 
DMEM, Dulbecco's Modefied Eagle's Medium with F12 nutrient mix (DME/F12), and 
Hams F10 (all obtained from Gibco). In each instance the medium was supplemented 
with L-glutamine, penicillin/streptomycin, and various concentrations of sera and growth 
factors.
The effect on cell culture of conditioned medium was also studied. RPMI 1640 medium 
was tumour conditioned by incubation for 2 days with B16 melanocytes and was 
combined as a 1:1 mixture with M l99. Medium conditioned with DMEM from BAE-1 
cells and 3T3-L1 fibroblasts (both used after 2 days incubation) was also combined 1:1
63
with Ml 99. The use of endothelial cell plating medium (serum free) and endothelial cell 
growth medium (serum free), both obtained from Sigma, was also examined.
Growth serum
The culture medium was supplemented with between 10 and 20% foetal calf serum in 
order to determine the most suitable requirements for endothelial cell growth This was 
determined by assessing the increase in the size of the endothelial cell colonies and the 
extent of non-endothelial cell growth.
The effectiveness of supplementing the medium with platelet poor human serum (PPHS) 
in conjunction with foetal calf serum was also studied (Gitlin and D'Amore 1983, Belloni 
et al., 1992). The cells were cultured with between 0 % and 5% PPHS in the presence 
of 10-20% FCS.
Growth factors and supplements
The culture medium was supplemented with 75pg/ml ECGS, 80pg/ml heparin, and the 
effect of the addition of the supplements glutathione, transferrin, vitamin C, selenium 
dioxide (see section 2.2.7) was also observed.
3.2.5. The Final Method for the Isolation and Culture of Murine Lung 
Microvascular Endothelial Cells
For each preparation ten C57 mice, either male or female, of approximately 30-40g 
weight were killed by cervical dislocation. The lungs were exposed and perfused in situ 
with 0.05% collagenase (Sigma Type II) in Ca/Mg-free HBSS which had been filter 
sterilised. The perfused lungs were excised and transferred into a sterile 30 ml universal 
vial containing HEPES buffer solution at 4°C
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Under sterile conditions, the lungs were carefully immersed in 70% ethanol for 30 
seconds and transferred directly into a beaker containing fresh buffer solution at 4°C. 
This process was carried out in order to fix the pleural membrane which contains 
mesothelial cells.
Only the peripheral section of each lobe of the lungs was required for the isolation 
procedures this selected for microvascular endothelial cells without large vessel 
contamination. The appropriate section from each lung was removed, chopped into 1- 
2mm pieces and transferred into a fresh buffer solution. The lung tissue was strained in 
order to remove the buffer and incubated for 1 hour at 37°C, with gentle agitation, in 10 
ml of an enzyme digestion mixture consisting of 0.1% collagenase/dispase solution 
containing 20U/ml DNase 1 and 0.147gg/ml TLCK.
The incubate was homogenised using a Dounce homogeniser (4 strokes) and sheared 
using a long glass Pasteur pipette for 5 minutes to break up the fibres. The suspension 
was centrifuged at 600g for 5 minutes (Jouan bench centrifuge), the supernatant carefully 
removed and the pellet resuspended in 15ml of 25% BSA (prepared in buffer). The 
resulting suspension was sheared again with a Pasteur pipette to ensure complete 
dispersal of the tissue and centrifuged at 1200g for 15 minutes.
The pellet was resuspended in buffer and the BSA solution was centrifuged again at 
1200g for a further 15 minutes. The pellets were pooled together, washed with buffer, 
centrifuged at 600g for 5 minutes and resuspended in the remaining 5ml of the enzyme 
mixture for a further 3 hours at 37°C under gentle agitation.
The enzyme digest was dispersed using a Pasteur pipette and centrifuged at 600g for 5 
minutes. The supernatant was removed and the pellet resuspended in 1ml of buffer. The 
cell suspension was layered on top of a pre-set 50% isotonic Percoll gradient and 
centrifuged at 1200g for 20 minutes. The capillary fragments, appearing approximately 
one third of the way down the gradient, were transferred into a clean universal vial,
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containing buffer, and washed twice in buffer by centrifugation at 600g for 5 minutes. 
The pellet was resuspended in a 1:1 mixture of buffer and Hams-FlO, centrifuged at 
600g for 5 minutes and finally suspended in freshly prepared complete culture medium.
The fragments were plated on to 6 wells of a 35mm tissue culture dish pre-coated with 
collagen type I, from calf skin (see section 2.2.5). After 2-3 hours in culture the medium 
was removed, the cells washed with Ca/Mg-free HBSS. The cultures were incubated in 
a humidified C02 incubator at 37°C in fresh complete culture medium (see section 
2.2.7), thereafter, the medium was changed every other day. After 4 days in culture the 
PPHS was reduced in concentration from 5% to 2%.
Subculture o f the cells
Due to the presence of several contaminating cell types, especially smooth muscle cells, 
pericytes and fibroblasts, the endothelial cells were selectively cloned after approximately 
5-7 days in culture. The cultures were washed 3 times with Ca/Mg-free HBSS. 
Penicylinder cloning rings (size 7mm diameter) were fixed to the surface of the dish with 
sterilised high density vacuum grease (Dow Coming, USA) and the selected colonies 
were trypsinised using 0.05% trypsin/0.02% EDTA for 2-5 minutes at 37°C.
The action of the trypsin was inhibited by the addition of culture medium and the cells 
were gently removed using a long glass Pasteur pipette. The cells were plated on to 
freshly collagen coated 6-well tissue culture dishes in complete culture medium.
3.2.6. Cell Purity
Several non-endothelial cell types were regularly found to contaminate the culture. 
Contaminating cells included macrophages, pericytes, smooth muscle cells, fibroblasts 
and possibly mesothelial cells. Non-endothelial cells in culture were identified by
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morphology and through characterisation studies (see section 5). The extent of 
contamination was examined routinely by light microscopy and photographed using a 
Nikon 35mm camera. The following procedures were employed in order to reduce non- 
endothelial cell contamination:
1. The lungs were carefully washed with 70% ethanol in order to fix the pleural 
membrane containing mesothelial cells (Chopra et al., 1990; Nishida et al., 1993).
2. The cells were washed with Ca/Mg free HBSS 2-3 hours after plating to remove any 
unattached cells (Zetter 1984).
3. After 3 days in culture the cells were incubated with Ca/Mg-free HBSS for 15-20 
minutes at 37°C (Abbott et al., 1992).




3.3.1. Preliminary Isolation and Culture
The original isolation procedure used the lungs of six C57 mice. Cells obtained by this 
procedure were seeded on to one 6-well tissue culture plate. The tissue was dissected 
selecting only the peripheral section in order to reduce the possibility of contamination 
from large vessel endothelial cells. Having minced the tissue, it was centrifuged at a very 
low speed (200g) in an attempt to remove some of the red blood cells and open the 
microvessels, enabling access of the enzyme solution to the microvascular endothelial 
cells.
The lung tissue was incubated with a 0.5% collagenase enzyme digestion solution 
initially for 1 hour at 37°C. This collagenase digestion initiated the disintegration of the 
tissue however the pieces remained almost completely intact. The cells removed by 
digestion with the enzyme solution were collected by gentle centrifugation (200g) of the 
tissue forming a pellet. This cell pellet was washed by further centrifugation and plated 
on to gelatin coated plates in culture medium M l99.
This preliminary isolation technique was very unspecific, and produced few endothelial 
cells. The endothelial cells obtained by this method were isolated as single cells, which 
after only a few days in culture became non-viable. Alternatively, any viable cells were 
over-grown by faster proliferating non-endothelial cell contaminants such as fibroblasts 
and smooth muscle cells. Improvement of the isolation technique was required to 
alleviate the lack of specificity and the problem of single cell production.
As a result of the preliminary isolations, several factors were assessed as possible causes 
of this lack of specificity produced by the initial method. Collagenase digestion may
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have been too harsh, causing complete disruption of the capillary fragments thereby 
increasing the likelihood of fibroblasts, smooth muscle cells and macrophages to 
contaminate the culture. Alternatively it was also possible that digestion of the tissue 
was incomplete and vessel fragments were not being released from the surrounding 
connective tissue.
As well as the problems posed by the isolation technique, it was also necessary to 
consider the effectiveness of the extracellular matrix, gelatin, to provide a suitable 
attachment factor for the cells and the ability of the medium to satisfy the growth 
requirements.
3.3.2. Development of the Isolation and Culture Techniques.
Initial variations in enzyme digestion
The initial alterations to the preliminary isolation technique was to the collagenase 
digestion. The concentration of collagenase was maintained at 0.5% however, the 
duration of collagenase digestion was increased to 1%, 2, and 3 hours. This resulted in a 
notable increase of contaminating cells and no obvious capillary fragments being 
produced, suggesting excessive non-specific disruption of the tissue. A reduction in 
length of collagenase digestion to 30 minutes however, reduced the quantity of 
contaminating cells and after 2 days in culture a few small colonies of 10-15 cells were 
apparent, (Figure 2) as well as several single cells which became non-viable after 2-3 
days in culture. As a result of these findings the effect of a reduction in the 
concentration of collagenase used over a longer time interval was examined in an attempt 
to increase the yield of cell colonies isolated.
Isolation by collagenase digestion was studied with 0.2% and 0.1% collagenase solutions 
for time periods of 30 minutes up to 3 hours. Although a few colonies were isolated
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using these alternative protocols, none of these alternative isolation procedures resulted 
in a substantial increase in the yield of cell colonies produced. Due to the relative 
ineffectiveness of these protocols, the use of collagenase/dispase was investigated as an 
alternative to the harsher collagenase. The effect of collagenase with the neutral 
protease dispase, which offers a more gentle enzymic digestion leaving the blood vessels 
intact (Zetter 1984), was therefore be assessed for an increased period of incubation. 
This study was accompanied with an investigation into the use of a second mild enzyme 
digestion step in an effort to provide a more sensitive and specific isolation procedure.
Under the culture conditions employed at the time of the initial isolation procedures, any 
colonies isolated by collagenase digestion did not proliferate, therefore in parallel with 
the manipulations in the isolation technique, improvements in the culture conditions were 
also investigated.
Initial variations in culture conditions
The contents of the culture medium were very important for cell growth, however, 
suitability of the medium may vary with the species and tissue from which the cells were 
isolated (Gitlin and D' Amore 1983). A wide variety of culture medium, supplements 
and sera have been used in the study of endothelial cell culture offering various results . 
In this study Medium 199 was chosen as the standard culture medium as it had provided 
suitable culture conditions for large vessel endothelial cells isolated by primary culture. 
The lack of cell growth from initial isolations however, prompted an investigation into 
the effectiveness of Ml 99 as a suitable culture medium for microvascular endothelial 
cells.
For each isolation procedure the cells were seeded on to one 6-well plate. A direct 
comparison was made between the standard M l99 and the alternative medium. For each
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isolation protocol, 3 wells were incubated with standard culture medium M l99 and 3 
wells were incubated with the alternative culture medium.
Altering the culture conditions offered varying results. Conditioned medium is thought 
to be very useful in promoting culture of capillary endothelial cells (Folkman et al., 1979; 
Beer Stoltz and Jacobson, 1991), however, culture with a 1:1 mixture of M199 and 
either tumour conditioned medium or medium conditioned with BAE-1 cells or 
fibroblasts did not show any significant improvement on endothelial cell growth 
compared with M l99 alone. Culture with serum free endothelial cell plating and growth 
medium had no effect on cell growth. The ineffectiveness of these different types of 
culture medium to promote cell growth could have been effected by the sparse cell 
densities.
Incubation with DME/F-12 nutrient mix supplemented with increased concentrations of 
FCS (20%) and platelet poor human serum (5%) provided slightly more suitable culture 
conditions for cell growth. The endothelial cell colonies were healthy and began to grow 
slowly; after 3-4 days the colonies contained 20-30 cells (Figure 3). These culture 
conditions however, also caused rapid proliferation of fibroblast and smooth muscle cells 
and after 5-6 days in culture the cells became completely overgrown with non-endothelial 
cell contaminants. Due to the lack of improvement in the selective growth of endothelial 
cells from these alterations, further modifications to the isolation procedure and culture 
conditions were sought.
Centrifugation and the introduction o f a second enzyme digestion
Variations of the centrifugation technique were investigated in order to determine the 
effect of the speed and duration of centrifugation on the cells during the washing 
procedures. Centrifugation speeds of 200-800g for 5-10 minutes altered the size of the 
cell pellet produced. The minimum speed and duration of centrifugation used during
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washing procedures did not appreciably reduce the amount of non-endothelial cell 
contamination. The maximum centrifugation speeds produced a larger pellet containing 
some debris, however this did not attach to the culture well and contamination by non- 
endothelial cells was not appreciably effected. The variations in centrifuge speed and 
duration did not appear to cause damage to the cells and therefore a higher 
centrifugation speed was chosen as this provided the most satisfactory washing regime 
whilst ensuring that no cells were lost in the supernatant. For routine washing 
procedures 600g for 5 minutes was employed as standard speed and duration of 
centrifugation. This centrifugation regime appeared to have no damaging effect on the 
isolation procedure.
A modification of the isolation technique involving two gentle enzyme digestion steps 
was investigated. A comparative study between collagenase/dispase and collagenase 
both obtained from Sigma was conducted using the two step enzyme digestion protocol. 
The dissected lung tissue was incubated with the appropriate enzyme (0.1 %) for 45 
minutes to initiate disintegration of the tissue. The incubate was then sheared with a 
Pasteur pipette in order to assist the break up of the connective tissue and expose the 
microvessels. This was followed by a second enzyme incubation for 2 hours to further 
digest the tissue fragments and remove any pericytes attached to the basement 
membrane. The use of 0.1% collagenase resulted in a large increase in non-endothelial 
cell contamination. Although the use of collagenase/dispase did not offer any significant 
improvement over collagenase alone in the isolation of endothelial cell colonies, no 
appreciable increase in the proportion of contaminating cells present was observed.
Introduction o f a homogenisation procedure
At this point the use of a homogenisation step was employed in an attempt to disrupt the 
connective tissue and provide easier access of the enzyme to the microvessels. The 
tissue was washed by centrifugation and incubated in 0.1% collagenase/dispase (Sigma)
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for one hour. The tissue was then homogenised with 2 strokes of a Dounce homogeniser 
and sheared using a Pasteur pipette. The resulting suspension was centrifuged and 
resuspended in collagenase/dispase for a second period of incubation lasting 2 hours. 
After the second incubation the pellet obtained by centrifugation was washed, 
resuspended in standard M l99 culture medium and plated on to gelatin coated culture 
wells. The homogenisation procedure produced a large amount of tissue debris which 
did not attach to the wells and was removed when the medium was changed.
This homogenisation and two step enzyme digestion technique showed an improvement 
in the isolation of the cells, a few colonies of 10-15 cells were isolated but again did not 
grow. The yield of non-endothelial cells isolated did not increase significantly and 
therefore manipulation of this method was investigated in order to increase the yield and 
selectivity of the isolation technique. This homogenisation and two step digestion 
method was also conducted on lung tissue using to 0.1% collagenase. This resulted in a 
large increase in contaminating cells which masked any evidence of endothelial cell 
isolation.
Cell sieving and preliminary Percoll gradient centifugation
Cell sieving using nylon screens with different mesh sizes, is a technique widely 
employed to selectively collect vessel fragments on the basis of size without 
contaminating single cells. The effect of cell sieving was therefore investigated in an 
attempt to selectively isolate microvascular endothelial cell fragments. This procedure 
was ineffective and rapidly dismissed because of the gelatinous nature of the 
homogenised tissue and the difficulty of successfully removing all of the necessary 
material from the sieve.
Another attempt to selectively isolate the endothelial cells involved the use of a Percoll 
gradient. A discontinuous density gradient was prepared using layers of 40%, 25% and
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0% Percoll and the cell suspension was centrifuged at 600g for 15 minutes (Haisch et al 
1990). The homogenised tissue however did not show much separation under these 
conditions therefore an alternative Percoll gradient was required
Further modifications o f the isolation technique
Pretreatment of the lungs in situ was investigated in order to remove the blood from the 
vessels and give the vessels an initial exposure to collagenase (Belloni et al., 1992).
0.1% collagenase was considered to be too harsh as it resulted in excessive break up of 
the vessels, therefore a solution of 0.05% collagenase was employed.
Collagenase/dispase obtained from Boehringer was prepared in a solution of HEPES 
buffer. The pretreated tissue was incubated in collagenase/dispase for one hour with 
gentle agitation and homogenised with two strokes of the homogeniser. After washing 
with buffer and shearing with a Pasteur pipette the homogenate was resuspended in 
enzyme solution for a further 2 hours, washed and seeded on to a gelatin coated 6-well 
plate in M l99.
These modifications resulted in an increased yield of capillary fragments however, non 
endothelial contaminants were also prevalent (Figure 4). Further modifications of these 
techniques were employed in an attempt to increase the purity of the cultures. The 
collagenase/dispase solution was supplemented with TLCK and DNase 1. The solution 
was supplemented with TLCK which inhibits clostripain, a non-specific proteinase 
contaminant of collagenase preparations which damages cells (Hefley et al., 1981). 
DNase 1 was used to degrade DNA liberated from ruptured cells.
Following the initial preparation of the tissue and the enzyme digestion, the homogenised 
tissue was centrifuged using 25% BSA at 1200g for 15 minutes. This centrifugation step 
further purified the culture by causing the sedimentation of the more dense material 
which consisted principally of the capillary fragment. At this stage the capillary
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fragments were not sufficiently disrupted, and were therefore incubated with the enzyme 
solution for a further 2 hours before seeding. This modification resulted in a slightly 
purer culture, however contaminating cells present especially pericytes were possibly 
introduced into the culture as a result of the further disruption of the fragments during 
the second enzyme incubation. Therefore, purification of the culture following the 
second incubation was required, this involved separation using 50% Percoll gradient 
centrifugation. Centrifugation with 10% and 15% BSA (Madri et al., 1983) did not 
cause any separation and the final culture became overgrown with contaminating cells at 
a more accelerated rate.
Percoll gradient centrifugation
An increase in the incubation time of the second enzyme digestion to three hours did not 
appear to appreciably effect the non-endothelial cell contamination, in fact, further 
digestion the tissue slightly increased the number of colonies observed. Further 
modifications in the duration of the second incubation period however, resulted in 
excessive disintegration of the tissue fragments and an increase in single cell production.
Following the second incubation the cell pellet was loaded on top of a pre-spun 50% 
isotonic Percoll gradient and centrifuged for 20 minutes at 1200g. Percoll gradient 
centrifugation resulted in the formation of a distinct band of red blood cells at the bottom 
of the gradient and a band of single cells near the top of the gradient. The clusters of 
endothelial cells appeared in the centre of the gradient. This band also contained some 
fragments of lung tissue not completely disrupted by homogenisation or enzyme 
digestion; when seeded on to the wells however, this material did not attach and was 
therefore removed when the wells were washed and the medium changed.
Final modifications o f the isolation protocol
IS
The final isolation technique that was established involved pretreatment of the lungs in 
situ with 0.05% collagenase to initiate tissue digestion. The first one hour enzyme 
incubation was followed by homogenisation and shearing of the tissue to expose the 
microvessels. The fragments were separated by density centrifugation with 25% BSA, 
and incubated with the enzyme solution for a further three hours. The cell clusters that 
were obtained following this enzyme digestion procedure were separated by a 50% 
Percoll gradient centrifugation before plating on to one 6-well tissue culture dish (Figure 
5).
Subsequent attempts to improve the isolation technique met with some success, resulting 
in an increase in the microvascular endothelial cell yield and a decrease in the non- 
endothelial cell contamination. The variation in the yield of the cells isolated was 
assessed when the tissue was homogenised with up to ten strokes of the Dounce 
homogeniser. This study showed that four or five strokes of the homogeniser caused 
sufficient disruption to release the microvessels from the connective tissue but further 
homogenisation resulted in excessive disruption of the tissue fragments and therefore 
increased isolation of single cells and contaminants.
An important alteration which was made to the isolation technique involved treatment of 
the lungs immediately after they were excised. The lungs were treated with 70% ethanol 
in order to devitalise the pleural membrane which contains mesothelial cells (Chopra et 
al., 1990, Nishida et al., 1993). These are not immediately distinguishable from 
endothelial cells therefore removal of the pleural membrane was essential. As the pleural 
membrane of murine lungs is too small to remove manually therefore the method of 
fixing the membrane with ethanol was employed. The ability to distinguish between 
endothelial cells and mesothelial cells by conventional characterisation techniques was 
very difficult. Mesothelial cells can be distinguished from endothelial cells in culture, as 
microvascular endothelial cells can be induced in vitro to undergo angiogenesis (Chung- 
Welch et al., 1989). This is demonstrated by characterisation studies (section 5).
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Following the limited success of the initial variations in the culture conditions, further 
modifications to the growth conditions were investigated. This occurred in parallel with 
the modifications to the isolation technique described previously, and with the 
modifications of the extracellular matrix.
Alternative attachment factors and culture medium
Gelatin did not appear to be the most suitable attachment factor, as when the cells were 
disturbed, for example during washing, some of the cells had a tendency to detach from 
the surface of the well. As an alternative to gelatin, collagen type 1 from calf skin was 
used. This provided more suitable attachment for the cells and therefore a more 
satisfactory base for cell growth (Figure 6).
As an alternative to Ml 99, cell growth in Hams F-10 was investigated as this been 
shown to provide suitable culture conditions for brain microvascular endothelial cells 
(Abbott, et al. 1992). The medium was supplemented with concentrations of 10-20% 
FCS and 5% PPHS as was used with DME/F-12. Unlike cell growth in M199, in Hams 
F-10 the cells were able to form relatively large colonies. In the presence of 10% FCS 
and 5% PPHS the cells isolated seemed to grow successfully without being rapidly 
overgrown by non-endothelial cells. After the initial 3-4 days in culture the 
concentration of PPHS was reduced to 2% with no notable effect on cell growth being 
observed. 5% PPHS was required on first plating the cells as it appeared to stimulate 
initial endothelial cell growth without accentuating the growth of contaminating cell 
types. Cells could be grown for up to 21 days in culture however after this time 
contaminating cells were extensively incorporated into endothelial cell colonies therefore, 
purification by subculture prior to this time was required.
In addition to high concentrations of sera, the medium was supplemented with heparin 
which inhibits the growth of smooth muscle cells, and endothelial cell growth
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supplement. When used together heparin and ECGS have a synergistic effect increasing 
endothelial cell growth (Thornton et al., 1983; Abbott et al., 1992). Other supplements 
consisting of glutathione, selenium dioxide, transferrin, vitamin C and insulin were also 
beneficial in endothelial cell culture (Haisch et al., 1990; Abbott et al., 1992). Cell 
growth in Hams F10 medium in the presence of PPHS, ECGS and heparin offered the 
most suitable for endothelial cell proliferation and viability in culture. Figures 7, 8, 9 & 
10 depict the growth of lung microvascular endothelial cell colonies from day 1 to day 14 
in culture.
3.3.3. Lung Microvascular Endothelial Cell Growth and Morphology
When first plated out the capillary fragments isolated formed small colonies of 5-10 cells 
(Figure 5) and after 2-3 days in culture the fragments started to grow and divide as small 
colonies of polygonal shaped cells (Figure 7). However many of the single endothelial 
cells that were isolated became non-viable after approximately 3 days in culture. The 
cells remained in contact with the original colony and divided from the colony perimeter 
until they began to merge together after approximately 7 days in culture (Figure 11).
Cell purity
The contaminating cells that were observed in the cultures included fibroblasts, 
macrophages pericytes and smooth muscle cells (Figures 12, 13 & 14). The cultures 
were washed initially, 2-3 hours after plating; the clusters of endothelial cells adhered to 
the wells more rapidly than single cells, therefore this washing procedure considerably 
reduced contamination by non-endothelial cells. Treatment of the pleural membrane of 
the lungs with 70% ethanol was an important step in the elimination of contamination 
with mesothelial cells.
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Incubation of the cultures for 15 minutes at 37°C with Ca/Mg-free HBSS during the 
initial 2-3 days of culture also appeared to reduce the extent of non-endothelial 
contamination without affecting the endothelial cells themselves (Abbott et al., 1992). 
The endothelial cells show stronger adherence to the collagen coated surface of the wells 
and therefore incubation of the cells in a calcium free environment causes non-endothelial 
cells to detach more rapidly than the endothelial cells.
PPHS was used to supplement the medium as, unlike FCS, it does not contain the 
platelet factors released during clotting which are known to promote proliferation of 
non-endothelial cells such as fibroblasts, smooth muscle cells and pericytes (Gitlin and D' 
Amore, 1983). The presence of non-endothelial cells may however, contain some 
growth factors required for endothelial cell proliferation therefore a compromise between 
cell purity and cell proliferation may be necessary, as cells cultured in medium 
supplemented with PPHS alone did not appear to grow as rapidly as cells cultured with 
both PPHS and FCS.
Subculture
The procedure established for isolation of lung microvascular endothelial cells was 
modified in order to maximise the yield of endothelial cells while reducing non- 
endothelial cells to a minimum. The inability of the method to completely eliminate the 
presence of contaminating cells meant that the colonies formed needed to be subcultured 
by penicylinder ring cloning. Cultures allowed to grow to confluence from primary 
culture appeared heavily contaminated with non-endothelial cells. After approximately 7 
days in culture the colonies were cloned and seeded on to freshly collagen coated wells. 
These subcultured cells tended to grow and form colonies in a similar manner to those in 
primary culture (Figure 15). Subcultured cells reached confluence after approximately 
20 days in culture (Figure 16).
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Substrata and seeding densities
Cells were seeded on to 96, 24 and 6-well plates in order to determine the effect of the 
seeding density on cell growth. Attempts to grow cells on 96 and 24-well plates from 
the initial isolation were unsuccessful, as cultures which were contaminated with non- 
endothelial cells were overgrown rapidly and due to the size of the wells were difficult to 
purify . Attempts to grow cells on Primera 6-well plates designed specifically for 
primary culture (Falcon, Becton Dickenson) were unsuccessful as very few cells attached 
to the well. Cells obtained from the initial isolation were therefore seeded on to one 6- 
well plate, thus enabling cloning and purification techniques to be performed. Colonies 
isolated by the cloning technique were seeded on to 6-well plates. The cells obtained 
from this procedure were seeded at high density, as seeding cells in insufficient numbers 
resulted in a greatly reduced growth rate. Cells grown from subculture on 24-well plates 
were observed to grow more slowly even at the same relative seeding density, than cells 
grown on 6-well plates .
Cells for fluorescence microscopy were originally seeded on to glass coverslips coated 
with gelatin however although these cells were able to attach as single cells but did not 
grow. The uptake of fluorescent compounds by cells seeded on glass coverslips was 
identified by fluorescent microscopy, however in subsequent experiments involving 
fluorescence, cells were grown on plastic non-autofluorescent 2-well chamber slides as 
this demonstrated the fluorescent uptake by the cells under more suitable culture 
conditions.
For electron microscopy studies, cells were seeded on to collagen coated transparent 
Falcon filters and were exposed to medium from both the apical and basolateral 
chambers. The cells grew as colonies and appeared to have the same morphology under 
the light microscope as cells grown on plastic culture plates. The image obtained by light 
microscopy however was speckled in appearance due to shadows cast by the pores and 
the composition of the filters, making detailed examination of the cell culture and
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identification more difficult (Figure 17 & 18). Cell attachment on Nunc anopore 
transparent filters and Millipore CM transparent filters was poor regardless of being 
coated with gelatin or collagen.
Extracellular matrices
After establishing the isolation technique and culture conditions modifications of the 
attachment factors were investigated. Several attachment factors were assessed 
including gelatin, fibronectin and collagen. The treatment of the culture wells with 
collagen type 1 from calf skin provided the most suitable substrate for cell attachment, 
even in preference to type 1 collagen from rat tail. This was demonstrated in a study 
conducted in parallel with collagen from both sources. Gelatin (0.5% and 1%) showed 
some attachment however, cells that attached originally began to detach during the 
washing procedure. Fibronectin proved to be a suitable substrate for cell attachment and 
growth but showed no significant advantages over collagen. Cells seeded on to thin 
layer Matrigel coated wells resulted in the formation of tube-like structures characteristic 
of lung microvascluar endothelial cells (Figure 19).
Light, fluorescence and electron microscopy
Details of the materials and methods involved in these microscopy studies are shown in 
section 5.2.1
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Figure 2. A phase contrast photomicrograph showing a small colony of microvascular 
endothelial cells after 2 days in culture. The cells were isolated from murine 
lung following the preliminary isolation technique. Magnification X400
Figure 3. A phase contrast photomicrograph showing a small colony of microvascular 
endothelial cells after 3 days in culture. The cells were isolated by incubation 
with 0.1% collagenase for 3 hours and cultured in DME-F12 medium. 
Magnification X200
Figure 4. A phase contrast photomicrograph showing microvascular endothelial cell
clusters 1 day after plating. The cells were isolated using a modification of the 
preliminary isolation technique, which resulted in an increase in contaminating 
non-endothelial cells. Magnification X200
Figure 5. A phase contrast photomicrograph showing microvascular endothelial cell
clusters 24 hours after plating, where the cell clusters were separated by 50% 
Percoll gradient centrifugation. Magnification X400
Figure 6. A phase contrast photomicrograph showing a small colony of microvascular 
endothelial cells grown on a collagen coated culture well. Magnification 
X400.
Figure 7. A phase contrast photomicrograph showing a small colony of microvascular
endothelial cells after 2 days in culture. Magnification X400
Figure 8. A phase contrast photomicrograph showing a small colony of microvascular
endothelial cells after 7 days in culture. Magnification X200
Figure 9. A phase contrast photomicrograph showing a small colony of microvascular
endothelial cells after 10 days in culture. Magnification X200
Figure 10 A phase contrast photomicrograph showing a small colony of microvascular
endothelial cells after 14 days in culture. Magnification X200
Figure 11 A phase contrast photomicrograph showing 2 colonies of microvascular
endothelial cells merging together after 7 days in culture. Magnification X200
tt*
Figure 12 A phase contrast photomicrograph showing a small colony of microvascular 
endothelial cells and contaminating non-endothelial cells, probably pericytes 
and macrophages. Magnification X200
Figure 13. A phase contrast photomicrograph showing a colony of microvascular
endothelial cells and contaminating non-endothelial cells, probably fibroblasts. 
Magnification X400
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Figure 14. A phase contrast photomicrograph showing non-endothelial cell
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Figure 15. A phase contrast photomicrograph showing a colony of microvascular 
endothelial cells, passage 1, 7 days after plating. Magnification X200
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Figure 16. A phase contrast photomicrograph showing a confluent monolayer of 
microvascular endothelial cells, passage 1, after 20 days in culture. 
Magnification X200
Figure 17. A phase contrast photomicrograph showing a colony of microvascular 
endothelial cells grown on filter membranes from primary culture. 
Magnification X200
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Figure 18 A phase contrast photomicrograph showing a confluent monolayer of
microvascular endothelial cells grown initially on collagen coated culture wells, 
subcultured and seeded onto filter membranes. Magnification X200
Figure 19. A phase contrast photomicrograph showing microvascular endothelial cells




When developing this method for the isolation of lung microvascular endothelial cells the 
primary objective was to overcome the lack of specificity of some other reported 
techniques. Primary cultures of lung microvascular endothelial cells are highly likely to 
be contaminated with large vessel endothelial cells and non-endothelial cells such as 
pericytes, smooth muscle cells and mesothelial cells. This contamination, however, can 
be minimised initially at the level of cell isolation. The structure of the microvessel is 
such that pericytes and smooth muscle cells lie very close to the endothelium having 
discrete points of contact (Shepro and Morel 1993); thus detachment of endothelial cells 
from the surrounding tissue completely avoiding contaminants is a very difficult task.
The type of enzyme, concentration of enzyme solution, the duration and temperature of 
incubation can vary depending on the organ and species from which the cells are isolated. 
Many of the methods of isolation of lung microvascular endothelial cells described in the 
literature have modified these factors in order to optimise the isolation procedure 
(Chung-Welch et al., 1988; Chopra et al., 1990; Del Vecchio et al., 1992; Hewett and 
Murray 1993). Modifications the original isolation techniques including those described 
by Folkman et al., (1979) and Zetter (1984), have produced a large variety of isolation 
procedures. In this study, each time the isolation techniques is adapted, it is an attempt 
to improve the isolation method to maximise the number of endothelial cells without 
increasing the non-endothelial cell contaminants.
Although the preliminary isolation technique described previously (section 3.2.1) was 
unspecific, it provided an indication of the requirements needed when establishing the 
final method designed to isolate lung microvascular endothelial cells. With lung tissue,
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the micovessels are surrounded with large quantities of elastic connective tissue which 
impedes their release. Therefore, modifications of the preliminary isolation technique 
involved mechanical disruption of the tissue by homogenisation and dispersal using a 
Pasteur pipette. In addition, optimisation of the collagenase digestion technique 
produced a greater yield of microvessel endothelial cells, isolated as small clusters of 
cells. Isolation of the microvessel fragment by enzyme digestion is a widely used 
technique involving the use of collagenase (Chung-Welch et al., 1988; Del Vecchio et 
al., 1992), collagenase/dispase (Belloni et al., 1992) and other enzymes. In this study, 
after extensive investigations, the optimum conditions for collagenase digestion of the 
tissue were established where the use of collagenase/dispase was preferred. Collagenase 
with the neutral protease dispase offered a more gentle enzymic digestion leaving the 
blood vessels intact (Zetter 1984). The use of a second enzyme digestion step was 
employed in order to remove pericytes from the basement membrane.
Many of the modifications of the basic isolation technique reported here proved effective 
in purifying the cultures by reducing the large vessel endothelial cell and non-endothelial 
cell contamination. Pre-treatment of the lungs in situ removed blood from the tissue and 
initiate the release of the microvessels. Fixation of the pleural membrane devitalised 
mesothelial cells (Chopra et al., 1990), and density gradient and Percoll gradient 
centrifugation was effective in reducing contamination with fibroblast, pericyte, smooth 
muscle cell and macrophage impurities. The cultures were monitored daily by phase 
contrast microscopy to assess the extent of growth and contamination by non-endothelial 
cells.
Culture purity
By paying particular attention to the isolation technique, the extent of contamination by 
large vessel and non-endothelial cells was reduced. In culture, some of these 
contaminating cells are easily distinguishable, however they have a tendency to outgrow
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the endothelial cells, if they are present in sufficient quantities. In these studies, 
excessive contamination with smooth muscle cells for example showed a typical "hill and 
valley" effect achieved by compacting layers of cells on top of each other (Patton et al., 
1990). In addition, pericytes grew as large cells which spread out in an irregular form, 
having the ability to retract upon themselves forming nodules; while fibroblasts were seen 
as long spindle shaped cells which have extended filopodia (Shepro and Morel 1993). 
Mesothelial cells are indistinguishable from microvascular endothelial cells by phase 
contrast microscopy.
In this study, the majority of contaminating cells not removed in the isolation procedure 
could be removed by washing the cultures 2-3 hours after plating, treatment with 
Ca/Mg-free HBSS 2-3 days after plating and selective subculture with cloning 
penicylinders. In addition selective growth medium was used to provide suitable 
conditions for endothelial cell growth without stimulating excessive proliferation of the 
non-endothelial cell contaminants.
Culture conditions
Not only is there a wide variation between isolation techniques reported in the literature, 
but there is also great diversity in the types of culture medium used, growth factors, 
growth serum and extracellular matrices. Investigators have cultured lung microvascular 
endothelial cells in a variety of media including a 1:1 mixture of RPMI 1640 with 
endothelial cell conditioned medium (Del Vecchio et al., 1992), DMEM (Chung-Welch 
et al., 1988; Minuteeau-Hanschke et al., 1990), M199 (Hewett and Murray 1993) and 
DME-F12 (Belloni et al., 1992). Cultures have been supplemented with various 
concentrations of plasma-derived serum (PDS) prepared from platelet poor plasma, 
foetal calf serum (FCS) and growth factors.
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The growth factor which has been used most frequently to supplement lung 
microvascular endothelial cell cultures is endothelial cell growth supplement (ECGS) 
with the addition of heparin (Chung-Welch et al., 1988; Minuteeau-Hanschke et al., 
1990; Belloni et al., 1992; Hewett and Murray 1993). Alternatively, retinal derived 
growth factor with the addition of heparin (Del Vecchio et al., 1992) is also used as a 
growth supplement in the culture of lung microvessel endothelial cells.
In this study, the lack of significant improvement in microvascular endothelial cell 
growth in the initial studies investigating alternative culture conditions was possibly due 
a number of factors; the inability to provide adequate growth factors and constituents for 
selective murine lung microvascular endothelial cell growth and also the inadequate 
endothelial cell number obtained from the preliminary isolations. Having investigated 
several combinations of culture media, growth factors and sera, the most suitable 
conditions for culture of endothelial cells without greatly increased proliferation of non- 
endothelial cell contaminants proved to be Hams F-10 supplemented with both ECGS 
and heparin and a combination of platelet poor human serum (PPHS) and FCS. FCS 
contains a large number of endothelial cells growth promoting substances including 
platelet-derived endothelial cell growth factor (PD-ECGF) as well as inhibitory factors 
such as platelet derived growth factor (PDGF). High concentrations of FCS therefore, 
provided accelerated growth rates of both endothelial cells and non-endothelial cell 
contaminants. However a reduction in the concentration of FCS with the addition of 
PPHS provided a reasonable compromise between the cell growth rate and the purity of 
the culture. The addition of ECGS and heparin has been shown by Thornton et al., 
(1983) and Abbott et al., (1992) to synergistically increase endothelial cell growth. In 
addition, the cultures reported here were supplemented with selenium dioxide, 
glutathione, vitamin C and transferrin. The presence of these additives has been shown 




In this study, phase contrast light microscopy was used routinely as a method of 
assessing growth characteristics under the various conditions. This assessment included 
the effect on cell morphology, homogeneity and the growth rate of the cultures. The 
cells were seeded on to calf skin collagen (type I) coated culture wells which provided 
the preferred conditions for attachment and culture. It is possible that the preference of 
the cells for collagen as a substratum reflects the high content of collagens present in the 
connective tissues in vivo. In addition, specific binding sites for collagen may exist 
similar to those which have been shown to exist for fibronectin (Kowalczyk and 
McKeown-Longo 1992) and laminin (Aumailley et al., 1991). Treatment of culture 
wells with gelatin, fibronectin or other sources of collagen did not offer any significant 
advantage over calf skin collagen.
Cells isolated by the final method described in this study grew successfully showing the 
typical cobblestone morphology expected with a contact-inhibited culture (see section 
5.3.1). The cells isolated as small clusters of 5-10 cells grew and divided into distinct 
colonies. These colonies were selectively subcultured in order to avoid any non- 
endothelial cell contaminants and were seeded on to fresh collagen coated wells where 
they grew to confluence providing a relatively pure and reliable supply of murine lung 
microvascular endothelial cells. Passage 1 cells had a slightly more spindle shaped 
morphology than primary cultured cells which could be due to the effects of subculturing 
and the seeding density. All cultures were positive for all the characterisation studies 
(see section 5).
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4. P r im a r y  C u l t u r e  of 
M u r in e  B r a in  
M ic r o v a sc u l a r  
E n d o t h e l ia l  C e l l s
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4.1. Introduction
Studies involving cultures of brain microvascular endothelial cells have allowed advances 
in the structural and functional analysis of the blood-brain barrier, particularly the study 
of transport pathways (Audus and Borchardt 1986, Shah et al., 1989; Smith and 
Borchardt 1989; Abbott et al., 1992). Several methods of isolating brain microvascular 
endothelial cells have been described (Hughes and Lantos 1986; Bowman, et al., 1988; 
Tontsch and Bauer, 1989; Abbott, e ta l, 1992; Belloni, et al., 1992). In these and other 
studies there are wide variations in the starting material and isolation techniques, as well 
as considerable variability between the culture conditions. In this study microvascular 
endothelial cells were isolated and cultured using a modification of the method of Abbott 
et al., (1992), in order to produce a reliable and relatively pure supply of murine brain 
microvascular endothelial cells.
97
4.2. Materials and Methods
4.2.1. Isolation and culture of murine brain microvascular endothelial cells.
Murine brain microvascular endothelial cells were isolated using a modification of the 
methods of Hughes and Lantos (1986) and Abbott et al (1992). Each preparation 
involved ten C57 mice, either male or female, weighing between 30 and 40g. The 
animals were killed by cervical dislocation and decapitated. The brains were very 
carefully removed whole and put into a sterile 30ml universal vial, on ice, containing 
HEPES buffer.
The brains were dissected under sterile conditions using dissection instruments which had 
been sterilised and allowed to stand in a beaker of 70% alcohol during this procedure in 
order to maintain sterility. Each brain was dissected as follows: The cerebellum was 
removed using a scalpel and the brain was cut in half longitudinally. An attempt was 
made to remove the meninges using fine forceps however, as the brains were so small 
this was a very difficult procedure. The mid and hind brain was removed with curved 
forceps and the brain was then opened up and the white matter and striatum removed. 
The remaining grey matter was chopped into 1-2 mm pieces and transferred in to a sterile 
buffer solution on ice.
This procedure was repeated for each brain and the dissected material was centrifuged 
using a Jouan bench centrifuge at 1500 rpm (600g) for 5 minutes. The resulting pellet 
was resuspended in 10ml of a prepared enzyme digestion mixture containing 0.1% 
collagenase dispase, 0.147pg/ml TLCK and 20U/ml DNasel, which was then incubated, 
gently agitating, for 1 hour at 37°C.
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After incubation the suspension was sheared using a long glass Pasteur pipette until no 
resistance was felt, in order to disperse the grey matter. This procedure was repeated 
using a long glass Pasteur pipette which had been fire-polished in order to narrow the tip 
of the pipette and therefore further disperse the grey matter. The suspension was then 
centrifuged at 1500 rpm for 5 minutes, and the supernatant was carefully removed with a 
pipette. The pellet was resuspended in 15ml of 25% BSA (prepared in buffer) and spun 
at 3000 rpm (1200g) for 15 minutes.
The upper layer of the gradient containing myelin, astrocytes and neurons was carefully 
extracted ensuring the complete removal of all the myelin. The pellet containing the 
capillary fragments was resuspended in buffer and the upper layer containing myelin, 
astrocytes, neurons and the remaining capillary fragments was re-centrifuged to ensure 
the maximum removal of capillary fragments. The capillary fragments were pooled into 
a clean universal vial, to ensure that there was no myelin contamination and washed in 
buffer by centrifugation at 600g for 5 minutes. The pellet was resuspended in the 
remaining 5ml of enzyme digest and incubated with gentle agitation for a further 3 hours 
at 37°C.
During the incubation periods several preparations were made. The Percoll gradient was 
prepared by pre-centrifuging a 50% isotonic Percoll solution at 16500 rpm for 1 hour at 
4°C (see section 2.2.4). The culture plates were collagen coated and the growth medium 
was freshly prepared (see section 2.2).
After incubation, the enzyme digest was dispersed using a long glass Pasteur pipette and 
centrifuged at 600g for 15 minutes. The pellet was resuspended in buffer and layered on 
top of the Percoll gradient. After centrifuging at 1200g for 20 minutes the capillary 
fragments formed a distinct band about 4/5 ths of the way down the gradient. The 
fragments were carefully removed with a Pasteur pipette and transferred into a clean
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universal containing buffer. The fragments were washed primarily in buffer and 
subsequently in a 1:1 mixture of buffer and Hams F-10.
The pellet containing capillary fragments was resuspended in complete culture medium 
comprising Hams F10 medium containing 10% foetal calf serum, 5% platelet poor 
human serum, 2mM L-glutamine, 100 IU/ml penicillin and lOOpg /ml streptomycin, 80 
pg /ml heparin, 75 pg /ml endothelial cell growth supplement, and 4% supplements. The 
fragments were plated into 6 wells of a 35 mm tissue culture dish pre-coated with 
collagen and incubated in a humidified C02 incubator at 37°C. Fragments were also 
plated into 96 and 24-well plates according to experimental requirements. The medium 
was changed every other day and after 4 days in culture the PPHS was reduced in 
concentration from 5% to 2%.
Subculture o f cells
The cells were subcultured on reaching confluence after approximately 10-12 days in 
culture. For subculture the cells were washed gently with Ca/Mg-free HBSS three times 
and then incubated for 20 minutes in Ca/Mg-free HBSS containing 0.02% EDTA. The 
cells were then treated with 0.05% trypsin/ 0.02% EDTA in Ca/Mg-free HBSS for 5 
minutes at 37°C. The action of the trypsin was inhibited by the addition of complete 
culture medium and the cell suspension was then plated into freshly coated 6 well dishes 
at a ratio of 1:2 -1:4 depending on experimental requirements.
4.2.2. Cell purity
The extent of contamination of the cultures by non-endothelial cells was examined 
routinely by phase contrast light microscopy and photographed using a Nikon 35mm 
camera. Contaminating cells included fibroblasts, astrocytes and pericytes. Two 
methods for purifying cultures were employed:
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1. The cultures were washed 2-3 hours after plating as capillary fragments adhere more 
rapidly to the surface of the well than single cells (Zetter 1984), therefore this provided 
an initial method of purification.
2. The cells were washed and incubated with Ca/Mg-Free HBSS at 37°C for 15-20 
minutes 3 days after plating.
4.2.3. Growth rates
The extent of growth of the cultures was routinely studied by observing the variation in 
the density of the cultures during growth. The cultures were photographed regularly 
under various conditions.
Extracellular matrices
Growth of the cultures on different extracellular matrices was observed:
1. The growth of cultures on collagen type 1 from calf skin (Sigma), and collagen type 1 
from rat tail (Boehringer Mannheim) was compared. The collagen was fixed to the wells 
by wet exposure to ammonia vapour at a concentration of 0.33mg/ml (see section 2.2.5).
2. The growth of the cells on gelatin coated wells was assessed. Gelatin (tissue culture 
grade) was obtained from Sigma was prepared as a 1% solution and sterilised by 
autoclaving at 121°C for 15 minutes. The gelatin solution was incubated on the plates 
for 1 hour at room temperature. The excess solution was aspirated the plates were 
washed with Ca/Mg-Free HBSS and the cells were added.
3. The effect of fibronectin coated wells on cell culture was also examined. Fibronectin 
(Sigma) was prepared at a concentration of 25pg/ml and added to the wells. After 1 
hour the excess fibronectin was aspirated and the cells were seeded on to the wells.
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Effect of sera on growth
The effect of variation of serum concentration on the growth of the cultures was 
observed. The concentration of foetal calf serum varied from 10-20%, and the 
concentration of platelet poor human serum varied from 0-5%.
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4.3. Results
4.3.1. Brain Microvascular Endothelial Cell Isolation and Culture
Isolation technique
The isolation technique was adapted from a method established for isolation and culture 
of rat brain microvascular endothelial cells by Abbott et al (1992) which was based on 
the technique of Hughes and Lantos (1986). Ten murine brains were used for each 
isolation in order to seed one 6-well plate. Each brain was very carefully dissected as the 
selection of only the grey matter reduced contamination by non-endothelial cells. Careful 
dissection, in conjunction with BSA density dependent centrifugation and Percoll 
gradient centrifugation improved the purity of the culture. By following these 
preparations, variation in purity between different cultures was kept to a minimum.
The enzyme digestion solution used in the isolation procedure produced capillary 
fragments (Figure 20) from which the cell colonies were formed. The choice of the 
enzyme required for digestion of the tissue and isolation of the capillary fragment was 
important, as the use of 0.1% collagenase obtained from Sigma compared to 0.1% 
collagenase/dispase obtained from Boehringer Mannheim caused excessive disintegration 
of the capillary fragments producing a single cell suspension. The single cells isolated by 
digestion with collagenase became non-viable after the initial culture and were removed 
during the washing procedure, whereas digestion with collagenase/dispase resulted in the 
isolation of capillary fragments, which went on to form confluent microvascular 
endothelial cell monolayers.
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Excessive agitation of the tissue during incubation or prolonged incubation of the tissue 
with 0.1% collagenase/dispase also resulted in an increase of single cells in culture. On 
the other hand, insufficient incubation or agitation of the tissue resulted in inadequate 
disintegration of the capillary fragments. Fragments which were too large did not adhere 
to the surface of the wells and were therefore removed when the medium was changed.
Unlike the isolation of lung microvascular endothelial cells this technique did not require 
a homogenisation step, as the brain tissue was easily broken up by shearing with a long 
glass Pasteur pipette. The additional shearing of the tissue with a fire-polished pipette 
was essential in the isolation procedure in order to produce sufficient disintegration of 
the tissue. Omission of this step resulted in a much reduced yield of capillary fragments.
Culture conditions
The capillary fragments obtained from one isolation were seeded on to one or two 6-well 
culture dishes freshly coated with collagen type 1 from calf skin resulting in the cells 
reaching confluence in 10-12 days. The composition of the culture medium was 
important for cell growth. Cells were cultured with Hams F10 medium in the presence 
of PPHS, ECGS, heparin and growth supplements which provided the most suitable 
conditions for endothelial cell proliferation and viability in culture.
4.3.2. Brain Microvascular Endothelial Cell Growth and Morphology
Cell growth and morphology
When first plated out the capillary fragments appeared as small clusters of cells (Figure 
20) which after 2-3 days in culture started to grow and divide as small colonies of spindle 
shaped cells (Figure 21). The majority of single cells isolated became non-viable shortly 
after the initial culture. The cells remained in contact with the original colony and
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divided from the colony perimeter with colonies expanding radially forming typical 
swirling patterns as they merged to form a confluent monolayer (Figures 22, 23&24).
Subculture
When the cells reached confluence 10-12 days after plating they were either utilised for 
experimental purposes or were subcultured. The cells which were subcultured on to 
freshly coated 6-well plates grew as colonies (Figure 25) in a very similar manner to the 
cells isolated from primary culture until they reached confluence (Figure 26). The time 
taken to reach confluence was dependent on seeding densities. Subcultured cells 
retained their spindle-shaped morphology similar to that of primary cultured cells, 
however the subcultured cells did not form such densely packed monolayers The cells 
were only subcultured once before they were used for experimental purposes as further 
subculturing of cells was unsatisfactory due to poor cell attachment and growth. In 
addition, the cells had a more granular appearance.
Cell purity
Some of the cultures were observed to contain contaminating cells including fibroblasts, 
smooth muscle cells, and pericytes (Figures 27 & 28) The degree of purity varied 
slightly between cultures, although the steps taken to improve the purity of the culture 
both at the time of isolation and culture were reasonably effective. Replacing the 
medium after 2-3 hours in culture removed any unattached cells and as the capillary 
fragments adhered more rapidly than single cells (approximately 2 hours) the unattached 
cells removed tended to be non-endothelial.
Further purification occurred in the early stages of culture: incubation with Ca/Mg-free 
HBSS for 15-20 minutes after 2-3 days in culture reduced the extent of contamination 
without affecting the endothelial cells themselves as they showed stronger adherence to 
the culture well than did the contaminants. Foetal calf serum concentrations of between
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10 and 20% and concentrations of between 0-5% platelet poor human serum were 
studied in order to assess the effect on culture purity. The extent of proliferation of non- 
endothelial and endothelial cells was observed by light microscopy. The introduction of 
increased concentrations of FCS were observed to correspond with increases in 
contaminating cells in culture, especially pericytes (Figure 29).
PPHS, a plasma derived serum was used as a supplement in conjunction with the FCS, as 
PPHS does not contain the platelet derived factors which are able to promote the 
proliferation of contaminating cells. Initial concentrations of 5% PPHS and 10% FCS 
were required for expanding individual endothelial cell colonies, thereafter 2% PPHS and 
10% FCS were used for routine culture. These serum concentrations were considered to 
be the most suitable for endothelial cell growth whilst not causing excessive proliferation 
of the contaminating cells.
Extracellular matrices
An important factor for cell growth was the treatment of the culture wells with collagen 
type 1 from calf skin. The attachment factors, gelatin, fibronectin and collagen were 
assessed by light microscopy on the basis of cell homogeneity and growth rate. Collagen 
type 1 from calf skin gave the preferred cell attachment, even in preference to type 1 
collagen from rat tail. Parallel studies involving calf skin and rat tail collagen showed 
that rat tail collagen did not offer the same extent of attachment as calf skin collagen and 
as a result the cells took longer to reach confluence.
Gelatin resulted in initial attachment of cells, however many cells appeared to detach 
during the washing procedure. Cell attachment and growth on fibronectin was 
satisfactory but showed no significant improvement over collagen.
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Growth on various substrata
Brain microvascular endothelial cells were seeded on to 24 and 6-well plates. Cells were 
also seeded on to 2 well chamber slides for use with fluorescent studies, Falcon 
transparent filter membranes and Nunc anopore filters. Cells for binding and 
photoaffinity labelling studies cells were grown routinely on 6-well plates. Routine 
culture on 6-well plates appeared to be most suitable for cell growth.
Cells were also grown on collagen coated filters for use in electron microscopy studies. 
Nunc filters did not prove to be suitable for cell attachment, very few cells attached to 
coated or uncoated filters and therefore produced unsatisfactory growth. Falcon filters 
provided a suitable substrate for cell growth. Cells seeded on to these filters directly 
from primary culture reached confluence in 10-12 days (Figure 30). Examination and 
identification of the cells under the light microscope was impeded due to the speckled 
appearance of the cells produced by the filters.
Seeding density
From the initial isolation, the cells were routinely seeded on to one 6-well tissue culture 
dish, which reached confluence after 10-12 days in culture. Cells seeded on to two or 
four 6-well plates reached confluence after approximately 18 and 24 days respectively. 
Cells passaged 1:2 reached confluence after approximately 7 days. Cells seeded on to 
one 24-well plate reached confluence after 14-16 days in culture.
Growth rates
The effects of different substrata, extracellular matrices, medium and seeding densities on 
the cell morphology and growth rates were routinely examined by light microscopy The 
rate of cell growth was constantly estimated by the increased size of the colonies and the 
time taken for the cultures to reach confluence. An initial lag phase is typical of 
endothelial cell growth (Rupnick et al., 1988). From the original isolation the cells are
107
slow to grow and divide, however, as the cell number increases so the growth rate 
increases. This observation was important when selecting the seeding densities for 
primary culture and passaging cells, the cells also appear healthier when seeded at a high 
cell density.
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Figure 20 A phase contrast photomicrograph showing a capillary fragment isolated 
from murine brain, with some cell outgrowth 12 hours after plating. 
Magnification X400
Figure 21. A phase contrast photomicrograph showing small colonies of spindle shaped
cells 2 days after plating, where the capillary fragment is still prominent.
Magnification X400.
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Figure 22. A phase contrast photomicrograph showing typical colonies of microvascular 
endothelial cells continuing to grow from the vessel fragments 3 days after 
plating. Magnification X200.
Figure 23. A phase contrast photomicrograph showing two distinct colonies of brain
microvascular endothelial cells merging together after 4 days in culture.
Magnification X200.
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Figure 24 A phase contrast photomicrograph showing a relatively pure confluent 
monolayer 10 days after plating. Magnification X200.
Figure 25. A phase contrast photomicrograph showing small colonies of cells 2 days 
after subculture (passage 1) onto a fresh collagen coated 6-well plate. 
Magnification X400.
I l l
Figure 26. A phase contrast photomicrograph showing a confluent monolayer of
subcultured cells (passage 1) where the cells seem to have retained the spindle 
shaped morphology. Magnification X200.
Figure 27. A phase contrast photomicrograph showing contaminating non-endothelial 
cells probably fibroblasts and pericytes. Magnification X200.
Figure 28. A phase contrast photomicrograph showing non-endothelial cell
contaminants within a confluent monolayer, probably pericytes. Magnification 
X200.
Figure 29. A phase contrast photomicrograph showing non-endothelial cell 
contaminants probably pericytes or glial cells. Magnification X200.
Figure 30. A phase contrast photomicrograph showing a confluent monolayer o f brain 





This isolation technique involved careful dissection selecting only the grey matter thereby 
restricting the endothelial cells isolated to the microvasculature. In addition, separation 
of microvessel fragments from single cells and other contaminants occurred by BSA 
density dependant centrifugation and Percoll gradient centrifugation. These steps were 
important for purity of the culture as the removal of all unwanted tissue resulted in 
reduced contamination by smooth muscle cells, astrocytes and pericytes. The methods 
described in the literature for the enzyme digestion step in the isolation of brain 
microvascular endothelial cells from the same and different species are very diverse 
(Bowman et al., 1983; Audus and Borchardt 1986; Rupnick et al., 1988; Tontsch and 
Bauer 1989; Dorovini-Zis et al., 1991; Abbott et al., 1992). It involves various types of 
enzymes, concentration, temperature and duration of incubation of the enzyme solution 
(Bowman et al., 1990). The reason why these diverse techniques are successful is 
unknown. The techniques employed for the isolation and culture of microvascular 
endothelial cells from murine brain by the method described here provided a reliable and 
relatively pure supply of cells.
Culture purity
In this study, the majority of contaminating non-endothelial cells were removed at the 
time of isolation. Unlike some techniques (Folkman et al., 1979; Carson and 
Haudenschild 1986; Beer Stoltz and Jacobson 1991), this method did not require 
weeding, selective cloning or FACS sorting to improve the purity of the cultures. 
Complete removal of the meninges, the white matter and any noticeable large vessels was 
an important factor in the purity of the final culture. However due to the size of the
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brains removal of the meninges and white matter was very intricate and therefore slight 
variation in the purity of the cultures did occur.
Both the isolation technique and the culture conditions were important in maintaining a 
pure culture of microvascular endothelial cells. As with the cultures of lung 
microvascular endothelial cells, treatment of the cultures 2-3 hours after plating removed 
any unattached single cells improving culture purity. This technique of differential 
plating has been used in this and other studies to reduce contamination by single cells and 
non-endothelial cell contaminants in various organ derived microvessel cultures (Gitlin 
and D'Amore 1983; Rupnick et a l, 1988; Chung-Welch et a l, 1988). In contrast, 
Carson and Haudenschild (1986) have suggested that this treatment at such an early 
stage in the culture does not significantly reduce non-endothelial cell contamination but 
actually reduces the microvascular endothelial cell yield.
In agreement with Abbott et a l (1992), further treatment with Ca/Mg-ffee HBSS 2-3 
days after plating also improved culture purity. Growth of these cells in selective culture 
medium provided preferential conditions for endothelial cell growth without immoderate 
proliferation of non-endothelial cell contaminants.
Culture conditions
As with lung microvascular endothelial cells, brain microvascular endothelial cells were 
routinely cultured in Hams F-10 media supplemented with the growth factor ECGS, 
insulin, vitamin C, selenium dioxide, transferrin, glutathione and heparin which provided 
improved cell growth (Thornton et a l, 1983; Schor et a l, 1983; Haisch et a l, 1990; 
Abbott et a l, 1992). The cultures reported here were supplemented with a combination 
of FCS and platelet poor human serum (PPHS) which provided a reasonable compromise 
between the cell growth rate and the purity of the culture (see section 3.4). The 
presence of some contaminating cells may provide growth factors which support
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endothelial cell growth during the initial stages of culture and, in addition, may 
contribute to some of the endothelial cell functions in vitro as they do in vivo (Rupnick 
eta l., 1988).
Growth characteristics
Cultures monitored daily by phase contrast light microscopy were assessed for variability 
in growth characteristics including cell morphology, homogeneity and growth rate. The 
cells were routinely cultured on calf skin collagen coated culture wells which provided 
the most suitable substrata for cell attachment and growth.
Microvascular endothelial cells isolated in this study were morphologically consistent 
with those described in other reports (Bowman et ah, 1983; Carson and Haudenschild 
1986; Dorovini-Zis et al., 1991; Abbott et al., 1992). They showed a typical pattern of 
growth in culture from isolation as capillary fragments through the formation of large 
colonies of cells which merged to form monolayers of spindle shaped cells. Occasionally 
phenotypic variations were seen within these cultures. Rupnick, et al. (1988) suggested 
that phenotypic variations displayed within a culture could be due to differences in the 
microanatomical source of the cells. Colonies expressing phenotypic variation may be 
selectively cloned and grown to form confluent monolayers which display cobblestone 
morphology (Rupnick, e ta l, 1988; Belloni etal., 1992).
The growth rate was assessed qualitatively by microscopic means. The cell density was 
an important factor in growth rate. Sparsely seeded cell fragments formed small clusters 
of cells but grew at a reduced rate in comparison with cells seeded at a higher density. 
However, in agreement with other studies, after this initial lag in cell growth the growth 
rate improved until the cultures reached confluence (Carson and Haudenschild 1986; 
Rupnick et al., 1988; Abbott et al., 1992). The time taken to reach confluence therefore 
varied depending on the seeding density which may be due to a release of endothelial cell
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growth factors from the cells themselves. This may stimulate endothelial cell 
proliferation similar to the way that endothelial cell conditioned medium is used to 
promote microvascular endothelial cell growth.
The isolation and culture of murine brain microvascular endothelial cells by the method 
described here has provided a reliable and relatively pure supply of cells which retain 
their endothelial characteristics in vitro (see section 5). As a result, these cultures have 
proved to be suitable to permit the study of receptor mediated uptake (see section 6).
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Characterisation studies provided a method of determining the microvascular endothelial 
origin of the cells and distinguished them from non-endothelial cell contaminants. These 
studies were based upon the properties of endothelial cells in vivo and in vitro, however 
some organ and species specific differences are thought to exist (Rupnick et al., 1988; 
Belloni et al., 1992; Nishida et al., 1993). In this study, identification of endothelial cell 
origin was determined by light and electron microscopy, the uptake of fluorescently 
labelled acetylated low density lipoprotein (Bo-Ac-LDL), expression of Von Willebrand 
factor, the ability to provide a non-thrombogenic surface to platelets and the ability to 
undergo in vitro angiogenesis. In addition, the existence of organ specific differences 
between brain and lung microvascular endothelial cells in culture was also investigated.
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5.2. Materials and Methods
5.2.1. Light and Electron Microscopy
Light microscopy
General cell growth and morphology was observed daily, using an inverted biological 
microscope (WILD, M40). More detailed cell morphology was also examined using a 
phase contrast microscope (diaphot-TMD, Nikon, U.K. Ltd.), and photographed (F301, 
Nikon, U.K. Ltd.) routinely in order to estimate cell growth and the extent of 
contamination by non-endothelial cells.
Preparation o f samples fo r transmission electron microscopy
Transmission electron microscopy (TEM) studies were performed on cells that were 
grown on filter membranes (Cyclopore, Falcon) to a near-confluent state (see section 
2.2.8). The cells were washed three times in 0.1M phosphate buffer adjusted to pH7.4. 
The samples were carefully removed from the plastic holders using a scalpel blade and 
were subsequently cut into quarters and prefixed with 2.5% gluteraldehyde (BDH 
chemicals) in 0.1M phosphate buffer (pH 7.4) at 37°C for 20 minutes.
The samples were washed in 0.1M phosphate buffer for 15 minutes with at least three 
changes of buffer, and then were post-fixed at room temperature for 30 minutes using 
1% osmium tetroxide (0 s04, BDH chemicals) in phosphate buffer; this procedure also 
stained the cells brown. The cells were washed again for 15 minutes and the samples 
were dehydrated using the different concentrations of ethanol and propylene oxide 
(BDH) shown below:
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Dehydrating medium Time (minutes)
75 %v/v ethanol 15
80 %v/v ethanol 15
95 %v/v ethanol 15
100 %v/v ethanol (dry) 2x15
100 % v/v propylene oxide 2x15
The samples were gradually exposed to resin by application of the following embedding 
solutions: 1) a 1:3 mixture of resin (Taab premix medium embedding resin, Taab 
Laboratories, Reading): propylene oxide for 1 hour; 2) a 1:1 mixture for 2 hours; 3) a 
3:1 mixture for 1 hour; and finally 4) 100% resin for 24 hours with at least 3 changes of 
resin. After this procedure the samples were placed in separate embedding moulds 
(Taab), topped up with resin and oven dried at 50°C for 48 -72 hours.
A microtome (C. Reichert OM U3) fitted with a diamond knife was used to prepare 90 
nm thin sections. The sections were placed on copper grids and were subsequently 
stained, in the dark, with 2% uranyl acetate for 7 minutes, washed 4 times with distilled 
water and stained for a further 7 minutes with Reynolds Lead Citrate in a petri dish lined 
with filter paper soaked in 1M NaOH. The sections were washed 4 times with distilled 
water, dried and viewed in a Jeol 1200 Ex Transmission Electron Microscope
Preparation o f samples fo r scanning electron microscopy
For Scanning Electron Microscopy (SEM), cells were also grown on Falcon Cyclopore 
filters to reach confluence. The cell samples were washed for 15 minutes at 37°C with 
0.1M sodium cacodylate buffer containing 5% sucrose, removed from the plastic holders 
and cut into small pieces. The cells were prefixed with 2.5% glutaraldehyde, 5% sucrose
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in 0.1M sodium cacodylate buffer pH7.4 for 45 minutes at 37°C and washed for 15 
minutes with 3 changes.
The samples were post-fixed using 1% osmium tetroxide in 0.1M sodium cacodylate 
buffer containing 5%w/v sucrose for 15 minutes at room temperature and washed again 
for 15 minutes with 3 changes. The cells were dehydrated in graded acetone as shown 
below:




100 2x  10
100 dry 2x  10
The cells were critical-point dried and sputter coated with a thin layer of gold (Edwards 
sputter coater S150B). The small sections of cell coated filter were fixed to 10mm x 
10mm stubs (Jeol) with conductive carbon cement (Leit C) and examined using a Jeol 
T330 Scanning Electron Microscope.
5.2.2. Uptake of Acetylated Low Density Lipoprotein
The ability of endothelial cells to incorporate Ac-LDL was demonstrated with the 
fluorescent probe Bodipy (Molecular Probes, Inc). Bodipy is a neutral dye which is 
covalently bound to the apoprotein portion of the LDL complex and is therefore not 
removed during cell manipulations. Cell cultures grown on plastic 2-well chamber slides 
(Labtek, Gibco) or glass coverslips, both coated with collagen (see section 2.2.5). The 
cells were incubated with 10 pg/ml Bo-Ac-LDL in complete Hams F10 medium for 4
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hours at 37°C. Following incubation the cells were washed several times with Ca/Mg- 
free HBSS and mounted with a fluorescence protecting mounting medium (Fluorsave, 
Calbiochem). Fluorescence was observed using a Nikon Optiphot-2 fluorescence 
microscope at an excitation wavelength of 450-490 nm.
Positive and negative controls
Positive and negative control studies were performed concomitantly with the samples 
requiring characterisation. BAE-1 cells and HUVECS were used to provide positive 
comparisons, whilst 3T3-L1 fibroblasts were used to provide negative comparisons. 
Mixed populations of endothelial and non-endothelial cells from primary culture were 
also examined.
5.2.3. Expression of Von Willebrand factor
Preparation o f reagents
A buffer was prepared using PBS containing 0.05% BSA at pH7.4 for dilution's and 
initial washing procedures.
0.05M Tris/saline buffer was prepared from 0.79g Tris and 0.9g NaCl in 100ml distilled 
water and adjusted to pH5.6 with 10% HC1.
A 2units/ml solution of thrombin (Sigma) was prepared from a 2mg/10ml (10 units/ml) 
stock solution.
0.01M Imidazole (Sigma) was prepared from 17mg in 2.5ml Tris/saline.
The DAB stain (3-3' Diaminobenzedine tetra hydrochloride, Sigma) was prepared from 
several reagents. 3.75mg DAB was dissolved in 4.5ml tris/saline, to this was added
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0.5ml of 0.01M imidazole, this solution was stored in the dark, on ice, until required 
Prior to use 167 pi of the mixture was removed and 167p.l of 30% hydrogen peroxide 
was added.
The Von Willebrand factor used was a peroxide conjugated Rabbit Anti-Human von 
Willebrand Factor obtained from Dakopatts, which was diluted with PBS- 0.05% BSA 
to give a 1:40 dilution.
Cellfixation and staining procedure
The presence of Von Willebrand factor was assessed by using an antibody against human 
Von Willebrand factor. The cells used for Factor VIII staining were grown on standard 
6-well plates until they reached semi-confluence, they were then washed 3-4 times with 
PBS-0.05%BSA and stimulated with 2units/ml thrombin for 15 minutes at 37°C. The 
cells were again washed 3-4 times with PBS-0.05% BSA and fixed with 10% formalin 
(Sigma) for 1 hour at 4°C.
After fixation and further washing with PBS-0.05%BSA, 250pl/well of the specific 
monoclonal antibody, peroxide conjugated rabbit anti-human von Willebrand factor was 
added to the wells and incubated for 45 minutes at room temperature. The cells were 
washed firstly with PBS-0.05%BSA and then twice with tris/saline buffer pH5.6. The 
samples were incubated with 250 pg/well of the freshly prepared DAB reagent for 3-5 
minutes, and washed 3 times with tris/saline buffer. The cells were counter stained with 
250pl of hematoxylin (Harris type, Sigma) which was removed immediately by washing 
with buffer 3-4 times and the cells were kept in buffer to be viewed using the Nikon 
Diaphot microscope.
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Positive and negative controls
Characterisation studies were performed on primary cultured cells which were isolated 
and cultured to provide a mixed population of endothelial and non-endothelial cells. 
Controls were incubated with 0.5ml of normal rabbit serum (Sigma), diluted with PBS- 
0.05% BSA to give a 1:16 solution.
5.2.4. Platelet Adhesion
Preparation o f platelets
18ml of rabbit blood was collected in a syringe containing 2ml of tri-sodium citrate 
(3.2%). Platelet-rich plasma was prepared by centrifugation at 1200 rpm (480g) for 10 
minutes. The supernatant was carefully transferred into a clean tube and supplemented 
with 75pl of prostacyclin (40mg/ml). The platelets were pelleted by centrifugation at 
2400 rpm (960g) for 15 minutes. The pellet was washed in 10ml of Hepes buffered 
tyrode (HBT) solution pH7.4 containing 50jul of prostacyclin. The HBT solution was 









The pellet was washed again and the cell number determined. The final platelet 
suspension was adjusted to 5 x 108 cells/ml and left in HBT for 1 hour, after this time the 
platelets were ready for use.
Platelet adhesion assay
The cells were grown, as normal, on collagen coated 6-well plates until they reached 
semi-confluence. One hour prior to the assay, the cell cultures were washed and 
incubated at 37°C with Hams F-10 medium (without supplements) containing 25mM 
HEPES and 5mg/ml BSA in order to reduce serum components bound to the cell 
surface.
To each culture well 1 x 108 platelets were added and incubated at 37°C for 30 minutes. 
Non-adherent platelets were removed by washing 10 times with Hams F-10-BSA. 
Platelet adherence was determined by phase contrast microscopy.
Mixed populations of endothelial and non-endothelial cells were studied in order to 
ascertain whether a difference existed. Adhesion to collagen coated and uncoated plates 
was also assessed.
5.2.5. Growth of Lung Microvascular Endothelial Cells on Matrigel
Preparation o f Matrigel coated plates
Matrigel, a basement membrane matrix, was obtained from Collaborative Biomedical 
Products (Becton Dickinson). A thin gel method was required for plating cells on top of 
the gel. The Matrigel was thawed out overnight at 4°C in order to keep the Matrigel 
from forming an irreversible gelled compound, which occurs at 22-35°C. The gel was 
mixed to homogeneity with pre-cooled pipettes and aliquoted on to the wells, which
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were kept on ice, at a concentration of 50pl/cm2. The plates were placed at 37°C for 30 
minutes before use.
Cell culture on Matrigel coated wells
The cells were cultured, as normal, on collagen coated plates until they formed large 
colonies. The cells were removed from the wells at this time by the standard 
trypsinization procedure for lung microvascular endothelial cells and plated on to 
Matrigel coated wells in complete Hams F-10 medium. The cells were allowed to grow 




Phase-contrast light microscopy was used extensively in the study of cell morphology 
and growth of lung and brain microvascular endothelial cells. Comparative studies of 
growth and morphology were performed in order to investigate the existence of organ- 
specific variations between brain and lung microvascular endothelial cells. The 
identification of non-endothelial cell contaminants and the extent of this contamination 
throughout the cultures was also routinely investigated.
Cell growth
The cell growth patterns were distinctive for microvascular endothelial cells. The 
capillary fragments isolated from the grey matter of the brain adhered to the surface of 
the culture dishes; thereafter the cells sprouted from the vessel fragments forming small 
colonies of cells. Initially, the cells grew as individual colonies with the capillary 
fragments remaining visible in the centre of the colony, (Figure 31), growth continued 
until the colonies merged to form a confluent monolayer.
In comparison, fragments isolated from lung tissue adhered to the surface of the culture 
dish as small clusters of four or five cells. Vessel fragments similar to those isolated 
from brain tissue were difficult to obtain, due to the large quantity of connective tissue 
present in the lung. Due to the presence of contaminating cells, lung microvascular 
endothelial cell colonies were not allowed to produce a confluent monolayer from 
primary culture. Instead, colonies were cloned before extensive growth occurred. When
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the cells were subcultured, both brain and lung microvascular endothelial cells grew as 
individual colonies before merging to form confluent monolayers.
Cell morphology
Microvascular endothelial cells derived from murine brain and lung tissue had quite 
distinctive morphologies. During the initial stages of primary culture, endothelial ceils 
isolated from brain tissue formed spindle-shaped colonies (Figure 31) which grew to 
confluence forming some swirling patterns. Cells isolated from lung tissue however 
formed colonies with a more cobblestone morphology (Figure 32).
Confluent cultures of lung microvascular endothelial cells were obtained with passage 1 
cells. These cells formed very dense contact-inhibited monolayers, but lost some of the 
distinctive cobblestone morphology observed with the colonies in primary culture. 
Microvascular endothelial cells isolated from the brain also formed these very dense 
contact inhibited monolayers on reaching confluence. The characteristic cell morphology 
was retained when confluent monolayers were formed with both primary cultured and 
passage 1 cells.
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Figure 31. A phase contrast photomicrograph showing a colony of brain microvascular 
endothelial cells 3 days after plating, where the original capillary fragment 
remains noticeable. Magnification X400.
Figure 32. A phase contrast photomicrograph showing a large colony of lung
microvascular endothelial cells displaying the typical cobblestone morphology, 
10 days after plating. Magnification X200.
5.3.2. Electron Microscopy
Transmission electron microscopy
Electron microscopy was used in conjunction with several other characterisation 
techniques as a method of identifying endothelial cells, as the ultrastructure of these cells 
offer several distinguishing features. Transmission micrographs revealed the endothelia 
to be very thin and flat, with tight junctions at points of cell-cell contact, this is shown 
clearly in Figures 33 & 34 where the tight junctions and points of contact have a blurred 
appearance.
Several plasmalemma vesicles were found on the apical membrane (Figure 35), and 
coated pits (Figure 36) were seen at the apical and basolateral membranes, where some 
of the coated pits appeared to have a thin membrane covering the opening (Figure 37). 
The formation of the vesicles can also be seen in Figure 38. Figure 39 is a high 
magnification electron micrograph clearly showing mitochondrion and rough 
endoplasmic reticulum in the cytoplasm.
Von Willibrand factor is located in the Weibel-Palade (W-P) bodies. The presence of W- 
P bodies indicated positive identification of endothelial cells, this is demonstrated in 
Figure 37, however inability to demonstrate W-P bodies does not rule out endothelial 
cell origin. The appearance of W-P bodies is variable in endothelial cells while they are 
still positive for factor VIII related antigen, and in these cells although W-P bodies were 
observed, although they were not present in abundance.
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Scanning electron microscopy
The cells required for scanning electron microscopy were grown to confluence on 
transparent filter membranes, where the cells were exposed to medium on the apical and 
basolateral surfaces. The endothelial cell monolayer was examined by both light and 
electron microscopy. Light micrographs (magnification X200) and transmission electron 
micrographs indicated that the monolayer consisted of a high density of cells with formed 
tight cell-cell contacts, this was apparent for both brain and lung endothelial cells (Figure 
40 & 42).
Scanning electron microscopy demonstrated that the cells did not form a complete 
monolayer with every cell-cell contact forming a tight junction. This may be due to the 
dehydration procedure used in the preparation of the samples, as several breaks in the 
cells themselves were apparent. However some processes were observed which linked 
the cells together (Figure 41 & 43).
The transmission electron micrographs did demonstrate that tight junctions existed 
between the cells. However, although TEM and SEM studies were conducted in 
parallel, the buffers used and the dehydration procedures were different and this may 
explain the absence of tight junctions in the SEM preparation but not the TEM 
preparation. SEM showed the cells to be long and thin, and although tight junctions are 
not apparent some may exist between the cells which are not readily visible by scanning 
electron microscopy.
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Figure 33. A Transmission electron micrograph showing a brain microvascular
endothelial cell junction. The arrows indicate the points of contact between 
two cells which form the tight junction.
Figure 34. A Transmission electron micrograph showing a lung microvascular
endothelial cell junction, where the arrow indicates the junction between two
cells.
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Figure 35. A Transmission electron micrograph showing plasmalemma vesicles on the 
apical membrane of the lung cell {arrowheads). Mitochondrion and rough 
endoplasmic reticulum can also be seen in the cell cytoplasm {arrows).
Figure 36. A Transmission electron micrograph showing coated pits at the apical and 
basolateral membranes of the brain cell {arrowheads). The presence of 
Weibel-Palade bodies is also shown {arrows).
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1Figure 37. A Transmission electron micrograph showing coated pits some of which appear to have a thin membrane covering the opening 
{arrowheads). The open arrow indicates the cell nucleus. Mitochondrion can also been seen in the cell cytoplasm {arrows).
Figure 38. A Transmission electron micrograph showing vesicle formation on the
basolateralmembrane of a lung micro vascular endothelial cell {arrow). The 
mitochindrion and rough endoplasmic reticulum can also be clearly seen 
{arrowheads).
Figure 39. A very high magnification transmission electron micrograph showing
mitochondrion {arrowheads) and rough endoplasmic reticulum {arrows) in the 
cell cytoplasm.
Figure 40. A phase contrast photomicrograph showing a confluent monolayer of lung 
microvascular endothelial cells grown on a collagen coated filter membrane 
prior to treatment for electron microscopy studies. Magnification X200.
Figure 41. A scanning electron micrograph of lung microvascular endothelial cells.
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Figure 42. A phase contrast photomicrograph showing a confluent monolayer of brain 
microvascular endothelial cells grown on a collagen coated filter membrane 
prior to treatment for electron microscopy studies. Magnification X200.
Figure 43. A scanning electron micrograph of brain microvascular endothelial cells.
5.3.3. Acetylated LDL Uptake
The fluorescent probe, Bodipy, was incorporated into the Ac-LDL, in order to allow 
fluorescent identification of the endothelial cells. After incubation of the cells for 4 hours 
at 37°C the extent of uptake of the fluorescent probe (Bo-Ac-LDL) was assessed using 
fluorescent microscopy. The positive and negative controls, BAE-1 cells and fibroblasts 
respectively, demonstrated that Bo-Ac-LDL was extensively incorporated into the BAE- 
1 cells. In contrast, only trace amounts of the fluorescent probe were observed in 
fibroblasts and other types of contaminating cells. Figures 44 & 45 compare visible and 
fluorescent photographs that demonstrate the extensive incorporation of Bo-Ac-LDL 
into BAE-1 cells that were seeded on to glass coverslips.
Both lung and brain microvascular endothelial cells grown on chamber slides 
demonstrated extensive uptake of Bo-Ac-LDL (Figure 46 & 47). Mixed cultures of 
endothelial cells and rion-endothelial cell contaminants obtained from primary culture 
were seeded on to collagen coated glass coverslips and incubated with Bo-Ac-LDL, in 
order to directly compare the extent of incorporation of Bo-Ac-LDL in endothelial and 
non-endothelial cells. Figures 48 & 49 show visible and ultraviolet photographs 
respectively, which clearly demonstrate the variation in uptake of the fluorescent probe 
by endothelial and non-endothelial cells. The extent of uptake of Bo-Ac-LDL therefore 
provided another tool to enable the identification of endothelial cells.
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Figure 44. A phase contrast photomicrograph showing Bovine aortic endothelial cells 
(BAE-l) a positive control for the uptake of Bo-Ac-LDL. Magnification 
X800.
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Figure 46. A fluorescence micrograph showing the uptake of Bo-Ac-LDL into lung 
microvascular endothelial cells. Magnification X I200
Figure 47. A fluorescence micrograph showing the uptake of Bo-Ac-LDL into brain
microvascular endothelial cells. Magnification X 1200
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Figure 48. A phase contrast photomicrograph showing a mixed population of lung
microvascular endothelial cells and non-endothelial cell contaminants prepared 
for uptake of Bo-AC-LDL. Magnification X800.
Figure 49. A fluorescence micrograph showing the selective uptake of Bo-Ac-LDL into
lung microvascular endothelial cells but not into the non-endothelial cells.
Magnification X800.
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5.3.4. Expression of Von Willebrand factor
Von Willebrand factor (Factor Vlll-related antigen) is used extensively as a highly 
specific marker for endothelial cells. Unlike most von Willebrand factor assays which 
use fluorescent conjugated antibodies and fluorescence microscopy, the method utilised 
in the present study involved the use of a peroxide conjugated von Willebrand factor 
which was stained with a DAB reagent. The cells required for this assay were grown 
under routine culture conditions and assessed for expression of von Willebrand factor by 
phase contrast microscopy.
Incubation of the cells with thrombin stimulated production of von Willebrand factor. 
The cells were fixed with 10% formalin, incubated with the peroxide conjugated 
antibody, and then stained with freshly prepared DAB reagent; the cells were counter 
stained with haematoxylin before being viewed by phase contrast microscopy. Positive 
specific staining was present in cultures of lung and brain microvascular endothelial cells 
(Figure 50 & 51). Mixed cultures containing endothelial cells and contaminating smooth 
muscle cells showed a distinct difference in the intensity of staining. The endothelial cells 
appeared to stain dark purple/brown in colour whereas the smooth muscle cells had a 
pale purple appearance which was probably due to the presence of the haematoxylin 
solution (Figures 52 & 53). Controls showed that intense staining was not present when 
cultures were exposed to normal rabbit serum.
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Figure 50. A phase contrast photomicrograph showing the expression of Von
Willebrand factor in lung microvascular endothelial cells as an intense brown 
stain. Magnification X400.
Figure 51. A phase contrast photomicrograph showing the expression of Von
Willebrand factor in brain microvascular endothelial cells as an intense brown
stain. Magnification X200.
145
Figure 52. A phase contrast photomicrograph showing the expression of Von
Willebrand factor in a mixed culture of lung microvascular endothelial cells and 
non-endothelial cell contaminants. Magnification X400.
Figure 53. A phase contrast photomicrograph showing the expression of Von
Willebrand factor in a mixed culture of brain microvascular endothelial cells
and non-endothelial cell contaminants. Magnification X400.
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5.3.5. Platelet Adhesion Studies
Endothelial cells were found to demonstrate a characteristic non-thrombogenic, non­
adhesive surface in platelet adhesion assays which was not shown with smooth muscle 
cells, fibroblasts and pericytes. Therefore assessment of the distribution of platelet 
adherence provided a rapid method of identification of endothelial cells and non- 
endothelial cell contaminants. The adherence of platelets to the collagen coated culture 
wells also provided a method of determination of the cell-cell contacts exhibited by the 
cell colonies.
Figure 54 is a photograph of a culture of non-endothelial cell contaminants, including 
pericytes and smooth muscle cells, which shows platelet adherence to the apical surface 
of the cells as well as the culture well. Figure 55 shows the edge of a colony of brain 
microvascular endothelial cells, where the platelets did not adhere to the surface of the 
cells but adhered to the surface of the well, and a contaminating cell that was present in 
the culture.
Figures 56 & 57 depict cultures of lung microvascular endothelial cells. Figure 56 shows 
a colony of cells where the platelets did not adhere to the cell surface but adhered to the 
surface of the well, with no obvious gaps existing between the cells. Figure 57 shows 
the edge of a colony of cells which encompassed non-endothelial cells as well as 
exhibiting them at the colony perimeter. Platelets were clearly demonstrated to adhere to 
the non-endothelial cells as well as being fairly widespread between cells, indicating the 
lack of tight cell-cell contacts within this colony, this was probably due to the presence 
of these contaminating cells throughout the colony.
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Figure 54. A phase contrast photomicrograph showing platelet adhesion to non- 
endothelial cells. Magnification X200.
Figure 55. A phase contrast photomicrograph showing the edge of a brain microvascular 
endothelial cell colony where platelets adhere to the collagen coated well only. 
Magnification X400.
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Figure 56. A phase contrast photomicrograph showing the edge of a lung microvascular 
endothelial cell colony where platelets adhere to the collagen coated well only. 
Magnification X400.
Figure 57. A phase contrast photomicrograph showing the edge of a lung microvascular 
endothelial cell colony interspersed with non-endothelial cells. Platelets adhere 
to the non-endothelial cells, gaps between cells and the surface of the well 
plate. Magnification X400.
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5.3.6. In vitro Angiogenesis by Lung Microvascular Endothelial Cells Grown on 
Matrigel
Microvascular endothelial cells in culture are capable of undergoing morphological 
differentiation to form capillary tube-like structures, providing a method of 
differentiating between endothelial and mesothelial cells. Unlike endothelial cells, 
mesothelial cells do not have the ability to undergo angiogenesis in vitro (Chung-Welch 
et a l, 1989) when grown on the substrate Matrigel, a basement membrane matrix 
extracted from mouse sarcoma. Differentiation between microvessel and large vessel 
endothelial cells can also be established by this method and, although primary cultures of 
large vessel endothelial cells have been shown to differentiate into capillaiy-like 
structures in vitro, this occurs after a minimum of 12 hours in culture whereas 
microvascular endothelial cells differentiate after 4 hours in culture (Nishida et a l, 
1993).
Figure 58 shows a colony of lung microvascular endothelial cells immediately prior to 
seeding on to Matrigel coated culture wells and is a typical representation of lung 
endothelial cells isolated in primary culture. Figure 59 shows the capillary like structures 
formed after a 4 hour incubation at 37 °C, on Matrigel coated culture wells, and Figure 
60 shows the more extensive tube formation after 12 hours in culture.
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Figure 58. A phase contrast photomicrograph showing lung microvascular endothelial 
cells prior to seeding on Matrigel coated culture wells. Magnification X400.
Figure 59. A phase contrast photomicrograph showing tube formation by lung
microvascular endothelial cells 4 hours after seeding on to Matrigel coated 
culture wells. Magnification X200.
Figure 60. A phase contrast photomicrograph showing more extensive tube formation 
by lung microvascular endothelial cells 12 hours after seeding on to Matrigel 




Microvascular endothelial cell growth and morphology was distinctive where cells grew 
in a characteristic manner forming contact-inhibited monolayers. Some of the 
contaminating cells present in these cultures such as fibroblasts, pericytes and smooth 
muscle cells could be distinguished from endothelial cells by examination of the cell 
morphology (see section 3.4).
The dominant cell type in primary cultures of brain microvascular endothelial cell 
cultures showed a spindle shaped morphology. This morphology is consistent with brain 
microvascular endothelial cells from other sources (Carson and Hausenchild 1986; 
Dorovini-Zis et a l, 1991; Beer Stoltz and Jacobson 1991; Abbott et a l, 1992), although 
phenotypic variations in cultured brain microvascular endothelial cells have been shown 
to exist (Rupnick e ta l, 1988).
In contrast, the predominant cell type in primary cultures of lung microvascular 
endothelial cells showed a typical cobblestone morphology. This is consistent with lung 
microvascular endothelial cells from other sources (Ryan 1990; Belloni et a l, 1992; 
Hewett and Murray 1993). In this study, the appearance of elongated cells in a culture 
of lung endothelial cells, forming a similar pattern to that observed with brain cells, could 
indicate the presence of contaminating mesothelial cells (Hewett and Murray 1993), 
although mesothelial cells often display cobblestone morphology (Chung-Welch et a l,
1989).
Microvessel endothelial cells have been shown to express a number of organ specific 
differences as well as differences within various vascular beds. The phenotypic variations
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reported here between brain and lung endothelial cells could be due to organ specific 
differences or differences in the microanatomical source of the cells with in the tissue. 
Cell morphology alone, however, was insufficient to characterise endothelial cell origin.
Transmission and scanning electron microscopy
Many of the ultrastructural features found in the transmission electron micrographs are 
consistent with an endothelial cell phenotype. This includes the presence of 
plasmalemmal vesicles and coated pits on the apical and basolateral membranes and tight 
junctions at the point of cell contact. Although these features are common to endothelial 
cells they are not exclusive (Gerritsen et al., 1988). The identification of a Weibel- 
Palade body (Figure 37) can be used as proof of endothelial cell origin as they have not 
been reported to be present in other cell types. Lack of Weibel-Palade bodies does not 
rule out endothelial origin, as the frequency is variable between species and they are 
thought to be less abundant in murine tissues (Folkman et al., 1979).
The ultrastructural properties of the endothelial cell in vivo are well characterised and 
display distinct organ specific features (Gerritsen et al., 1988). Beer Stoltz and Jacobson 
(1991) however, suggested that many of the distinctive variations of these features were 
lost in vitro, possibly due to the effect of proteolytic enzymes in the isolation procedure. 
In the present study, no significant organ specific variations were seen between the 
ultrastructure of brain and lung microvascular endothelial cells. This could therefore be 
due to the isolation procedure and culture conditions.
Scanning electron microscopy offered no indication that a contact-inhibited monolayer 
was formed. This, however, was probably due to damage caused to the cells during the 
dehydration procedure. Given more time modifications of the dehydration process 
would have been attempted.
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Uptake o f acetylated LDL
Stein and Stein (1980) demonstrated that endothelial cells, macrophages, smooth muscle 
cells and fibroblasts take up and degrade acetylated LDL (Ac-LDL) in preference to 
LDL. Acetylated LDL is taken into the cell via specific "scavenger" receptors. This 
uptake and degradation occurs 30 times faster in endothelial cells than in other cells and 
therefore Voyta et al (1984) used the specific uptake of Dil-Ac-LDL as a marker for 
endothelial cell identification.
Primary cultures of microvascular endothelial cells from both murine lung and brain 
tissue stained positive for the uptake of Bodipy acetylated LDL showing punctate 
fluorescence, localised cytoplasmically (Figures 46 & 47). Bo-Ac-LDL was taken up by 
endothelial cells at a faster rate than macrophages, smooth muscle cells or fibroblasts 
thus confirming their endothelial cell origin. No significant difference in the extent of 
uptake between brain and lung microvascular endothelial cells was observed.
With microvascular endothelial cells isolated from the lung there was also the possibility 
of mesothelial cell contamination. Mesothelial cells have been shown to take up Dil-Ac- 
LDL in less than 4 hours (Chung-Welch et a l , 1989), and are therefore indistinguishable 
from microvascular endothelial cells by this means. However, taking into account the 
pretreatment of the lungs prior to isolation in this study and the in vitro angiogenesis 
studies described later, it is possible to confirm that these cells are indeed of endothelial 
origin.
Expression o f Von Willebrand factor
Von Willebrand factor is localised to endothelial cells and megakaryocytes (Zimmerman 
et al., 1983), and is used extensively as reliable, highly specific marker for endothelial 
cells. Both lung and brain microvascular endothelial cells in this study were found to 
express von Willebrand factor. A slight variation in the intensity of staining between
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lung and brain cells was observed (Figures 50 & 51). This could be due to organ specific 
variations or alternatively due to variability in the staining technique.
Although von Willebrand factor is thought to represent an endothelial cell specific 
marker, mesothelial cells have also been shown to express von Willebrand factor in 
culture. The staining intensity for mesothelial cells, however, is faint and more diffuse 
than for endothelial cells (van Hinsbergh et al., 1990). In addition, a negative result for 
von Willebrand factor does not rule out endothelial cell origin. Lymphatic endothelia 
(Mukai 1980) and endothelial cells isolated from porcine tissues (Rosenthal and Gotleib
1990), for example, do not express Von Willebrand factor.
Platelet adhesion
The endothelium demonstrates a non-thrombogenic, non-adhesive surface to platelets in 
vivo and in vitro (Zetter 1984; Belloni et al, 1992). Platelet adhesion assays reported 
here supported the other characterisation studies in demonstrating endothelial cell origin 
of both brain and lung cells (Figures 55 & 56). The platelets were seen to adhere to the 
collagen coated surface of the culture dish, smooth muscle cells and other contaminants 
at the edge of the colonies as well as within colonies. In some cases, adhesion was also 
shown between cells where tight cell-cell contacts were not apparent. The lack of tight 
cell-cell junctions could be due to the presence of contaminating non-endothelial cells 
within the colony.
In vitro Angiogenesis by lung microvascular endothelial cells
A number of features, including those related to the extracellular matrix have been shown 
to play an important role in the formation of capillary "tube-likeM structures by 
microvascular endothelial cells in culture (Ingber and Folkman 1989; Lawley and Kubota 
1989; Vlodavsky et al., 1991; Kinsella et al., 1992). Conventional characterisation 
techniques are not sufficient to conclusively distinguish between endothelial and
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mesothelial cells in culture; therefore, in vitro angiogenesis is the only functional test 
which can qualitatively distinguish between these cells (Chung-Welch et al., 1989). In 
addition, smooth muscle cells, fibroblasts and pericytes do not undergo in vitro 
angiogenesis providing another method of differentiating them from endothelial cells.
When grown Matrigel, the cells isolated from lung tissue in this study formed the 
capillary structures confirming endothelial cell origin (Figure 60). Although, under some 
conditions, epithelial cells can also form tubular structures in vitro (Montesano et al.,
1991), the combination of conventional characterisation studies and in vitro angiogenic 
studies provided sufficient evidence to confirm the endothelial origin of these cells.
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6. B in d in g  o f  [125I-tyr2 , N le 4 , 
D -P he7] a-MSH t o  M u r in e  
B r a in  M ic r o v a s c u la r  
E n d o t h e l ia l  C e l l s
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6.1. Introduction
Melanocortin peptides are neuropeptides which have a wide variety of influences on the 
nervous system including attention, learning, memory, behavioural and neuromuscular 
effects (Eberle, 1988). A number of melanocortin receptors have been identified in the 
brain (Mountjoy et al., 1993; Gantz et al., 1993a and b; Chhanjlani et al., 1993). It is 
conceivable that endocrine hormones, including a-melanocyte stimulating hormone (a- 
MSH), might be transported by receptor-mediated transcytosis making use of receptors 
expressed at the surface of the microvascular endothelia. In this study, the radio- 
iodinated derivative of [Nle4, D-Phe7] a-MSH, the superpotent analogue of a-MSH, has 
been used to examine the possibility that a receptor for MSH is expressed by murine 
brain microvascular endothelial cells, and to determine the binding characteristics at 4°C 
and 37°C.
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6.2. Materials and Methods
6.2.1. Synthesis of [Nle4, D-Phe7] a-MSH
The peptide [Nle4, D-Phe7] a-MSH, was synthesised by Dr G. W. J Olivier at the 
University of Bath (Ahmed et al., 1992). The synthetic procedure, therefore, will only 
be briefly described. A solid-phase synthesis protocol was used to prepare the peptide 
according to the Fmoc strategy developed by Atherton and Sheppard (1989). Pepsin K 
resin was used as the solid phase and the amino acids were sequentially linked to form 
the peptide. The peptide was then purified by semi-preparative HPLC whilst being 
continually monitored by UV spectrophotometry at 217nm. Fractions were collected 
and tested by analytical scale HPLC and their identity was confirmed by co- 
chromatography with standard [Nle4, D-Phe7] a-MSH obtained from Sigma and by FAB 
mass spectrometry. Mass spectrometry was carried out at Swansea University SERC 
MS Centre. Before use, the peptide was dissolved in sterile lOmM HC1 to produce a 
1 mg/ml stock solution which was stored in a sterile plastic screw topped eppendorf tube 
at 4°C.
6.2.2. Iodination of [Nle4, D-Phe7 ] a-MSH
Iodination of the peptide [Nle4, D-Phe7] a-MSH occurred at the Tyr2, using a protocol 
based on the chloramine T procedure described by Eberle (1988).
Preparation o f stock solutions
The following stock solutions were prepared and stored at 4°C:
0.25M Na2HPC>4 in distilled water.
160
0.25M NaH2PC>4 in distilled water
1% TFA (trifluoroacetic acid, Aldrich chemicals) in distilled water 
50, 60, and 80% methanol (HPLC grade) with 1% TFA.
Preparation of solutions
The following solutions were prepared freshly prior to the iodination:
1) 0.25M Phosphate buffer pH7.4, prepared from the stock solutions Na2HP0 4  and 
NaH2P 04
2) 0.25% BSA (0.0125g) in 1ml 0.25M phosphate buffer and 4ml distilled water.
3) 1% Polypep ( 0.05g, Sigma) in 1ml 0.25M phosphate buffer and 4ml distilled water.
4) 0.1% Chloramine T (O.Olg, BDH chemicals) in 10ml distilled water dissolved 
immediately before use.
5) 1.5pi of [Nle4, D-Phe7] a-MSH from the 1 mg/ml stock solution in 25pi 0.25M 
phosphate buffer, prepared in a 1.5ml plastic eppendorf tube.
Preparation o f the column
Purification of the freshly iodinated peptide [125I-Tyr2, Nle4, D-Phe7] a-MSH was carried 
out on mini, disposable C l8 reverse-phase column with Spherisorb ODS Bond Elut' 
(Analytical international, MFG codeOH53). The column was prepared and conditioned 
for the purification according to the following procedure:
prewash X3 with 1%TFA in water 
wash X3 with 1% TFA in 80% methanol 
wash XI with 1ml polypep 
wash X3 with 1% TFA in 80% methanol 
wash X3 with 1% TFA in water.
Iodination o f [Nle4, D-Phe7]  a-MSH
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The iodination procedure was performed in a radioactive fume hood. lOmCi of sodium 
iodide (125INa, ICN Biomedicals, inc.) was added to the Eppendorf containing 1.5pi 
peptide in 25 pi phosphate buffer. The reaction was initiated by the addition of lOpl of 
freshly prepared chloramine T. After exactly 30 seconds the reaction was stopped by the 
addition of 0.6ml of 0.25% BSA.
Purification o f [I25I-Tyr2, Nle4, D-Phe7]  a-MSH
The freshly iodinated peptide was loaded on to the pre-conditioned C l8 column and the 
initial elutent was discarded. The column was washed twice with 0.8ml of phosphate 
buffer, again discarding the elutent. The column was then washed X4 with 1ml of 50% 
methanol/1% TFA in water, followed by washing X2 with 1ml of 60% methanol/1% 
TFA in water. The elutent from these washing procedures was pooled together and 
saved.
The peptide was further purified by HPLC using a C18 reverse-phase wide pore (300A) 
column, 25cm length and 4.6mm diameter. The washes retained from the initial 
purification were loaded on to the column (1 ml/minute, normal flow rate) and run with 
an exponential gradient starting at 95% A (1%TFA in water), 5% B (70% 
acetonitrile/1% TFA) and reaching 40% A, 60% B after 50 minutes before returning to 
the original proportions. The procedure was monitored by UV detection at 217nm. 
Fifteen 1ml fractions were collected 27 minutes from the start of the gradient and 
assayed on a gamma counter (LKB wallac 1277 gammamaster). The mono-iodinated 
peptide required was contained in only one or two fractions separated from the more 
lipophilic di-iodinated peptide which eluted later, and the free 125INa which came off 
earlier. The iodinated peptide, [125I-Tyr2, Nle4, D-Phe7] a-MSH was stored at -20°C 
for up to 2 weeks.
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6.2.3. Binding of [125I-Tyr2, Nle4, D-Phe7] a-MSH at 4°C
Binding studies were performed using a Millipore Multi Screen Assay System (Roessler 
et al., 1993). The cells were grown to confluence on 6-well plates and removed from the 
culture wells using the trypsinisation method described previously (see section 4.2.1). 
The cells were counted using a haemocytometer chamber and found to be greater than 
95% viable by trypan exclusion (see section 2.1.4). The cells were diluted to ensure that 
lOOpl of cells were plated on to 96 well membrane filtration units (multiscreen-HV) at a 
density of between 1 x 105 cells /well and 5 x 105 cells /well in complete culture media.
After incubation for up to 1 hour at 37°C, the medium was removed using a vacuum 
manifold supplied with the system and washed 3 times with PBS at 4°C. The plates were 
incubated overnight at 4°C with the appropriate concentration of [125I-Tyr2, Nle4, D- 
Phe7] a-MSH diluted in freshly prepared binding buffer (serum-free RPMI 1640 
medium, with 25mM HEPES and 0.2% BSA) in the presence and absence of a 1000-fold 
excess unlabelled [Nle4, D-Phe7] a-MSH. Preliminary binding assays were performed 
using 1 x 105 cells /well with two concentrations of [125I-Tyr2, Nle4, D-Phe7] a-MSH. 
Binding isotherms were performed using 2 x 105 cells /well and 5 x 105 cells /well with 
increasing concentrations of ligand.
After incubation the cells were washed 3 times with PBS at 4°C and the membrane disks 
were punched out, using an 8-well punch system with disposable tips, directly into 
gamma tubes (LP4, Western Laboratories U.K.). Radioactivity was counted on a 
gamma counter. Between three and six replicates were assayed for each concentration.
6.2.4. Binding and Uptake of [125I-Tyr2, Nle4, D-Phe7] a-MSH at 37°C
Binding isotherms at 37°C were performed using one concentration of [125I-Tyr2, Nle4, 
D-Phe7] a-MSH incubated over various time intervals, between 15 minutes and 4 hours. 
The cells were plated on to the 96 well membrane filtration units at a density of between
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1 x 105 cells/well and 5 x 105 cells/well in complete culture medium. A separate plate 
was required for each time point.
The plates were incubated at 37°C for up to 1 hour and the medium was then removed 
using the vacuum system. The cells were washed 3 times with PBS, pre-warmed to 
37°C prior to use, and incubated with 1 x 10" 10 m, [125I-Tyr2, Nle4, D-Phe7] a-MSH in 
binding buffer, in the presence and absence of 1000-fold excess unlabelled [Nle4, D-Phe7] 
a-MSH, at 37°C. The plates were incubated at 37°C for various time intervals.
After the appropriate time interval the plate was removed from the incubator and washed 
3 times with pre-warmed PBS. At this point some of the cells received an acid wash in 
order to determine the extent of uptake of the peptide. These cells were exposed to 
[125I-Tyr2, Nle4, D-Phe7] a-MSH with no cold ligand present. The acid wash required a 
5 minute incubation with pre-warmed citrate buffer pH2.5 consisting of 21.01 g citric 
acid.H20, 5.43g NaCl and 23.44ml of 1M NaOH, made up to llitre with distilled water. 
The cells were washed a further twice with PBS, and the membrane discs were punched 
out into the gamma tubes and counted on the gamma counter.




6.3.1. Iodination of [Nle4, D-Phe7] a-MSH
The identity of the peptide [Nle4, D-Phe7] a-MSH was confirmed by FAB mass 
spectrometry: M+H+calculated weight 1646.8, determined weight 1647. Following the 
iodination procedure the peptide was purified using a pre-conditioned C18 reverse phase 
column and further purified by HPLC. Figure 61 shows a characteristic HPLC elution 
profile which produced three peaks corresponding to non-iodinated, mono-iodinated and 
di-iodinated peptide. Sixteen 1ml fractions were collected from the column at 25 to 40 
minutes after injection The activity of the fractions containing the iodinated peptide, 
which was measured on the gamma counter corresponded with the latter two peaks on 
the HPLC trace. The first peak showed no significant activity.
6.3.2. Binding of [125I-Tyr2, Nle4, D-Phe7] a-MSH at 4°C
Preliminary binding studies were performed on murine brain microvascular endothelial 
cells (MBMVEC) in order to investigate the possibility that melanocortin receptors were 
present on the surface of brain endothelial cells. Prior to the incubation with [125I-Tyr2, 
Nle4, D-Phe7] a-MSH, the cells were incubated in complete culture medium in order to 
ensure that the cells had recovered from the trypsinisation procedure. Initial experiments 
were performed using two single concentrations of ligand, 1 x 10“10 M and 5 x 10"10 M 
[i25I-Tyr2, Nle4, D-Phe7] a-MSH and incubated with 1 x 105 cells/well at 4°C overnight 
(approximately 18 hours) in an attempt to ensure that equilibrium was reached.
Each preliminary study confirmed the existence of some specific binding (Figure 62). 
Total binding was expressed as counts per minute (CPM) of [125I-Tyr2, Nle4, D-Phe7] a-
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MSH and non-specific binding was expressed in CPM and determined in the presence of 
a 1000-fold excess of unlabelled [Nle4, D-Phe7] a-MSH. The specific binding was 
obtained by subtracting non-specific binding from total binding. Preliminary binding 
studies were also performed on lung microvascular endothelial cells, however these 
studies showed no evidence of specific binding (Figure 63).
Although preliminary binding studies with brain microvascular endothelial cells 
demonstrated specific binding, it was relatively low. This low specific binding could be 
due to a low number of receptors being expressed per cell or, alternatively, it could be as 
a result of a low binding affinity. The preliminary binding assays also exhibited a 
relatively high amount of non-specific binding. This high non-specific binding was 
shown even in the presence of 0.2% BSA in the binding medium which was required to 
coat the plastic well and the filter, and therefore decrease the extent of non-specific 
binding. Similar binding studies involving human melanoma cells have also showed high 
non-specific binding (Eberle et al., 1991).
The presence of an increased number of cells on the filter may lower the non-specific 
binding, as the area of the filter exposed to the ligand would be decreased. In an attempt 
to improve the specificity of the study and reduce the extent of non-specific binding to 
the plastic well and the filter, binding isotherms were performed where the number of 
cells per well was increased to 2 x 105 cells/well (Figure 64) and 5 x 105 cells/well 
(Figure 65).
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Cell Density 1 x 10"10M [125I-Tyr2, Nle4, 
D-Phe7] a-MSH
5 x 10‘10 M [125I-Tyr2, 
Nle4, D-Phe7] a-MSH
1 x 105 304.44 ± 45.7 1771.62 ±121.68
2 x  105 398.82 ±13.48 1357.32 ± 94.5
5x  105 ** 1658.08 ±72.6
Table 1. The effect of increasing cell density on the non-specific binding of [125I-Tyr2, 
Nle4, D-Phe7] a-MSH, in the presence of 1000-fold excess unlabelled [Nle4, D- 
Phe7] a-MSH, to MBMVEC. Each data point is expressed in CPM and 
represents the mean and standard deviation of five samples.
Table 1 shows the proportion of binding designated as non-specific binding for 
concentrations of 1 x 10'10 M and 5 x 10"10 M in the presence of 1000-fold excess of the 
unlabelled ligand. The extent of non-specific binding was variable however, it did not 
show an overall significant decrease as the cell number increased. With 1 x 10-10 M 
[125I-Tyr2, Nle4, D-Phe7] a-MSH there was no significant difference between 1 x 105 
cells/well and 2 x 105cells/well however, at 5 x 10"10 M [125I-Tyr2, Nle4, D-Phe7] a- 
MSH, the extent of non-specific binding decreased significantly between 1 x 105 
cells/well and 2 x 105cells/well, but not between 2 x 105 cells/well and 5 x 105cells/well. 
This was determined using a two sample t-test and pooled variences after checking with 
an F-test. The non-specific binding therefore, may still be attributed to binding to the 
plastic and the filter however there may also be some non-specific binding to the cell 
surface.
167
Figures 62 and 64 showed that the specific binding in the presence of 2 x 105cells per 
well was significantly greater than that determined in the presence of 1 x 105 cells per 
well in the preliminary studies, at concentrations of 1 x 10"10M and 5 x 10~10 M [125I- 
Tyr2, Nle4, D-Phe7] a-MSH (Table 2). This was determined using a non-parametric test 
to calculate to confidence intervals for the difference in medians. The difference in 
specific binding obtained with studies using 5 x 105 cells per well (Table 2) however, was 
not significantly greater than the specific binding obtained with studies using 2 x 105 cells 
per well. It should be remembered that it is necessary to carry out these experiments 
using cells obtained from different isolations and therefore a degree of variability in the 
receptor number might be expected. With B16 cells, the number of receptors per cell has 
been shown to be variable (Sahm et al., 1994).
Cell Density 1 x 10"10M [12sI-Tyr2, Nle4, 
D-Phe7] a-MSH
5 x HP10 M [125I-Tyr2, 
Nle4, D-Phe7] a-MSH
1 X 105 107.36 645.44
2 x  105 297.02 1119.86
5 x  10s ** 1398.1
Table 2. The effect of increasing cell density on the specific binding of [125I-Tyr2, Nle4, 
D-Phe7] a-MSH to MBMVEC. Each data point is expressed in CPM and was 
calculated by subtracting non-specific binding from total binding.
The saturation binding data was analysed by MINSQ, a non-linear regression analysis 
computer program, in order to estimate the number of receptors per cell and the binding
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affinity. The formation of ligand-receptor complexes are governed by the Langmuir 
isotherm model. The relationship between the amount of ligand bound to the receptor 




[H] = concentration of free hormone
[HR] = concentration of ligand-receptor complex
[R] = concentration of free receptor
Ka = association constant ( [HR]/[H][R] )
n = total number of receptors
Kd = dissociation constant (1/Ka)
One approach to determining the total number of binding sites, n, and the affinity 
constant, Ka is to construct a Scatchard plot showing bound/free against bound. 
However in this study binding isotherms did not start to plateau and therefore although a 
fit was obtained, any analysis of the data from the Scatchard plot is not conclusive 
(Figure 66). An estimation of the binding affinity and cell number from the isotherm 
shown in Figure 64 using MINSQ suggested a dissociation constant (Kd) of 3.1 x 10"8M 
with the number of receptors per cell being approximately 120, but again this is not 
conclusive. The outcome of these results will be discussed in section 6.4.
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Figure 61. A characteristic HPLC trace from the purification of the reaction products 
from the iodination of [Nle4, D-Phe7] a-MSH as measured by UV absorption. 










Ccncertraian [ 1251-Tyf2,Nle4,D-Hie7]otM3I(M x 1010)
Figure 62. A preliminary study showing the binding of [125I-Tyr2, Nle4, D-Phe7] a-MSH 
to murine brain microvascular endothelial cells (1 x 105 cells per well) at 4°C, 
using two different concentrations of [125I-Tyr2, Nle4, D-Phe7] a-MSH. Each 
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Figure 63. A preliminary binding study of [125I-Tyr2, Nle4, D-Phe7] a-MSH to murine 
lung microvascular endothelial cells (1 x 105 cells per well) at 4°C, using two 
different concentrations of [125I-Tyr2, Nle4, D-Phe7] a-MSH. Each data point 











Figure 64. A binding isotherm of [125I-Tyr2, Nle4, D-Phe7] a-MSH to MBMVEC (2 x 
105cells/well) at 4°C. Each data point represents the mean and standard 
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Figure 65. A binding isotherm of [125I-Tyr2, Nle4, D-Phe7] a-MSH to MBMVEC (5 x 
105cells/well) at 4°C. Each data point represents the mean and standard 
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Figure 66. A Scatchard Plot analysis of the binding isotherm shown in Figure 64,
showing bound [125I-Tyr2, Nle4, D-Phe7] a-MSH/ffee [125I-Tyr2, Nle4, D- 
Phe7] a-MSH (moles / cell) against bound [125I-Tyr2, Nle4, D-Phe7] a-MSH 
(moles / cell) with 95% confidence limits.
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6.3.3. Binding and Uptake of [125I-Tyr2, Nle4, D-Phe7] a-MSH at 37°C
The binding and uptake of [125I-Tyr2, Nle4, D-Phe7] a-MSH by murine brain 
microvascular endothelial cells was studied at 37° C. The cells were incubated with 1 x 
10"10M [125I-Tyr2, Nle4, D-Phe7] a-MSH for between 15 minutes and 4 hours before 
being washed with PBS. After this time some cells were exposed to an acid-wash 
treatment in order to remove the extracellular bound ligand. This treatment provided a 
method of determining the extent of uptake of the iodinated peptide into the cells, 
because any remaining radioactivity associated with the cells would have to have been 
internalised (Richards 1992).
Figure 67 demonstrates the binding of [125I-Tyr2, Nle4, D-Phe7] a-MSH to brain 
endothelial cells at 37° C. At 37° C, the specific binding represents with amount of 
ligand associated with the cell. This includes the amount of ligand bound to the cell 
surface and the amount of ligand internalised by the cell. The specific binding, expressed 
in counts per minute (CPM), increased rapidly during the initial 30 minute incubation. 
The specific binding increased further over the subsequent 30 minutes reaching a 
maximum of 163.6 CPM. After this time no further increase in the specific binding was 
demonstrated, a plateau was reached and a very gradual decrease was observed (Table
3).
Initially, the non-specific binding was found to be lower than the specific binding. The 
non-specific binding was however found to increase gradually during the incubation 
period until the specific and non-specific binding were the same (Table 3). This non­
specific binding is possibly associated with the filter, although a proportion of it could be 
associated with non-specific binding to the cell surface.
The cells were exposed to an acid wash treatment in order to remove any extracellular 
bound ligand be it by specific or non-specific binding, therefore the values obtained 
represent the internalised peptide (Table 3). The data from the acid washed cells
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displayed similar characteristics to the specific binding curve, that is, during the initial 
incubation period an increase in radiolabelled peptide was observed. This reached a 
plateau after 30 minutes incubation. As expected, the amount of radioactivity associated 
with the acid washed cells was less than that associated with specific binding, as specific 
binding represented the amount of peptide bound plus the amount internalised, whereas 
acid washed data represents peptide internalised only. This suggests that at 37°C [125I- 
Tyr2, Nle4, D-Phe7] a-MSH was internalised by brain microvascular endothelial cells, but 











30 minutes 199.5 ± 49.2 78 ± 13.8 100.1 ± 13 121.5
60 minutes 265 ± 29.4 102.7 ±4.1 103.5 ±4.17 163.6
180 minutes 355 ± 114.8 168.7 ± 14.2 152.2 ±6.8 161.8
Table 3. Incubation of murine brain microvascular endothelial cells with [125I-Tyr2, Nle4, 
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Figure 67. A binding isotherm of 1 x 10"10M [125I-Tyr2, Nle4, D-Phe7] a-MSH to
MBMVEC (5 x 105cells/well) at 37° C. Each data point represents the mean 
and standard deviation of five wells.
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6.4. Discussion
Iodination of [Nle4, D-Phe7]  a-MSH
Following the iodination of [Nle4, D-Phe7] a-MSH, the iodinated products were purified 
by HPLC, revealing three peaks of which two were identifed as having high amounts of 
radioactivity. This elution profile correlates with that described by Eberle (1988). The 
first peak represented the non-iodinated peptide, the second and third peaks represent the 
mono-iodinated and di-iodinated peptides respectively. The mono-iodinated peptide 
being less lipophilic is eluted before the di-iodinated peptide. Iodination and purification 
of [Nle4, D-Phe7] a-MSH by the methods described in this study produced a 
reproducible yield of mono-iodinated peptide.
Binding o f [125I-Tyr2, Nle4, D-Phe7]  a-MSH at 4 CC
[i25I-Tyr2, Nle4, D-Phe7] a-MSH is a super potent analogue of a-MSH due to prolonged 
action on reptilian/amphibian bioassays which has been shown to possess a binding 
affinity and biological activity ten times that of a-MSH (Eberle 1988). It has been 
widely used in the study of the isolation and activity of the MSH receptors as its high 
activity allows the detection of low receptor populations (Sahm et al., 1994; Dyer et al., 
1993; Rosselli-Rehfiiss et al., 1993; Gantz et al., 1993a; Ahmed et al., 1992; Mountjoy 
etal., 1992; Lunec et al., 1992; Leiba etal., 1990).
The concentrations of [125I-Tyr2, Nle4, D-Phe7] a-MSH were selected for this study on 
the basis of the binding affinity of the peptide to the a-MSH receptor in B16 cells. 
Although increasing the concentration of the peptide has been shown to give a more 
reliable binding affinity it also increases the non-specific binding therefore a compromise 
concentration was reached (Erskine 1993). At 4°C binding of [125I-Tyr2, Nle4, D-Phe7]
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a-MSH is limited to the cell membrane, it is not internalised, (Richards 1992) and the
receptor ligand complex is not degraded (Siegrist et al., 1992). The binding isotherms
conducted with 2 x 105cells per well and 5 x 105cells per well indicated that the extent of 
specific binding is very low and that there was also a high proportion of non-specific 
binding. This is not unusual, as some human melanoma cells have been shown to exhibit 
low specific binding of [125I-Tyr2, Nle4, D-Phe7] a-MSH (Eberle et al., 1991) and the
analogue 125I-[Nle4] a-MSH (Eberle et al., 1991; Siegrist et a l, 1992). In both cases,
the specific binding is less than the non-specific binding.
No specific binding of [125I-Tyr2, Nle4, D-Phe7] a-MSH was observed with murine lung 
microvascular endothelial cells suggesting that microvascular endothelial cells are 
heterogeneous with respect to organ specificity.
The theory of Scatchard analysis of a binding isotherm is that it provides a method of 
determining the number of receptor populations and estimating the binding affinity and 
number of binding sites. Several assumptions must be made when using Scatchard 
analysis (Bolander 1989):
1. The labelled hormone is biologically identical to the native hormone.
2. The labelled hormone is homogeneous.
3. The receptor is homogeneous.
4. The receptor acts independently.
5. The receptor is unoccupied prior to the incubation.
6. The reaction is at equilibrium.
7. There is no specific non-receptor binding.
In this study, Scatchard analysis was inconclusive. Although the points lie within the 
95% confidence limits and a line can be fitted which suggests one population of
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receptors, the fit is not satisfactory. This is typical of experimental data prepared with 
cells with low numbers of receptors and high non-specific binding.
The value for the dissociation constant Kd obtained using MINSQ was estimated at 
31nM. This value can be compared to the values of Kd obtained for binding to the 
melanocortin receptor expressed in B16 melanoma cells (MC1-R) (0.48±0.08nM, Sahm 
eta l., 1994), rat hypothalamus (MC3-R) (1.66nM, Sahm e ta l., 1993) and to extraorbital 
rat lacrimal gland tissue (2.2±0.2nM, Leiba et al., 1990). This may indicate that the 
binding affinity of [125I-Tyr2, Nle4, D-Phe7] a-MSH for the receptor expressed on brain 
microvascular endothelial cells is less than that obtained for other melanocortin 
receptors. In comparison, the dissociation constant obtained for the binding of 
transferrin to receptors expressed on liver endothelial cells has been demonstrated to be 
0.189pM (Tavassoli 1988) indicating a weak binding affinity. [125I-Tyr2, Nle4, D-Phe7] 
a-MSH recognises various melanocortin receptors with different binding affinities 
therefore, the expression of an alternative melanocortin receptor on brain endothelial 
cells may account for the different binding affinity.
If the binding affinity of [125I-Tyr2, Nle4, D-Phe7] a-MSH for the receptor on brain 
endothelial cells is relatively low in comparison with other melanocortin receptors 
therefore, the low amount of specific activity could be due in part to the binding affinity 
but it may also be due to the very low receptor number. The estimated receptor number 
is 120 receptors per cell, this is low in comparison to DIO human melanoma cells which 
have an estimated 966 receptors per cell (Siegrist et al., 1992) and B16 cells where the 
number of receptors per cell has been shown to vary from 5,000 to 20,000 (Sahm et al., 
1994). The variability in the specific binding of [125I-Tyr2, Nle4, D-Phe7] a-MSH to 
brain microvascular endothelial cells with different cell densities (Table 2) could be as a 
result of the variability in the number of receptors expressed per cell, as shown with B16 
cells, or due to the experimental variability associated with the low affinity or low 
receptor number.
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Binding o f [125I-Tyr2, Nle4, D-Phe7]  a-MSH at 37 CC
At 37°C, where the metabolic processes are functioning, binding of [125I-Tyr2, Nle4, D- 
Phe7] a-MSH reached a maximum after 60 minutes, thereafter specific binding reached a 
steady-state plateau. This specific binding represents the surface bound and internalized 
ligand. The proportion of specific binding that was associated with the internalised 
ligand was determined by acid wash at each time point during the incubation at 37°C; 
this follows a similar pattern to the specific binding.
When comparing the binding of brain endothelial cells at 37°C with other cell types, the 
incubation of [125I-Tyr2, Nle4, D-Phe7] a-MSH with B16 cells at 37°C shows a large 
increase in the specific binding, reaching a maximum after 30 minutes and decreasing 
thereafter. The reason for this decrease is unknown, however, it could be explained by 
intracellular degradation of the ligand or dissociation of the ligand from the receptor. 
The measure of internalisation by acid wash, demonstrated a gradual increase reaching a 
maximum after 60 minutes declining gradually thereafter (Richards 1992). A similar 
pattern of uptake at 37°C was demonstrated with the binding of radio-iodinated 
transferrin to rat liver endothelial cells (Kd 0.189pM and 1.8 x 106 receptors per cell). 
The amount of internalised ligand increased rapidly for the initial 15 minutes declining 
gradually thereafter; this was explained as being due to the rate of extemalisation 
exceeding the internalisation as a result of down regulation of the receptors (Tavassoli 
1988).
In the present study, this pattern of uptake was not demonstrated during the binding of 
[125I-Tyr2, Nle4, D-Phe7] a-MSH with brain microvascular endothelial cells at 37°C. 
This was possibly due to the low receptor number which would not be able to take up 
the ligand in sufficient quantities to produce this large initial increase. The pattern of 
uptake demonstrated in this study could suggest internalisation and transport across the 
cell where the receptor is recycled and the ligand is externalised intact as a steady state is 
reached.
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The transport processes associated with large vessel and microvessel endothelial cells are 
heterogeneous (see section 1.1.3). In addition, the microvascular endothelial cells of the 
blood-brain barrier possess several unique features which provide a very selective barrier 
to macromolecules (see section 1.1.13). Transcytosis through the blood-brain barrier 
occurs by intracellular routes: fluid-phase endocytosis, adsorptive transcytosis and 
receptor-mediated transcytosis.
In this study, the identification of a receptor expressed on the surface of brain 
microvascular endothelial cells which specifically binds [125I-Tyr2, Nle4, D-Phe7] a-MSH, 
is thought to internalise the receptor-ligand complex which may be transported across 
the cell by receptor mediated transcytosis. It is also possible that a proportion of the 
internalised ligand may be taken up by fluid-phase endocytosis or non-specific adsorptive 
transcytosis. This could be estimated using the fluid-phase marker horse-radish 
peroxidase (HRP) or a molecule taken up by adsorptive endocytosis such as wheat germ 
agglutinin (WGA), a lectin which binds to carbohydrate molecules on the cell surface 
(Broadwell 1993).
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7. P h o t o a ffin it y  L a b e l l in g  
o f  M ur in e  B r a in  
M ic r o v a sc u l a r  
En d o t h e l ia l  Ce l l s .
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7.1. Introduction
Photoaffinity labelling is an important technique in the identification, isolation and 
characterisation of hormone receptor proteins (Eberle 1988). Previously, it has been 
used to demonstrate the existence of a-MSH receptors on various murine and human 
melanoma cells (Ahmed et a l, 1992; Siegrist et a l, 1992) and primary cultures of rat 
Schwann cells (Dyer et al., 1993). In this study the mono-iodinated photoaffinity probe 
[i251-Tyr2, Nle4, D-Phe7, ATB-Lys11] a-MSH was used to label the receptor proteins on 
murine brain microvascular endothelial cells using the method of Ahmed et al., (1992) 
which described the photoaffinity labelling of B16 melanoma cells. This was followed by 
SDS-PAGE analysis and autoradiography.
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7.2. Materials and Methods
7.2.1. Synthesis of [Nle4, D-Phe7, ATB-Lys11] a-M SH
The photoaffinity peptide [Nle4, D-Phe7, ATB-Lys11] a-M SH was synthesised by Dr G. 
W. J. Olivier at the University of Bath. A detailed protocol of the peptide synthesis is 
described by Ahmed et al (1992).
7.2.2. Iodination of [Nle4, D-Phe7, ATB-Lys11] a-M SH
The peptide [Nle4, D-Phe7, ATB-Lys11] a-MSH was iodinated at the Tyr2 by Dr G. W. 
J. Olivier using the method of Eberle et al (1988) detailed in section 6.2.2. The mono- 
iodinated peptide was used in all experiments. All synthesis and iodination procedures 
were performed in a dark room under red safety light.
7.2.3. Photoaffinity Labelling of Brain microvascular Endothelial Cells
The following procedure described for the photoaffinity labelling of murine brain 
microvascular endothelial cells was adapted from the procedure described by Ahmed et 
al (1992) for the labelling of B16 melanoma cells.
Tissue culture
The cells used for photoaffinity labelling were grown on 6-well plates and subcultured 
using the standard trypsinisation procedure for brain microvascular endothelial cells (see 
section 4.2.1). Four confluent 6-well plates at passage 1, grown under routine 
conditions, were used for the photoaffinity labelling studies.
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Preparation of stock solutions.
0.5M Tris-HCl buffer pH6.8 was prepared by dissolving 12.lg of tris base (Bio-Rad 
Labs) in 150ml of distilled water. The pH was adjusted to 6.8 with 6M HC1 and made 
up to a final volume of200ml with distilled water.
1.5M Tris-HCl buffer pH8.8 was prepared by dissolving 36.3g of tris base in 150ml of 
distilled water. The pH was adjusted with 6M HC1 and made up to 200ml with distilled 
water.
A solubilization buffer was prepared as follows:
lOmM Tris-HCL, pH 7.4.
1.5% Triton X-100, (Sigma)
ImM phenylmethanesulphonyl fluoride (PMSF, Sigma),
ImMEDTA
lpg/ml leupeptin (Sigma)
20% (w/v) sodium dodecylsulphate SDS (BDH chemicals) was prepared by dissolving 
20g SDS in distilled water with gentle stirring. The SDS solution was made up to 100ml 
with distilled water and stored at room temperature.
The Acrylamide/Bis (Bio-Rad Labs) solution was prepared by dissolving 29.2g 
Acrylamine and 0.8g N'N’-bis-methylene-acrylamide in 100ml distilled water. The final 
solution was filtered and stored at 4°C in the dark.
An SDS sample buffer was prepared as follows:
62.5mMTris-HCL pH6.8,
2%(w/v) SDS,
10% (v/v) glycerol,(Fisons Ltd.)
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0.001% Bromophenol Blue,(Fisons Ltd.)
5% (v/v) 2-mercaptoethanol (Sigma)
l
The electrode (running) buffer was prepared as a 5X concentrated solution consisting of 
25mM Tris, 192mM glycine and 1% SDS at pH8.3 and diluted with distilled water for 
each run.
0.1% Coomassie Brilliant Blue staining solution was prepared from 0.5g Coomassie blue 
with the addition of 40% (200ml) methanol, 10% (50ml) acetic acid and 50% (250ml) 
distilled water.
The de-staining solution was made up of 40% methanol, 10% acetic acid and 50% 
distilled water.
Photoaffinity labelling
All manipulations with the photoaffinity probe prior to UV irradiation were conducted in 
the dark. The cell samples were washed 3 times in freshly prepared binding buffer 
(serum-free RPMI 1640 medium, with 25mM HEPES and 0.2% BSA), and the cells 
were incubated, at 4°C, with the radiolabelled photoaffinity probe [1251-Tyr2, Nle4, D- 
Phe7, ATB-Lys11] a-MSH at a concentration of 2 x 10"10M. The cells were incubated in 
the presence and absence of 1000-fold excess of the unlabelled [Nle4 D-Phe7, ] a-MSH.
After a 4 hour incubation the cells were washed and then irradiated for 5 minutes on ice, 
with UV light of wavelength 320nm, thereafter all procedures were performed at the 
bench under normal light conditions After UV treatment the cells were scraped from the 
wells, suspended in PBS and washed by centrifugation at 1600g for 10 minutes to 
remove any unbound ligand.
The cells were resuspended in solubilization buffer at 4°C for 1 hour and ultracentrifuged 
at 30 000 g for 1 hour to remove any non-solubilised material. The solubilised receptor
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complexes were stored at -20°C until required for SDS/polyacrylamide gel 
electrophoresis.
SDS/polyacrylamide gel electrophoresis.
SDS/PAGE was performed using the Laemmli discontinuous buffer system (1970) using 
10% acrylamide monomer in the separating gel and 4% in the stacking gel. The gels 
were prepared according to the following protocol:
Separating Gel Stacking Gel
Distilled water 20.1ml 6.1ml
1.5M Tris-HCl 12.5ml -
0.5M Tris-HCl - 2.5ml
20% SDS 0.25ml 0.1ml
Acrylamide/Bis 16.65ml 1.3ml
10% ammonium persulphate 0.5ml 0.1ml
TEMED 25pl lOpl.
The 10% ammonium persulphate (APS) was freshly prepared in distilled water on the 
day of use. The APS and TEMED (Bio-Rad) cause cross linking of the acrylamide and 
therefore were added to the solutions just prior to casting the gels.
The gel electrophoresis apparatus was set up according to the manufacturers instructions 
(PROTEAN II apparatus, Bio Rad) to give a 0.75mm thick gel. The separating gel was 
cast and allowed to set for 1 hour, thereafter the stacking gel was prepared, cast and 
allowed to set.
SDS sample buffer was added to the samples and left to solubilise at room temperature 
for approximately 30 minutes. The samples were loaded on to the gel and
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electrophoresed in parallel with 14C pre-labelled molecular mass markers, in order to 
determine the apparent molecular mass of the samples.
The markers used were myosin (200kDa), phosphorylase B (97.4kDa), BSA (69kDa), 
ovalbumin (46kDa), carbonic anhydrase (30kDa) and lysosyme (14.3kDa). Each of 
these markers was stained with Coomassie blue and heated for a minute before loading 
on to the gel.
Following electrophoresis, the gel was stained with Coomassie blue for 30 minutes, de­
stained and dried in a gel drier (Bio-Rad) for 1 hour. The gel was exposed on a pre­
flashed X-ray film (Hyperfilm MP, Amersham) with an intensifying screen (Hyperscreen, 
Amersham) for 3-5 days at -70°C.
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7.3. Results
Photoaffinity labelling studies were performed on murine brain microvascular endothelial 
cells using the photoaffinity probe [125I-Tyr2 Nle4 D-Phe7 ATB-lys11] aMSH which has 
been shown to bind specifically to B16 melanoma cells (Ahmed et a l, 1992). These 
studies were carried out in the presence and absence of an excess of a 1000-fold excess 
of the unlabelled peptide [Nle4, D-Phe7] a-MSH, in order to demonstrate specific 
binding. SDS-PAGE analysis of the solubilized membrane proteins in the presence of the 
radioiodinated, photoaffinity labelled peptide only, resulted in the identification of three 
sharp bands (Figure 68). With two of these bands, labelling was reduced but not 
completely abolished with an excess of unlabelled peptide, however with one of these 
bands labelling was not present when the cells were incubated with an excess of 
unlabelled peptide. This latter band appeared at an apparent molecular mass of 
approximately 45kD, which is similar to the molecular mass for the receptor on B16 and 
other melanoma cells (Ahmed et al., 1992) and for primary rat Schwann cells which are 
of non-melanocyte origin (Dyer et al., 1993).
In Figure 68, the single lane 8 on the right of the gel shows the molecular mass markers. 
Lanes 1 and 2 respectively in the SDS-PAGE analysis shows the presence of proteins 
crosslinked with the radioiodinated, photoaffinity labelled peptide in the presence and 
absence of 1000-fold excess unlabelled peptide. Lanes 5 and 6 are replicates of lanes 1 
and 2.
The two other strong bands had apparently higher molecular masses of approximately 
57kDa and 90kDa. These bands may be due to non-specific labelling of proteins or non­
specific labelling of multiple aggregates of the receptor which could be explained by the 
mild conditions of solubilization used (Ahmed et al., 1992).
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Figure 68. SDS-PAGE analysis of murine brain microvascular endothelial cells. Lanes 1 
and 2 respectively represent the photoaffinity labelled proteins in the presence 
and absence of 1000-fold excess unlabelled peptide. Lanes 5 and 6 are 
replicates of lanes 1 and 2. Arrow 1 indicates the specific labelling of a protein 
with an apparent molecular mass of 45 kDa. Arrows 2 and 3 represent non­
specific labelling of membrane proteins or multiple aggregates of the receptor.
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7.4. Discussion
Further investigations into the expression of the receptors on the endothelial cells were 
conducted in the form of photoaffinity labelling. This is a useful tool for identification 
and isolation of receptors. These studies support the initial evidence from the binding 
analysis that a receptor for a-MSH was expressed. A distinct band, which was not seen 
in the presence of excess unlabelled peptide, at an apparent molecular weight of 45 kD 
suggests the expression of a specific receptor with a similar molecular weight to that 
observed with B16 melanoma cells and primary rat Schwann cells (Ahmed et al., 1992; 
Dyer et a l , 1993). The assumption is made that the radio-iodinated, photoaffinity 
labelled peptide [125I-Tyr2 Nle4 D-Phe7 ATB-lys11] aMSH has the same affinity for the 
receptor as the unlabelled peptide [Nle4 D-Phe7] a-MSH.
The presence of a higher molecular weight band at 57kDa thought to be due to non­
specific binding has also been identified by SDS-PAGE analysis of B16 cells using the 
same photoaffinity probe (Ahmed et a l, 1992). The 90kDa band however, could 
represent a multiple aggregate of the receptor as this would possess a molecular mass of 
approximately 88kDa, that is twice the molecular mass of the receptor (43kDa) together 
with the molecular mass of the peptide (2kDa).
It is possible that a family of neural melanocortin receptors exists which could account 
for the diverse pattern of MSH binding exhibited throughout various regions of the brain 
and the diverse functions of the melanocortin peptides (Eberle 1988). The physiological 
role of a receptor in the brain microvascular endothelium is unknown. It is possible that 
unlike in B16 melanoma cells, in the case of endothelial cells the peptide is taken into the 
endothelial cell, not degraded but transported across the cell by receptor mediated 
transcytosis. The indication that multiple melanocortin receptors exist has been 
supported by cloning of the genes which encode the melanocortin receptors (see section
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1.1.16). This work has identified that although the receptors have distinct activities, they 
all belong to the G-protein family of receptors (Mountjoy et al., 1992; Chhajlani et al., 
1993; Cone and Mountjoy 1993; Gantz et a l, 1993 a and b). Purification and cloning of 
the a-MSH receptor on brain microvascular endothelial cells would therefore provide a 
further insight into the structure and functions of this receptor.
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8. Ge n e r a l  D isc u ssio n
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Endothelial cell heterogeneity has been widely documented in the literature for in vivo, in 
vitro and in situ studies. Recent advances in the isolation techniques and culture 
conditions for organ-specific large vessel and microvessel endothelial cells has resulted in 
the examination of the diverse functions and structural features of endothelial cells. In 
this study, the isolation and growth of pure cultures of microvascular endothelial cells 
from the lungs of C57 mice provides the prospect of developing an in vitro model for the 
study of the endothelium with regard to extravasation of macromolecules and the role of 
the endothelium in metastasis of melanoma. Endothelial cells from murine tissues, 
however, are reported to be more sensitive to culture conditions than cells isolated from 
other species (Folkman et al., 1979).
The lung has the potential to provide a vast quantity of microvascular endothelial cells, 
however, due to its intricate structure and diversity of cell types, isolation of pure 
cultures of microvascular endothelial cells has proved to be an elaborate and time 
consuming exercise. The isolation of microvascular endothelial cells required initial 
detachment of the microvessels from the surrounding connective tissue followed by 
purification of the cultures, ensuring separation from large vessel endothelia and non- 
endothelial cell contaminants. The final technique established for the isolation and 
culture of murine lung microvascular endothelial cells was modified from several 
preliminary studies based on studies shown in the literature for isolation and culture of 
microvascular endothelial cells from various organs (Abbott et al., 1992; Nishida et al., 
1993; Belloni et al., 1992; Folkman et al., 1979; Zetter, 1984). Modification of the 
isolation technique and culture conditions was required in order to establish the optimum 
isolation and culture conditions.
The isolation and culture of brain microvascular endothelial cells provide a valuable 
model system for in vitro studies of the blood-brain barrier. Many investigations have 
been conducted into the structure and function of the blood-brain barrier due to its 
unique properties, including the regulation of the transport of nutrients, peptides and
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drugs. A wide variety of techniques have been established for the isolation and culture of 
brain microvascular endothelial cells from a number of different species (Bowman et al., 
1983; Audus and Borchardt 1986; Rupnick et al., 1988; Abbott et al., 1992; Dorovini- 
Zis et al., 1991; Tontsch and Bauer 1989). These methods involve a number of isolation 
techniques including homogenisation, density gradient centrifugation and cell sieving, as 
well as using a great variety of culture conditions and supplements. The aim of this and 
other studies is to determine the most suitable isolation and culture conditions which 
result in the production of high yields of pure microvascular endothelial cells in both 
primary culture and subcultivation which retain the properties of the brain endothelium in 
vivo.
The isolation technique and culture conditions are important in establishing pure cultures 
of microvascular endothelial cells. In this study, a similar procedure has been utilised for 
the isolation of brain and lung microvascular endothelial cells although several 
modifications have been employed in order to adapt to the differences in tissue 
composition. The culture conditions used satisfied the growth requirements for both cell 
types providing selective conditions for endothelial cell growth whilst maintaining cell 
morphology, homogeneity and several organ specific functions. The endothelial origin of 
the cells isolated from both brain and lung tissue was determined using a number of 
characterisation studies. Expression of Von Willebrand factor, uptake of acetylated 
LDL, electron microscopy and platelet adhesion studies supported the endothelial cell 
origin but did not indicate any organ specific differences. In contrast, differences in the 
morphology of brain and lung microvascular endothelial cells was apparent.
Morphological heterogeneity has been well documented in vivo and through in situ 
ultrastructural studies, however, contrasting opinions exist on the morphological 
heterogeneity of organ-derived microvascular endothelial cells in culture. Phenotypic 
variability was identified in cultures of cerebral microvascular endothelial cells by 
Rupnick et al. (1988). In contrast, Beer Stoltz and Jacobson (1991) found no
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morphological heterogeneity between microvascular endothelial cells isolated from 
bovine brain and adrenal medulla. Belloni et al. (1992) also found no morphological 
heterogeneity between microvascular endothelial cells isolated from murine brain, lung 
and liver. In this study, morphological heterogeneity was demonstrated between murine 
brain and lung microvascular endothelial cells. The use of the alternative culture 
conditions and extracellular matrices however, can have a marked effect on cell 
morphology. Therefore, optimisation of the growth conditions must be investigated in 
order to mimic microvascular cell morphology in vivo.
Biochemical heterogeneity between organ-specific microvascular endothelial cells has 
been well documented. A number of cell surface components have been identified such 
as cell specific glycoproteins (Belloni and Nicolson 1988; Beer Stoltz and Jacobson 
1991; Del Vecchio et a l, 1992) and cell surface antigens (Auerbach et a l, 1985) and 
receptors (Ryan 1989) which confirm the organ specificity of microvascular endothelial 
cells in culture. Due to the strategic position of the endothelium, these cell surface 
receptors could be exploited in drug targetting (Ryan 1989). These organ-specific 
differences can also be recognised by tumour cells which selectively adhere to the 
vascular endothelium in metastasis (Pauli et al., 1990; Zhu et al., 1991 and 1992). In 
this study the biochemical heterogeneity of organ-derived microvascular endothelial cells 
was demonstrated by the expression of an a-MSH receptor on brain microvascular 
endothelial cells which was absent on lung microvascular endothelial cells.
The expression of an a-MSH receptor on brain microvascular endothelial cells was 
initially identified using binding studies at 4°C. This indicated the existence of a very 
small population of MSH receptors where [125I-Tyr2, Nle4, D-Phe7] a-MSH displayed an 
estimated specific binding affinity (Kd) of 3.1 x 10_8M. Due to the low receptor number, 
a high proportion of non-specific binding was observed. This could be due to non­
specific binding to the plastic well and to proteins on the cell surface
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The existence of a specific binding site for a-MSH was confirmed by photoaffinity 
labelling. This identified the presence of a specific receptor with an apparent molecular 
mass of approximately 45kDa.
Brain microvascular endothelial cells have been shown to express a number of receptors 
such as insulin, low density lipoprotein and transferrin (Jeffries et al., 1984; Raub and 
Newton 1991). The receptor has the ability to bind and internalise the specific ligand 
through coated pits which exist on the plamsa membrane. Depending on the nature of 
the receptor-ligand complex, it follows one of four routes (Basu 1990): 1) the receptors 
recycled and ligands degraded (e.g. low density lipoprotein); 2) the receptors and ligands 
are both recycled (e.g. transferrin); 3) the receptors and ligands are degraded (e.g. 
epidermal growth factor) and 4) the receptors are degraded and the ligands are 
transported across the cell (e.g. immunoglobulin A and M). The receptor for a-MSH 
expressed on murine brain microvascular endothelial cells could have a similar fate to the 
transferrin receptors whereby the ligand is transported across the cell and the receptor is 
recycled. This could account for the binding profile of [125I-Tyr2, Nle4, D-Phe7] a-MSH 
to brain microvascular endothelial cells at 37°C where the increase in internalised ligand 
reaches a steady-state.
The physiological role of an a-MSH receptor on brain microvascular endothelial cells is 
unknown. In vivo studies have indicated that intravenously injected a-MSH reduces the 
regional permeability of the blood-brain barrier. These studies have suggested therefore, 
that the behavioural response of the melanocortin peptides may be partly as the result of 
selective actions on the blood-brain barrier. However, 0.01% of a quantity of 
peripherally injected a-MSH has been shown to reach the brain, since the 
biotransformation of the hormone correlates with behavioural activity. This suggests 
that small quantities of peptide can induce notable behavioural effects (Eberle 1988). As 
the in vivo uptake of a-MSH across the blood-brain barrier is small, it has been assumed 
that uptake is passive, however from the evidence presented in this study, it is possible
199
that uptake occurs via receptor mediated transcytosis by a small specific population of 
receptors on the microvascular endothelium.
Endothelial cell biology has been associated with a number of other areas of research 
including cancer research, drug targeting and immunology. The endothelium provides a 
highly specific anatomical barrier possessing specific cell surface receptors which could 
be exploited in drug delivery systems by selective transport of macromolecules 
throughout the vasculature. The pulmonary microvasculature for example, represents 
the majority of endothelial cells in the lung where many of the important functions 
attributable to the pulmonary vasculature occur. The blood-brain barrier in particular, 
provides a highly selective barrier limiting the access of macromolecules into the brain, 
and many studies have been conducted which attempt to overcome this barrier and 
selectively deliver therapeutic concentrations of drug. In addition, tumour angiogenesis 
and metastasis may also be attributable to the individual characteristics of organ-specific 
endothelial cells such as growth factor responses and expression of cell adhesion 
molecules.
The investigation of in vitro systems which mimic the organ specific endothelium have 
the potential to provide an insight into the role of the endothelium in metastasis of 
malignant tumours such as melanoma and in the regulation of specific carrier systems in 
drug delivery.
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